{
    "items": "224",
    "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
    "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
    "feed": [
        {
            "title": "Hold That Spinoff Stock: Selling Could Cost You Big",
            "url": "https://www.forbes.com/sites/jimosman/2024/02/04/hold-that-spinoff-stock-selling-could-cost-you-big/",
            "time_published": "20240204T160000",
            "authors": [
                "Jim Osman"
            ],
            "summary": "The legendary investor Peter Lynch once said, \"Invest in what you know.\" Lynch emphasized the importance of understanding the companies or investments you're involved in, suggesting that investors will make better decisions if they invest in industries or companies they're familiar with or have ...",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65beb7ef4281fc77cd49dc20/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999696"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.905476"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.682689"
                }
            ],
            "overall_sentiment_score": 0.338951,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MDLZ",
                    "relevance_score": "0.01978",
                    "ticker_sentiment_score": "0.069379",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KNF",
                    "relevance_score": "0.079",
                    "ticker_sentiment_score": "0.02953",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MO",
                    "relevance_score": "0.01978",
                    "ticker_sentiment_score": "0.069379",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNOW",
                    "relevance_score": "0.01978",
                    "ticker_sentiment_score": "0.021224",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.01978",
                    "ticker_sentiment_score": "0.054423",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.01978",
                    "ticker_sentiment_score": "0.130559",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BROS",
                    "relevance_score": "0.01978",
                    "ticker_sentiment_score": "0.021224",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.01978",
                    "ticker_sentiment_score": "0.069379",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ENOV",
                    "relevance_score": "0.039548",
                    "ticker_sentiment_score": "0.167857",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LOVE",
                    "relevance_score": "0.01978",
                    "ticker_sentiment_score": "0.021224",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZTS",
                    "relevance_score": "0.01978",
                    "ticker_sentiment_score": "0.069379",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FLEX",
                    "relevance_score": "0.01978",
                    "ticker_sentiment_score": "0.130559",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TOST",
                    "relevance_score": "0.01978",
                    "ticker_sentiment_score": "0.021224",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WOR",
                    "relevance_score": "0.01978",
                    "ticker_sentiment_score": "0.130559",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WS",
                    "relevance_score": "0.01978",
                    "ticker_sentiment_score": "0.130559",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PM",
                    "relevance_score": "0.01978",
                    "ticker_sentiment_score": "0.069379",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CXT",
                    "relevance_score": "0.079",
                    "ticker_sentiment_score": "0.103308",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.039548",
                    "ticker_sentiment_score": "0.060121",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDU",
                    "relevance_score": "0.098659",
                    "ticker_sentiment_score": "0.030886",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NXT(EXP20091224)",
                    "relevance_score": "0.01978",
                    "ticker_sentiment_score": "0.130559",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:NXT",
                    "relevance_score": "0.059292",
                    "ticker_sentiment_score": "0.101062",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2 Healthcare Dividend Kings to Buy and Hold Forever",
            "url": "https://www.fool.com/investing/2024/02/04/2-healthcare-dividend-kings-to-buy-and-hold-foreve/",
            "time_published": "20240204T132000",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "It's going to take a lot to interrupt these companies' streaks.",
            "banner_image": "https://g.foolcdn.com/editorial/images/762995/physicians-in-an-operating-room.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.905476"
                }
            ],
            "overall_sentiment_score": 0.189542,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ABT",
                    "relevance_score": "0.154455",
                    "ticker_sentiment_score": "0.085755",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.254573",
                    "ticker_sentiment_score": "-0.096638",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "AbbVie  ( ABBV )  Q4 Earnings Beat, Raises Sales View for Key Drugs",
            "url": "https://www.zacks.com/stock/news/2220511/abbvie-abbv-q4-earnings-beat-raises-sales-view-for-key-drugs",
            "time_published": "20240202T180400",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "AbbVie???s (ABBV) fourth-quarter earnings and sales beat estimates. Management hikes the 2027 forecast for new immunology drugs to more than $27 billion.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d5/8276.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.998645"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.12283,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "CHRS",
                    "relevance_score": "0.036926",
                    "ticker_sentiment_score": "-0.026577",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CERE",
                    "relevance_score": "0.036926",
                    "ticker_sentiment_score": "0.126273",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.288893",
                    "ticker_sentiment_score": "0.265849",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.146916",
                    "ticker_sentiment_score": "0.01294",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GMAB",
                    "relevance_score": "0.073773",
                    "ticker_sentiment_score": "0.26213",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.073773",
                    "ticker_sentiment_score": "0.131161",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "North America Cosmetic Surgery Market is Expected to Reach USD 29.2 billion, Advancing at a CAGR of 6.8% by 2031: Transparency Market Research, Inc.",
            "url": "https://www.benzinga.com/pressreleases/24/02/g36909586/north-america-cosmetic-surgery-market-is-expected-to-reach-usd-29-2-billion-advancing-at-a-cagr-of",
            "time_published": "20240202T140811",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Wilmington, Delaware, United States, Feb. 02, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The North America cosmetic surgery market is estimated to flourish at a CAGR of 6.8% from 2023 to 2031.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.430043,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MFCSF",
                    "relevance_score": "0.035502",
                    "ticker_sentiment_score": "0.25434",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.035502",
                    "ticker_sentiment_score": "0.05021",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.035502",
                    "ticker_sentiment_score": "0.366855",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "BHC",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "0.253102",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WMGTF",
                    "relevance_score": "0.106227",
                    "ticker_sentiment_score": "0.079304",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.035502",
                    "ticker_sentiment_score": "0.162941",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Dividend Aristocrat List 2024: 10 Highest-Yielding Stocks",
            "url": "https://www.forbes.com/sites/investor-hub/article/dividend-aristocrats-list/",
            "time_published": "20240201T171128",
            "authors": [
                "Catherine Brock"
            ],
            "summary": "Dividend Aristocrats List 2024: 10 Highest-Yielding Stocks Forbes ...",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65bbc5ef215138a41b2b7af7/0x0.jpg?format=jpg&crop=3316,1866,x0,y287,safe&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.249969,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.081691",
                    "ticker_sentiment_score": "0.146031",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DOV",
                    "relevance_score": "0.061315",
                    "ticker_sentiment_score": "0.087006",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IBM",
                    "relevance_score": "0.040899",
                    "ticker_sentiment_score": "0.101282",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.102013",
                    "ticker_sentiment_score": "0.153193",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WBA",
                    "relevance_score": "0.061315",
                    "ticker_sentiment_score": "-0.052164",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Biden Administration Starts Negotiations Over Medicare Drug Prices-Here's How Prices May Be Affected",
            "url": "https://www.forbes.com/sites/tylerroush/2024/02/01/biden-administration-starts-negotiations-over-medicare-drug-prices-heres-how-prices-may-be-affected/",
            "time_published": "20240201T155916",
            "authors": [
                "Ty Roush"
            ],
            "summary": "The Biden Administration started negotiations on Thursday with the manufacturers of 10 drugs widely used by older Americans, as part of an effort to cut prescription prices for the costliest medications covered by Medicare, which federal officials estimate could save the health program an ...",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65bbbf6b3630d3d86b3603b7/0x0.jpg?format=jpg&crop=2510,1410,x0,y0,safe&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": -0.040623,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.068896",
                    "ticker_sentiment_score": "-0.025316",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.068896",
                    "ticker_sentiment_score": "-0.025316",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.068896",
                    "ticker_sentiment_score": "-0.025316",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why ETF Yields Could Crash, And These 8%+ Payers Will Soar",
            "url": "https://www.forbes.com/sites/brettowens/2024/01/31/why-etf-yields-could-crash-and-these-8-payers-will-soar/",
            "time_published": "20240131T124500",
            "authors": [
                "Brett Owens"
            ],
            "summary": "This market bounce is strangling the payouts on everybody's favorite ETFs. But it's also given us a sweet setup to grab another group of funds kicking out big dividends, to the tune of 9%+ yields. Even better, many of these funds-wallflowers to \"popular-kid\" ETFs-were left off the invite list for ...",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65b3ebaadd4dc8c7a1cfb90b/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.147792,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.065061",
                    "ticker_sentiment_score": "0.149255",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.065061",
                    "ticker_sentiment_score": "0.149255",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.065061",
                    "ticker_sentiment_score": "0.149255",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.065061",
                    "ticker_sentiment_score": "0.149255",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat",
            "url": "https://www.cnbc.com/2024/01/30/healthy-returns-jj-merck-and-bristol-myers-squibb-in-the-hot-seat.html",
            "time_published": "20240130T185254",
            "authors": [
                "Ashley Capoot",
                "Annika Kim Constantino"
            ],
            "summary": "J&J, Merck and Bristol Myers Squibb face a pivotal few weeks ahead. Meanwhile, Apple will reportedly explore health applications for the Vision Pro headset.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107364710-17062139992021-11-18t014239z_377529114_rc2hwq9kgx1y_rtrmadp_0_merck-co-results.jpeg?v=1706214040&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Business",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.094894,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BMY",
                    "relevance_score": "0.15347",
                    "ticker_sentiment_score": "-0.00411",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.038592",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Blue Chip Stocks To Watch Ahead Of February 2024",
            "url": "https://stockmarket.com/featured/3-blue-chip-stocks-to-watch-ahead-of-february-2024-2024-01-30",
            "time_published": "20240130T155412",
            "authors": [
                "Joe Samuel"
            ],
            "summary": "Investing in the stock market offers individuals the opportunity to own a share of a company's assets and earnings. It's a way to grow wealth over time, though it comes with varying levels of risk.",
            "banner_image": "https://u3j7m9h7.rocketcdn.me/wp-content/uploads/2023/07/PG-stock.jpg",
            "source": "StockMarket.com",
            "category_within_source": "n/a",
            "source_domain": "stockmarket.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.998663"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.248002,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "IBM",
                    "relevance_score": "0.411656",
                    "ticker_sentiment_score": "0.411834",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.300946",
                    "ticker_sentiment_score": "0.227503",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.300946",
                    "ticker_sentiment_score": "0.355109",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Drug, Biotech Stocks' Q4 Earnings Due on Jan 31: NVO, NVS & GSK",
            "url": "https://www.zacks.com/stock/news/2217797/drug-biotech-stocks-q4-earnings-due-on-jan-31-nvo-nvs-gsk",
            "time_published": "20240130T140900",
            "authors": [
                "Ahan Chakraborty"
            ],
            "summary": "Let's look at three biotech/drug companies, NVO, NVS and GSK, slated to release quarterly results on Jan 31.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/34/973.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.224479,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NVS",
                    "relevance_score": "0.219809",
                    "ticker_sentiment_score": "0.103918",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GSK",
                    "relevance_score": "0.374714",
                    "ticker_sentiment_score": "0.159687",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.374714",
                    "ticker_sentiment_score": "0.176099",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.110973",
                    "ticker_sentiment_score": "0.255206",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "1 Mental Trick You Can Use If You Want to Invest in the S&P 500 but Don't Like the \"Magnificent Seven\"",
            "url": "https://www.fool.com/investing/2024/01/30/mental-trick-buy-market-magnificent-seven-stocks/",
            "time_published": "20240130T140300",
            "authors": [
                "Daniel Foelber"
            ],
            "summary": "These seven companies alone make up more than $12 trillion in value.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F761903%2Fcouple-planning-finances-budget-1200x800-5b2df79.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.244147,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.149192",
                    "ticker_sentiment_score": "0.188803",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.112182",
                    "ticker_sentiment_score": "0.176975",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.149192",
                    "ticker_sentiment_score": "0.193824",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.037504",
                    "ticker_sentiment_score": "0.107902",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.037504",
                    "ticker_sentiment_score": "0.136778",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.037504",
                    "ticker_sentiment_score": "0.136778",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.112182",
                    "ticker_sentiment_score": "0.142505",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.149192",
                    "ticker_sentiment_score": "0.188803",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.037504",
                    "ticker_sentiment_score": "0.136778",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.037504",
                    "ticker_sentiment_score": "0.136778",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.037504",
                    "ticker_sentiment_score": "0.136778",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.112182",
                    "ticker_sentiment_score": "0.169208",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.037504",
                    "ticker_sentiment_score": "0.136778",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Will Novo Nordisk Be a $1 Trillion Company by 2030?",
            "url": "https://www.fool.com/investing/2024/01/30/will-novo-nordisk-be-a-1-trillion-company-by-2030/",
            "time_published": "20240130T121500",
            "authors": [
                "Adam Spatacco"
            ],
            "summary": "Novo Nordisk's market cap has ballooned thanks to the overwhelming success of its Ozempic, Wegovy, and Rybelsus medications.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F762672%2Fdoctor-checking-blood-pressure.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.905476"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.289671,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NVO",
                    "relevance_score": "0.630923",
                    "ticker_sentiment_score": "0.426804",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.047749",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.047749",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.047749",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Wall Street's Greatest Dividend Stock Just Made History Again, and 99% of Investors Probably Don't Realize It Exists",
            "url": "https://www.fool.com/investing/2024/01/30/wall-street-greatest-dividend-stock-made-history/",
            "time_published": "20240130T102100",
            "authors": [
                "Sean Williams"
            ],
            "summary": "This virtually unknown company has been paying a consecutive dividend to its investors for more than 200 years.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F763000%2Fgetting-paid-dividends-getty.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.459462"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.191543,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "YORW",
                    "relevance_score": "0.190267",
                    "ticker_sentiment_score": "0.11675",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.114865",
                    "ticker_sentiment_score": "0.079162",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SWK",
                    "relevance_score": "0.114865",
                    "ticker_sentiment_score": "0.050688",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SWKH",
                    "relevance_score": "0.038407",
                    "ticker_sentiment_score": "0.065567",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.152741",
                    "ticker_sentiment_score": "0.231478",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.190267",
                    "ticker_sentiment_score": "0.132779",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.038407",
                    "ticker_sentiment_score": "0.151998",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "3 Perfect Stocks for Retirees to Buy Hand Over Fist in the New Bull Market",
            "url": "https://www.fool.com/investing/2024/01/30/3-perfect-stocks-for-retirees-buy-new-bull-market/",
            "time_published": "20240130T100600",
            "authors": [
                "Sean Williams"
            ],
            "summary": "These industry-leading, time-tested companies are ideal for retired investors.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F762966%2Fsenior-reading-financial-newspaper-invest-dividend-retire-money-getty.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999987"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.177882,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.027731",
                    "ticker_sentiment_score": "0.08153",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TWOH",
                    "relevance_score": "0.027731",
                    "ticker_sentiment_score": "0.028885",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "T",
                    "relevance_score": "0.271878",
                    "ticker_sentiment_score": "0.071518",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.297826",
                    "ticker_sentiment_score": "0.129413",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.137987",
                    "ticker_sentiment_score": "0.068015",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( NYSE:JNJ )  Downgraded to \"Buy\" at StockNews.com",
            "url": "https://www.defenseworld.net/2024/01/30/johnson-johnson-nysejnj-downgraded-to-buy-at-stocknews-com.html",
            "time_published": "20240130T084445",
            "authors": [
                "Defense World Staff"
            ],
            "summary": "StockNews.com lowered shares of Johnson & Johnson ( NYSE:JNJ - Free Report ) from a strong-buy rating to a buy rating in a research note published on Monday. Other analysts also recently issued research reports about the stock.",
            "banner_image": "https://www.marketbeat.com/logos/johnson--johnson-logo.png?v=20221020135923",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "www.defenseworld.net",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.752319"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.988915"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.243698,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "STT",
                    "relevance_score": "0.098255",
                    "ticker_sentiment_score": "0.17622",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.049221",
                    "ticker_sentiment_score": "0.057808",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.049221",
                    "ticker_sentiment_score": "0.057808",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.098255",
                    "ticker_sentiment_score": "0.17622",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.75914",
                    "ticker_sentiment_score": "0.398076",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Antibody drug conjugates focus draws global pharma giants attention to China, says GlobalData",
            "url": "https://www.financialexpress.com/healthcare/pharma-healthcare/antibody-drug-conjugates-focus-draws-global-pharma-giants-attention-to-china-says-globaldata/3377889/",
            "time_published": "20240130T023000",
            "authors": [
                "Health Desk"
            ],
            "summary": "Antibody-drug conjugates ( ADCs ) represent a significant breakthrough in targeted cancer therapy. By blending the specificity of monoclonal antibodies with the potency of cytotoxic drugs, ADCs offer a targeted approach to cancer treatment, minimizing the damage to healthy cells.",
            "banner_image": "https://www.financialexpress.com/wp-content/uploads/2024/01/syring_b22200.jpg",
            "source": "The Financial Express",
            "category_within_source": "n/a",
            "source_domain": "www.financialexpress.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.169481,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GLDAF",
                    "relevance_score": "0.194242",
                    "ticker_sentiment_score": "0.047814",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EXEL",
                    "relevance_score": "0.097854",
                    "ticker_sentiment_score": "0.031578",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.097854",
                    "ticker_sentiment_score": "0.031578",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADAG",
                    "relevance_score": "0.097854",
                    "ticker_sentiment_score": "0.031578",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BNTX",
                    "relevance_score": "0.097854",
                    "ticker_sentiment_score": "0.031578",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.097854",
                    "ticker_sentiment_score": "0.031578",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study",
            "url": "https://www.globenewswire.com/news-release/2024/01/29/2819438/0/en/Nanobiotix-Announces-Achievement-of-20M-Development-Milestone-Payment-Related-to-Ongoing-Global-Phase-3-Head-and-Neck-Cancer-Study.html",
            "time_published": "20240129T211500",
            "authors": [
                "Nanobiotix S.A."
            ],
            "summary": "PARIS and CAMBRIDGE, Mass., Jan. 29, 2024 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext : NANO -- NASDAQ: NBTX - the ''Company'' ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced ...",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/36fb7b98-27d7-46cb-b989-fa31626657b8",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.071739,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NBTX",
                    "relevance_score": "0.534927",
                    "ticker_sentiment_score": "0.076567",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.038843",
                    "ticker_sentiment_score": "-0.005935",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:NANO",
                    "relevance_score": "0.038843",
                    "ticker_sentiment_score": "-0.005935",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study - Nanobiotix  ( NASDAQ:NBTX ) ",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36833599/nanobiotix-announces-achievement-of-20m-development-milestone-payment-related-to-ongoing-global-ph",
            "time_published": "20240129T211500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "PARIS and CAMBRIDGE, Mass., Jan. 29, 2024 ( GLOBE NEWSWIRE ) -- NANOBIOTIX NBTX, a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced achievement of operational requirements in NANORAY-312, an ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": 0.069285,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NBTX",
                    "relevance_score": "0.558976",
                    "ticker_sentiment_score": "0.075064",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.038407",
                    "ticker_sentiment_score": "-0.00593",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Cartilage Degeneration Market Size Is Expected To Reach A Value Of More Than $15 Billion By 2028 As Per The Business Research Company's Cartilage Degeneration Global Market Report 2024",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36828226/cartilage-degeneration-market-size-is-expected-to-reach-a-value-of-more-than-15-billion-by-2028-as",
            "time_published": "20240129T163000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LONDON, Jan. 29, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Cartilage Degeneration Global Market Report 2024, the global cartilage degeneration market has witnessed a substantial upswing, with the market size surging from $11.88 billion in 2023 to $12.63 billion in 2024, ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.130274,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.116631",
                    "ticker_sentiment_score": "0.053561",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.058472",
                    "ticker_sentiment_score": "0.047017",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.058472",
                    "ticker_sentiment_score": "0.047017",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.058472",
                    "ticker_sentiment_score": "0.047017",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson To Pay $149M In Opioid Settlement, Washington State AG Says 'We Are Not Done' - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/markets/cannabis/24/01/36828018/johnson-johnson-to-pay-149m-in-opioid-settlement-washington-state-ag-says-we-are-not-done",
            "time_published": "20240129T161942",
            "authors": [
                "Nina Zdinjak"
            ],
            "summary": "Opioid producer and raw material supplier Johnson & Johnson JNJ reached a settlement last week in an opioid lawsuit with Washington state.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/New-Project-124.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": -0.078188,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.331765",
                    "ticker_sentiment_score": "-0.067945",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( JNJ )  Is a Trending Stock: Facts to Know Before Betting on It",
            "url": "https://www.zacks.com/stock/news/2216975/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it",
            "time_published": "20240129T140009",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default318.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.5855"
                }
            ],
            "overall_sentiment_score": 0.22202,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.474082",
                    "ticker_sentiment_score": "0.150631",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Better Buy in 2024: The \"Magnificent Seven\" or the \"Terrific 10\"?",
            "url": "https://www.fool.com/investing/2024/01/29/better-buy-the-magnificent-seven-or-terrific-ten/",
            "time_published": "20240129T112600",
            "authors": [
                "Daniel Foelber"
            ],
            "summary": "The financial and healthcare sectors make up a massive amount of the market.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F762431%2Fgettyimages-1419726675-1201x633-65d4be6.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999956"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.857896"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.333127,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.068995",
                    "ticker_sentiment_score": "0.101721",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.03453",
                    "ticker_sentiment_score": "0.122273",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVGO",
                    "relevance_score": "0.03453",
                    "ticker_sentiment_score": "0.201917",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.068995",
                    "ticker_sentiment_score": "0.120472",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.137474",
                    "ticker_sentiment_score": "0.163389",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.068995",
                    "ticker_sentiment_score": "0.111863",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.204936",
                    "ticker_sentiment_score": "0.271149",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.068995",
                    "ticker_sentiment_score": "0.101721",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.03453",
                    "ticker_sentiment_score": "0.122273",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MA",
                    "relevance_score": "0.171363",
                    "ticker_sentiment_score": "0.256013",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.03453",
                    "ticker_sentiment_score": "0.103812",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.068995",
                    "ticker_sentiment_score": "0.144218",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.137474",
                    "ticker_sentiment_score": "0.127343",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.238133",
                    "ticker_sentiment_score": "0.303144",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HD",
                    "relevance_score": "0.171363",
                    "ticker_sentiment_score": "0.277563",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Dementia and Movement Disorder Treatment Market to Grow by USD 8.55 billion, Market Share, Trends, and Growth ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/dementia-and-movement-disorder-treatment-market-to-grow-by-usd-8-55-billion-market-share-trends-and-growth-analysis----technavio-302045378.html",
            "time_published": "20240129T101500",
            "authors": [],
            "summary": "Dementia and Movement Disorder Treatment Market to Grow by USD 8.55 billion, Market Share, Trends, and Growth ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.263428,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "0.125702",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NBIX",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "0.125702",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SUPN",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "0.125702",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "0.125702",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "0.125702",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KNBWF",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "0.125702",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMRX",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "0.125702",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OGN",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "0.125702",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ACOR",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "0.125702",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "0.125702",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BHC",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "0.125702",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UCBJF",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "0.125702",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ESALF",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "0.125702",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "0.125702",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why It Matters That Consumers Are So Enraged By The Kyte Baby Debacle",
            "url": "https://www.forbes.com/sites/soniathompson/2024/01/28/why-it-matters-that-consumers-are-so-enraged-by-the-kyte-baby-debacle/",
            "time_published": "20240128T164903",
            "authors": [
                "Sonia Thompson"
            ],
            "summary": "Data shows that 71% of consumers want to know the brands they buy from are aligned with their values. And increasingly, real life examples continue to pop up that showcase consumers exercising their credit card activism by refusing to support brands that they feel are either not aligned with ...",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65b57ab57a268cd588be5e5c/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.331783,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.043342",
                    "ticker_sentiment_score": "0.081831",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "20 \"Tech\" Stocks Make Up Over 35% of the S&P 500. Here's What That Means for Your Portfolio.",
            "url": "https://www.fool.com/investing/2024/01/28/20-tech-stocks-sp-500-buy-2024-invest/",
            "time_published": "20240128T152000",
            "authors": [
                "Daniel Foelber"
            ],
            "summary": "The stock market isn't what it used to be.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F762430%2Fgettyimages-1190875206-1201x801-d21b45d.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.133088,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.087027",
                    "ticker_sentiment_score": "0.074589",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.087027",
                    "ticker_sentiment_score": "0.042305",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.043579",
                    "ticker_sentiment_score": "0.1158",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVGO",
                    "relevance_score": "0.043579",
                    "ticker_sentiment_score": "0.18538",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.043579",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CSCO",
                    "relevance_score": "0.043579",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.043579",
                    "ticker_sentiment_score": "0.1158",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.087027",
                    "ticker_sentiment_score": "-0.007225",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.130217",
                    "ticker_sentiment_score": "-0.007077",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TXN",
                    "relevance_score": "0.043579",
                    "ticker_sentiment_score": "0.18538",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.043579",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.043579",
                    "ticker_sentiment_score": "-0.003913",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.130217",
                    "ticker_sentiment_score": "0.046066",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.087027",
                    "ticker_sentiment_score": "0.042305",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MA",
                    "relevance_score": "0.043579",
                    "ticker_sentiment_score": "-0.003913",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QCOM",
                    "relevance_score": "0.043579",
                    "ticker_sentiment_score": "0.18538",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.043579",
                    "ticker_sentiment_score": "-0.011761",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NOW",
                    "relevance_score": "0.043579",
                    "ticker_sentiment_score": "0.18538",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.087027",
                    "ticker_sentiment_score": "-0.007225",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.130217",
                    "ticker_sentiment_score": "-0.007077",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMD",
                    "relevance_score": "0.043579",
                    "ticker_sentiment_score": "0.18538",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HD",
                    "relevance_score": "0.043579",
                    "ticker_sentiment_score": "-0.003913",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.043579",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.087027",
                    "ticker_sentiment_score": "-0.009277",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.043579",
                    "ticker_sentiment_score": "0.050725",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs",
            "url": "https://www.cnbc.com/2024/01/28/big-pharma-merck-bristol-myers-jj-prepare-to-lose-revenue.html",
            "time_published": "20240128T130001",
            "authors": [
                "Annika Kim Constantino"
            ],
            "summary": "Fast-approaching patent expirations will take a bite out of revenues and put the industry's top players in the hot seat over the next few years.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107343469-1701804491567-JJ-OB-Photo-ACJ-PRESS-1.jpg?v=1701804667&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Business",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999993"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.007249,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "HESG",
                    "relevance_score": "0.021427",
                    "ticker_sentiment_score": "0.115639",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.021427",
                    "ticker_sentiment_score": "-0.120651",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KRTX",
                    "relevance_score": "0.021427",
                    "ticker_sentiment_score": "0.076984",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SKXJF",
                    "relevance_score": "0.021427",
                    "ticker_sentiment_score": "-0.049995",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALVO",
                    "relevance_score": "0.021427",
                    "ticker_sentiment_score": "0.054415",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.042838",
                    "ticker_sentiment_score": "-0.019872",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSKYF",
                    "relevance_score": "0.021427",
                    "ticker_sentiment_score": "-0.049995",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.085553",
                    "ticker_sentiment_score": "0.030376",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Want to Invest $1,000 in the \"Magnificent Seven?\" Invest This Amount in an S&P 500 Index Fund",
            "url": "https://www.fool.com/investing/2024/01/28/invest-magnificent-seven-stock-sp-500-fund/",
            "time_published": "20240128T125500",
            "authors": [
                "Daniel Foelber"
            ],
            "summary": "The stock market has become more concentrated than ever before.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F762009%2Fmeeting-business-financial-planning-woman-wheelchair-disability-1200x800-5b2df79.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.99986"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.375374,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.050786",
                    "ticker_sentiment_score": "0.092402",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.050786",
                    "ticker_sentiment_score": "0.038918",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.101367",
                    "ticker_sentiment_score": "0.041458",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.050786",
                    "ticker_sentiment_score": "0.188381",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AVGO",
                    "relevance_score": "0.050786",
                    "ticker_sentiment_score": "0.038918",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.050786",
                    "ticker_sentiment_score": "0.188381",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.050786",
                    "ticker_sentiment_score": "0.096735",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.050786",
                    "ticker_sentiment_score": "0.096735",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TXN",
                    "relevance_score": "0.050786",
                    "ticker_sentiment_score": "0.038918",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.050786",
                    "ticker_sentiment_score": "0.096735",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.101367",
                    "ticker_sentiment_score": "0.041458",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.050786",
                    "ticker_sentiment_score": "0.188381",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MA",
                    "relevance_score": "0.050786",
                    "ticker_sentiment_score": "0.096735",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QCOM",
                    "relevance_score": "0.050786",
                    "ticker_sentiment_score": "0.038918",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NOW",
                    "relevance_score": "0.050786",
                    "ticker_sentiment_score": "0.038918",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.050786",
                    "ticker_sentiment_score": "0.096735",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.050786",
                    "ticker_sentiment_score": "0.096735",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMD",
                    "relevance_score": "0.050786",
                    "ticker_sentiment_score": "0.038918",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HD",
                    "relevance_score": "0.050786",
                    "ticker_sentiment_score": "0.096735",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Investing Has Its Own Lingo. We'll Help You Understand It.",
            "url": "https://www.fool.com/investing/2024/01/28/investing-has-its-own-lingo-well-help-you-understa/",
            "time_published": "20240128T092500",
            "authors": [
                "Motley Fool Staff"
            ],
            "summary": "We're here to make you smarter, happier, and richer, and today we're focusing on the smarter part.",
            "banner_image": "https://g.foolcdn.com/editorial/images/760956/image.jpeg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": 0.166031,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HMELF",
                    "relevance_score": "0.004249",
                    "ticker_sentiment_score": "-0.025413",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.004249",
                    "ticker_sentiment_score": "0.040853",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.004249",
                    "ticker_sentiment_score": "0.040853",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CWH",
                    "relevance_score": "0.004249",
                    "ticker_sentiment_score": "-0.005172",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.008497",
                    "ticker_sentiment_score": "0.14092",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.004249",
                    "ticker_sentiment_score": "0.136298",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NYT",
                    "relevance_score": "0.004249",
                    "ticker_sentiment_score": "0.162933",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Better Growth Stock: UnitedHealth Group vs. Johnson & Johnson",
            "url": "https://www.fool.com/investing/2024/01/27/better-growth-stock-unitedhealth-group-vs-johnson/",
            "time_published": "20240127T151500",
            "authors": [
                "David Jagielski"
            ],
            "summary": "These companies have been focusing on growing their operations, but which stock is likely to provide investors with better returns?",
            "banner_image": "https://g.foolcdn.com/editorial/images/762088/a-doctor-looking-at-a-tablet-with-another-person.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.961735"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.240472,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "0.141107",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.473427",
                    "ticker_sentiment_score": "0.489705",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.365166",
                    "ticker_sentiment_score": "0.24848",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Should You Buy the Dogs of the Dow in 2024?",
            "url": "https://www.fool.com/investing/2024/01/27/should-you-buy-the-dogs-of-the-dow-in-2024/",
            "time_published": "20240127T115900",
            "authors": [
                "Jeremy Bowman"
            ],
            "summary": "The popular dividend-investing strategy has been around for years. Is it right for you?",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F762238%2Fman-holding-cash-dividends.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.989041"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.192136,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.134527",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.129168",
                    "ticker_sentiment_score": "0.089459",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.134527",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.134527",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "AMBRX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ambrx Biopharma, Inc. - AMAM",
            "url": "https://www.prnewswire.com/news-releases/ambrx-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick--foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-ambrx-biopharma-inc---amam-302046072.html",
            "time_published": "20240127T041700",
            "authors": [
                "Kahn Swick & Foti",
                "LLC"
            ],
            "summary": "AMBRX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/2170784/Latest_KSF_M_A_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.210541,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.451494",
                    "ticker_sentiment_score": "0.195991",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.451494",
                    "ticker_sentiment_score": "0.195991",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Global Pompe Disease Drugs Market: USD 294.7 Million Growth Forecasted at a CAGR of 4.16% between 2024 to ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/global-pompe-disease-drugs-market-usd-294-7-million-growth-forecasted-at-a-cagr-of-4-16-between-2024-to-2028--technavio-302045515.html",
            "time_published": "20240126T233100",
            "authors": [],
            "summary": "Global Pompe Disease Drugs Market: USD 294.7 Million Growth Forecasted at a CAGR of 4.16% between 2024 to ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.350011,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "FOLD",
                    "relevance_score": "0.051774",
                    "ticker_sentiment_score": "0.080886",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAYZF",
                    "relevance_score": "0.051774",
                    "ticker_sentiment_score": "0.080886",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.051774",
                    "ticker_sentiment_score": "0.080886",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALPMF",
                    "relevance_score": "0.051774",
                    "ticker_sentiment_score": "0.080886",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVRO",
                    "relevance_score": "0.051774",
                    "ticker_sentiment_score": "0.080886",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JCRRF",
                    "relevance_score": "0.051774",
                    "ticker_sentiment_score": "0.080886",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.051774",
                    "ticker_sentiment_score": "0.080886",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices",
            "url": "https://www.cnbc.com/2024/01/26/merck-jj-ceos-agree-to-testify-in-senate-hearing-on-drug-prices-.html",
            "time_published": "20240126T211709",
            "authors": [
                "Annika Kim Constantino"
            ],
            "summary": "The CEOs of Merck, Johnson & Johnson and Bristol Myers Squibb will testify at the hearing on drug prices, Sen. Bernie Sanders said.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107255764-1686668756779-gettyimages-1235403027-AFP_9NA2ZY.jpeg?v=1686668795&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.03827,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "0.126295",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "0.052216",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "S&P 500 Dividend Aristocrats: Who's Out, Who's In",
            "url": "https://www.kiplinger.com/investing/sandp-500-dividend-aristocrats-whos-out-whos-in",
            "time_published": "20240126T195530",
            "authors": [
                "Dan Burrows"
            ],
            "summary": "The S&P 500 Dividend Aristocrats index looks only a little different as we head into the new year. Widely regarded as some of the best dividend stocks for dependable dividend growth, the S&P 500 Dividend Aristocrats is an index of S&P 500 companies that have raised their dividends for at least 25 ...",
            "banner_image": "https://cdn.mos.cms.futurecdn.net/x82x4uLxyhXNtrHX8yMU9R-415-80.jpg",
            "source": "Kiplinger",
            "category_within_source": "n/a",
            "source_domain": "www.kiplinger.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.98396"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.181501,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.178459",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VFC",
                    "relevance_score": "0.178459",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FAST",
                    "relevance_score": "0.348103",
                    "ticker_sentiment_score": "0.165383",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.178459",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WBA",
                    "relevance_score": "0.264897",
                    "ticker_sentiment_score": "-0.043928",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Stocks Rally Amid Big Earnings, Economic Data: Weekly Review",
            "url": "https://www.investors.com/news/stock-market-continues-to-rally-asml-netflix-tesla-intel-are-big-earnings-movers-weekly-review/",
            "time_published": "20240126T172900",
            "authors": [
                "IBD STAFF",
                "Investor's Business Daily"
            ],
            "summary": "Stock Market Continues To Rally. ASML, Netflix, Tesla, Intel Are Big Earnings Movers: Weekly Review Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/06/Stock-teslafrontnose-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.928139"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999897"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.08166,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "PCAR",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "0.013004",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "-0.067699",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "0.023613",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TEX",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "0.143388",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.060287",
                    "ticker_sentiment_score": "0.075292",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AWON",
                    "relevance_score": "0.020113",
                    "ticker_sentiment_score": "0.035033",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TXN",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "-0.107406",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "URI",
                    "relevance_score": "0.12023",
                    "ticker_sentiment_score": "0.159096",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TXT",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "0.202956",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "0.074287",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.080323",
                    "ticker_sentiment_score": "-0.014907",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNP",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "-0.224991",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.080323",
                    "ticker_sentiment_score": "-0.021101",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRCX",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "-0.107406",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SAVE",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "-0.13454",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GD",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "0.202956",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "0.035632",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NSC",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "-0.224991",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "KLAC",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "-0.107406",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.12023",
                    "ticker_sentiment_score": "0.084831",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HUM",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "0.124534",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NOC",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "0.202956",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAH",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "0.202956",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAL",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "-0.067699",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TMUS",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "0.036945",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "0.202956",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "-0.038213",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "0.143388",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NOW",
                    "relevance_score": "0.020113",
                    "ticker_sentiment_score": "0.105654",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.060287",
                    "ticker_sentiment_score": "0.118296",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "0.036031",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FCX",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "-0.163211",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "BRO",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "0.078443",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TAL",
                    "relevance_score": "0.060287",
                    "ticker_sentiment_score": "0.024078",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "-0.067699",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNI",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "-0.224991",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "The U.S. has no federal bereavement leave. What to know about options at work when someone you love dies",
            "url": "https://www.cnbc.com/2024/01/26/what-to-know-about-bereavement-leave-at-work-when-someone-you-love-dies.html",
            "time_published": "20240126T144540",
            "authors": [
                "Annie Nova"
            ],
            "summary": "The U.S. has no federal bereavement leave policy, but workers in mourning still have options. Here's what they should know.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107363343-1706043979763-gettyimages-1368009967-cha09884.jpeg?v=1706044002&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.230792,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.057767",
                    "ticker_sentiment_score": "0.092237",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Key Takeaways From JNJ's  ( JNJ )  Q4 Earnings Presentation",
            "url": "https://www.zacks.com/stock/news/2216453/key-takeaways-from-jnjs-jnj-q4-earnings-presentation",
            "time_published": "20240126T143000",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "J&J's (JNJ) Innovative Medicines as well as MedTech units outperform expectations in the fourth quarter. Here we discuss some highlights of its performance in the fourth quarter.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7d/1177.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.838487"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.211414,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "0.145984",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "0.123283",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "0.060868",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "When You Make A Mistake Take Responsibility",
            "url": "https://www.forbes.com/sites/jerryweissman/2024/01/26/when-you-make-a-mistake-take-responsibility/",
            "time_published": "20240126T140000",
            "authors": [
                "Jerry Weissman"
            ],
            "summary": "Boeing CEO David Calhoun and San Francisco Forty-Niner quarterback Brock Purdy have something in common: each of them took responsibility for their mistakes.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65b041aab8bc7aa159ef55c9/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": -0.074609,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.090816",
                    "ticker_sentiment_score": "0.020395",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UBER",
                    "relevance_score": "0.090816",
                    "ticker_sentiment_score": "0.020395",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.090816",
                    "ticker_sentiment_score": "0.020395",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.18046",
                    "ticker_sentiment_score": "-0.010155",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.090816",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Men's Skincare Products Market to Acquire a Size of USD 24,824.0 Million By 2030, According to Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36796496/mens-skincare-products-market-to-acquire-a-size-of-usd-24-824-0-million-by-2030-according-to-persi",
            "time_published": "20240126T084404",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 26, 2024 ( GLOBE NEWSWIRE ) -- Men's skincare products industry is a rapidly expanding and continually evolving sector that specializes in creating and distributing personal care products tailored for men's skin.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.30447,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.028456",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.028456",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Kuehn Law Encourages CPE, ROVR, AMAM, and JNPR Investors to Contact Law Firm - Ambrx Biopharma  ( NASDAQ:AMAM ) , Callon Petroleum  ( NYSE:CPE ) ",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36789166/kuehn-law-encourages-cpe-rovr-amam-and-jnpr-investors-to-contact-law-firm",
            "time_published": "20240125T202304",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "NEW YORK, Jan. 25, 2024 ( GLOBE NEWSWIRE ) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.955357"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.296649,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HPQ",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "0.266682",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CPE",
                    "relevance_score": "0.210274",
                    "ticker_sentiment_score": "0.344039",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "APA",
                    "relevance_score": "0.210274",
                    "ticker_sentiment_score": "0.344039",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.210274",
                    "ticker_sentiment_score": "0.478271",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "BX",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "0.051759",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "0.336739",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates AMAM, HARP, JNPR, TARO - Ambrx Biopharma  ( NASDAQ:AMAM ) , Harpoon Therapeutics  ( NASDAQ:HARP ) ",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36778188/shareholder-notice-halper-sadeh-llc-investigates-amam-harp-jnpr-taro",
            "time_published": "20240125T130347",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "NEW YORK, Jan. 25, 2024 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Ambrx Biopharma, Inc.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.06938,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "HPQ",
                    "relevance_score": "0.140896",
                    "ticker_sentiment_score": "0.102747",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNPR",
                    "relevance_score": "0.140896",
                    "ticker_sentiment_score": "0.102747",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TARO",
                    "relevance_score": "0.140896",
                    "ticker_sentiment_score": "0.011348",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.140896",
                    "ticker_sentiment_score": "0.095371",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HARP",
                    "relevance_score": "0.140896",
                    "ticker_sentiment_score": "0.095371",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.140896",
                    "ticker_sentiment_score": "0.095371",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Better Dividend Stock to Buy Now: Johnson & Johnson vs. Verizon",
            "url": "https://www.fool.com/investing/2024/01/25/better-dividend-stock-to-buy-now-johnson-johnson-v/",
            "time_published": "20240125T121900",
            "authors": [
                "Cory Renauer"
            ],
            "summary": "Both recently reported results from the fourth quarter of 2023 and their performances could hardly look more different.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F762457%2Finvestor-dark-room-devices-getty.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.990999"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999919"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.120029,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "VZ",
                    "relevance_score": "0.43852",
                    "ticker_sentiment_score": "0.385345",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.203643",
                    "ticker_sentiment_score": "0.175527",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "UAW endorses Joe Biden; Ohio bans gender-affirming care for minors",
            "url": "https://www.economist.com/in-brief/2024/01/25/uaw-endorses-joe-biden-ohio-bans-gender-affirming-care-for-minors",
            "time_published": "20240125T055405",
            "authors": [
                "The Economist"
            ],
            "summary": "UAW endorses Joe Biden. Ohio bans gender-affirming care for minors The Economist ...",
            "banner_image": "https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20240113_BLP599.jpg",
            "source": "The Economist",
            "category_within_source": "BusinessGoogleRSS",
            "source_domain": "www.economist.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.108222,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BA",
                    "relevance_score": "0.068112",
                    "ticker_sentiment_score": "0.002027",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.068112",
                    "ticker_sentiment_score": "-0.055308",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "UAW endorses Joe Biden; Ohio bans gender-affirming care for minors",
            "url": "https://www.economist.com/news/2024/01/25/uaw-endorses-joe-biden-ohio-bans-gender-affirming-care-for-minors",
            "time_published": "20240125T055405",
            "authors": [
                "The Economist"
            ],
            "summary": "UAW endorses Joe Biden. Ohio bans gender-affirming care for minors The Economist ...",
            "banner_image": "https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20240113_BLP599.jpg",
            "source": "The Economist",
            "category_within_source": "BusinessGoogleRSS",
            "source_domain": "www.economist.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.110579,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BA",
                    "relevance_score": "0.067536",
                    "ticker_sentiment_score": "0.002025",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.067536",
                    "ticker_sentiment_score": "-0.055246",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "UAW endorses Joe Biden; Trump on the attack",
            "url": "https://www.economist.com/in-brief/2024/01/25/uaw-endorses-joe-biden-trump-on-the-attack",
            "time_published": "20240125T055405",
            "authors": [
                "The Economist"
            ],
            "summary": "UAW endorses Joe Biden. Ohio bans gender-affirming care for minors The Economist ...",
            "banner_image": "https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20240113_BLP599.jpg",
            "source": "The Economist",
            "category_within_source": "FinanceGoogleRSS",
            "source_domain": "www.economist.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.100782,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.06623",
                    "ticker_sentiment_score": "0.102332",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.06623",
                    "ticker_sentiment_score": "-0.055112",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - AMAM, CSTR, RYZB, THRX",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36769662/stockholder-alert-the-m-a-class-action-firm-continues-investigating-the-merger-amam-cstr-ryzb-thrx",
            "time_published": "20240124T221658",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "NEW YORK, Jan. 24, 2024 ( GLOBE NEWSWIRE ) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC ( the \"M&A Class Action Firm\" ) , a national securities firm rated Top 50 in the 2018-2022 ISS Securities Class Action Services Report and ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.928769"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.348873,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CSTR",
                    "relevance_score": "0.269033",
                    "ticker_sentiment_score": "0.312256",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ONB",
                    "relevance_score": "0.068502",
                    "ticker_sentiment_score": "0.15954",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.269033",
                    "ticker_sentiment_score": "0.251355",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.068502",
                    "ticker_sentiment_score": "0.127176",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RYZB",
                    "relevance_score": "0.269033",
                    "ticker_sentiment_score": "0.239471",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "THRX",
                    "relevance_score": "0.269033",
                    "ticker_sentiment_score": "0.22137",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.068502",
                    "ticker_sentiment_score": "0.121075",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Washington state reaches a nearly $150 million settlement with Johnson & Johnson over opioid crisis",
            "url": "https://apnews.com/article/washington-opioids-johnson-johnson-settlement-58038e4877ca7b9bf458c54e110b12d8",
            "time_published": "20240124T210000",
            "authors": [
                "HALLIE GOLDEN",
                "MANUEL VALDES"
            ],
            "summary": "OLYMPIA, Wash. ( AP ) - The Washington state attorney general announced a $149.5 million settlement Wednesday with drugmaker Johnson & Johnson, more than four years after the state sued the company over its role fueling the opioid addiction crisis. \"They knew what the harm was.",
            "banner_image": "https://dims.apnews.com/dims4/default/5ab57e4/2147483647/strip/true/crop/5251x3498+0+2/resize/599x399!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2Fe2%2F2c%2F18c43a66a30e9451dfdf08f8f1e7%2F06280d5432514991b45bd245d9114d02",
            "source": "Associated Press",
            "category_within_source": "Business",
            "source_domain": "apnews.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.080233,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "-0.023132",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Gilead's Tecartus Dropped From FDA List Of CAR-T Therapy With Updated Label Warning Of \"Risks Of Secondary Cancer' - Gilead Sciences  ( NASDAQ:GILD ) ",
            "url": "https://www.benzinga.com/general/biotech/24/01/36760938/gileads-tecartus-dropped-from-fda-list-of-car-t-therapy-with-updated-label-warning-of-risks-of-se",
            "time_published": "20240124T153609",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Tuesday, the FDA announced to impose a classwide black box warning following its investigation into secondary T-cell cancers arising from the use of existing CAR-T therapies.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Gilead_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.07904,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GILD",
                    "relevance_score": "0.353898",
                    "ticker_sentiment_score": "-0.336118",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "LEGN",
                    "relevance_score": "0.12165",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.240489",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.240489",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Stock Market News for Jan 24, 2024",
            "url": "https://www.zacks.com/stock/news/2214906/stock-market-news-for-jan-24-2024",
            "time_published": "20240124T142100",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Wall Street closed mixed on Tuesday on strong to mixed quarterly earnings.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/9b/2956.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.682689"
                }
            ],
            "overall_sentiment_score": 0.040916,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LMT",
                    "relevance_score": "0.188928",
                    "ticker_sentiment_score": "0.069195",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.188928",
                    "ticker_sentiment_score": "0.069195",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "What's Going On Johnson & Johnson Stock Today? - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/general/biotech/24/01/36755938/whats-going-on-johnson-johnson-stock-today",
            "time_published": "20240124T125416",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Tuesday, Johnson & Johnson JNJ released better-than-expected earnings for its fourth quarter of 2023. It reported quarterly adjusted earnings of $2.29 per share, up 11.7% year-over-year, beating the consensus of $2.28. Sales increased 7.3% Y/Y to $21.4 billion, beating the consensus of $20.99 ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Johnson-and-Johnson.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.917436"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.043897,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.219809",
                    "ticker_sentiment_score": "0.065799",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.671304",
                    "ticker_sentiment_score": "-0.079756",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Nasdaq, S&P 500 Futures Jump As Wall Street Eagerly Awaits Tesla's Q4 Earnings: Analyst Says Rally Broadening But Favors These Stocks - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",
            "url": "https://www.benzinga.com/news/earnings/24/01/36755805/nasdaq-s-p-500-futures-jump-as-wall-street-eagerly-awaits-teslas-q4-earnings-analyst-says-rally-bro",
            "time_published": "20240124T124145",
            "authors": [
                "Shanthi Rexaline"
            ],
            "summary": "U.S. stock futures indicate a positive opening on Wednesday, buoyed by strong earnings reports from Netflix, Inc. NFLX and semiconductor equipment maker ASML Holding N.V. ASML. Investors are eagerly awaiting Tesla, Inc.'s TSLA fourth-quarter results, which are expected to take center stage.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Wall-Street-US-Stocks.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.967645"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.928139"
                }
            ],
            "overall_sentiment_score": 0.181687,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.172919",
                    "ticker_sentiment_score": "0.108241",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KMB",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "-0.100818",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TXN",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "-0.139714",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.220007",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MMM",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "-0.100818",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ASML",
                    "relevance_score": "0.172919",
                    "ticker_sentiment_score": "0.185069",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.175759",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "T",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BACHY",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.123025",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FCX",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GD",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "-0.139714",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WT",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.206003",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "FOREX:EUR",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.175",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Investor Optimism Improves Following Earnings Reports; S&P 500 Reaches Another High - Abbott Laboratories  ( NYSE:ABT ) , IBM  ( NYSE:IBM ) ",
            "url": "https://www.benzinga.com/news/earnings/24/01/36752497/investor-optimism-improves-following-earnings-reports-s-p-500-reaches-another-high",
            "time_published": "20240124T084959",
            "authors": [
                "Avi Kapoor"
            ],
            "summary": "The CNN Money Fear and Greed index showed a further increase in overall market sentiment, while the index remained in the \"Greed\" zone on Tuesday. U.S. stocks closed mixed on Tuesday, with the Dow Jones index snapping a three-day winning streak. However, the S&P 500 hit a new all-time closing ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/24/image18.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.818451"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": -0.053398,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ABT",
                    "relevance_score": "0.231332",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.231332",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "T",
                    "relevance_score": "0.116914",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.231332",
                    "ticker_sentiment_score": "0.525561",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "IBM",
                    "relevance_score": "0.231332",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.231332",
                    "ticker_sentiment_score": "0.525561",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "WBD",
                    "relevance_score": "0.116914",
                    "ticker_sentiment_score": "-0.206002",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "MMM",
                    "relevance_score": "0.231332",
                    "ticker_sentiment_score": "0.525561",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Virtualware Reports  ( MLVIR.PA )  Record €4.52 Million Revenue in 2023, a 40% Surge from Previous Year",
            "url": "https://www.globenewswire.com/news-release/2024/01/24/2814776/0/en/Virtualware-Reports-MLVIR-PA-Record-4-52-Million-Revenue-in-2023-a-40-Surge-from-Previous-Year.html",
            "time_published": "20240124T071000",
            "authors": [
                "VIRTUALWARE 2007 SA"
            ],
            "summary": "Bilbao, January 24 - European Virtual Reality company Virtualware ( MLVIR.PA ) ( EPA:MLVIR ) , reported record total revenues of €4.52 million in 2023, 40% more than in the previous year, just nine months after its IPO on Euronext Access Paris.",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/6aee44c0-62ac-4f66-9be0-b3578d202005",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.795202"
                }
            ],
            "overall_sentiment_score": 0.210832,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HTHIF",
                    "relevance_score": "0.039033",
                    "ticker_sentiment_score": "0.074235",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IBDSF",
                    "relevance_score": "0.039033",
                    "ticker_sentiment_score": "0.074235",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AOMFF",
                    "relevance_score": "0.039033",
                    "ticker_sentiment_score": "0.074235",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.039033",
                    "ticker_sentiment_score": "0.074235",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.039033",
                    "ticker_sentiment_score": "0.074235",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "S&P 500 notches third straight record high close",
            "url": "https://www.moneycontrol.com/news/business/markets/sp-500-notches-third-straight-record-high-close-12112521.html",
            "time_published": "20240124T005218",
            "authors": [],
            "summary": "It was the third straight all-time high for the benchmark stock index, and many investors view upcoming quarterly reports from the heavily weighted \"Magnificent 7\" group of megacap companies as key to whether Wall Street's recent rally continues or loses steam.",
            "banner_image": "https://images.moneycontrol.com/static-mcnews/2020/08/wall-street.jpg?impolicy=website&width=168&height=118",
            "source": "Money Control",
            "category_within_source": "Markets",
            "source_domain": "www.moneycontrol.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.858979"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.904684"
                }
            ],
            "overall_sentiment_score": 0.137646,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.072",
                    "ticker_sentiment_score": "0.109706",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.143415",
                    "ticker_sentiment_score": "-0.029508",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.072",
                    "ticker_sentiment_score": "0.313379",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.072",
                    "ticker_sentiment_score": "-0.058136",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.072",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.072",
                    "ticker_sentiment_score": "0.313379",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.072",
                    "ticker_sentiment_score": "0.079237",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028, Assesses DelveInsight",
            "url": "https://www.prnewswire.com/news-releases/implantable-drug-delivery-devices-global-market-to-exhibit-growth-at-a-considerable-cagr-of-6-by-2028-assesses-delveinsight-302041477.html",
            "time_published": "20240123T223100",
            "authors": [
                "DelveInsight Business Research",
                "LLP"
            ],
            "summary": "Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028 ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.262341,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BAYZF",
                    "relevance_score": "0.027103",
                    "ticker_sentiment_score": "0.088505",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.027103",
                    "ticker_sentiment_score": "0.088505",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HTSUF",
                    "relevance_score": "0.027103",
                    "ticker_sentiment_score": "0.027657",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.054175",
                    "ticker_sentiment_score": "0.028936",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TFX",
                    "relevance_score": "0.054175",
                    "ticker_sentiment_score": "0.068904",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ARUXF",
                    "relevance_score": "0.054175",
                    "ticker_sentiment_score": "0.074985",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.054175",
                    "ticker_sentiment_score": "0.079826",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ENDPQ",
                    "relevance_score": "0.027103",
                    "ticker_sentiment_score": "0.027657",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MCRPF",
                    "relevance_score": "0.027103",
                    "ticker_sentiment_score": "-0.01558",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.027103",
                    "ticker_sentiment_score": "0.025235",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.027103",
                    "ticker_sentiment_score": "0.027657",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GRRMF",
                    "relevance_score": "0.027103",
                    "ticker_sentiment_score": "0.025235",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FSNUF",
                    "relevance_score": "0.054175",
                    "ticker_sentiment_score": "0.068904",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TRUMF",
                    "relevance_score": "0.081184",
                    "ticker_sentiment_score": "0.063274",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BDX",
                    "relevance_score": "0.027103",
                    "ticker_sentiment_score": "0.025235",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALC",
                    "relevance_score": "0.027103",
                    "ticker_sentiment_score": "0.088505",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAX",
                    "relevance_score": "0.027103",
                    "ticker_sentiment_score": "0.088505",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LYPHF",
                    "relevance_score": "0.054175",
                    "ticker_sentiment_score": "0.074985",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WST",
                    "relevance_score": "0.027103",
                    "ticker_sentiment_score": "0.025235",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PODD",
                    "relevance_score": "0.027103",
                    "ticker_sentiment_score": "-0.01558",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.081184",
                    "ticker_sentiment_score": "0.070488",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UCBJF",
                    "relevance_score": "0.027103",
                    "ticker_sentiment_score": "0.027657",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSOI",
                    "relevance_score": "0.027103",
                    "ticker_sentiment_score": "0.176605",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "3 Stocks to Consider After Beating Earnings Estimates",
            "url": "https://www.zacks.com/commentary/2214526/3-stocks-to-consider-after-beating-earnings-estimates",
            "time_published": "20240123T201500",
            "authors": [
                "Ethan Feller"
            ],
            "summary": "Q4 earnings results are rolling in, and these stocks showed strong performance ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ce/407.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.995077"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.30199,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GEHC",
                    "relevance_score": "0.050465",
                    "ticker_sentiment_score": "0.029951",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.431065",
                    "ticker_sentiment_score": "0.260533",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.473208",
                    "ticker_sentiment_score": "0.413322",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.199859",
                    "ticker_sentiment_score": "0.247982",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( JNJ )  Q4 2023 Earnings Call Transcript",
            "url": "https://www.fool.com/earnings/call-transcripts/2024/01/23/johnson-johnson-jnj-q4-2023-earnings-call-transcri/",
            "time_published": "20240123T193016",
            "authors": [
                "Motley Fool Transcribing"
            ],
            "summary": "JNJ earnings call for the period ending December 31, 2023.",
            "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.838487"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.311323,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GVHIB",
                    "relevance_score": "0.004629",
                    "ticker_sentiment_score": "0.143773",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.004629",
                    "ticker_sentiment_score": "0.114142",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.004629",
                    "ticker_sentiment_score": "0.091259",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.004629",
                    "ticker_sentiment_score": "0.101356",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.004629",
                    "ticker_sentiment_score": "0.114142",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.004629",
                    "ticker_sentiment_score": "0.114142",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.055503",
                    "ticker_sentiment_score": "0.102029",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.013886",
                    "ticker_sentiment_score": "0.163014",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NBTX",
                    "relevance_score": "0.004629",
                    "ticker_sentiment_score": "-0.035545",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.004629",
                    "ticker_sentiment_score": "-0.021025",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "US Stocks Pause As Treasury Yields, Dollar Surge On Trimmed Fed Rate Cut Bets: What's Driving Markets Tuesday? - Alibaba Gr Holding  ( NYSE:BABA ) ",
            "url": "https://www.benzinga.com/markets/cryptocurrency/24/01/36744784/us-stocks-pause-as-treasury-yields-dollar-surge-on-trimmed-fed-rate-cut-bets-whats-driving",
            "time_published": "20240123T190743",
            "authors": [
                "Piero Cingari"
            ],
            "summary": "Wall Street took a breather on Tuesday, with the major U.S. stock indices trading near the flatline or showing slight declines during midday trading in New York as investors closely await a series of relevant earnings reports and crucial economic data slated for the remainder of the week.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/New-York-Stock-Exchange.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.997902"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.95493"
                }
            ],
            "overall_sentiment_score": 0.068003,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BABA",
                    "relevance_score": "0.151064",
                    "ticker_sentiment_score": "0.129937",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.151064",
                    "ticker_sentiment_score": "0.273111",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.151064",
                    "ticker_sentiment_score": "0.155311",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.151064",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIDU",
                    "relevance_score": "0.151064",
                    "ticker_sentiment_score": "0.129937",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.151064",
                    "ticker_sentiment_score": "-0.239315",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "TXN",
                    "relevance_score": "0.151064",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.075874",
                    "ticker_sentiment_score": "0.167522",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MMM",
                    "relevance_score": "0.151064",
                    "ticker_sentiment_score": "-0.210684",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.151064",
                    "ticker_sentiment_score": "-0.239315",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "NIO",
                    "relevance_score": "0.151064",
                    "ticker_sentiment_score": "0.129937",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.151064",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TKO",
                    "relevance_score": "0.151064",
                    "ticker_sentiment_score": "0.273111",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.151064",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.151064",
                    "ticker_sentiment_score": "-0.210684",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.075874",
                    "ticker_sentiment_score": "0.119312",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.151064",
                    "ticker_sentiment_score": "-0.00952",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:BTC",
                    "relevance_score": "0.151064",
                    "ticker_sentiment_score": "0.237911",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million",
            "url": "https://www.cnbc.com/2024/01/23/johnson-johnson-to-settle-talc-baby-powder-probe.html",
            "time_published": "20240123T185918",
            "authors": [
                "Annika Kim Constantino"
            ],
            "summary": "The settlement does not resolve the tens of thousands of lawsuits alleging that J&J's talc-based products caused cancer.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107221356-1680732858785-gettyimages-1480135077-img_0151_sdiba6q3.jpeg?v=1690578445&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Business",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.106787,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.097854",
                    "ticker_sentiment_score": "0.105276",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Global Process Mining Market Research Report 2023-2028: Opportunities in Artificial Intelligence and Machine Learning Integration and Rising Demand for Cloud-Based Solutions",
            "url": "https://www.prnewswire.com/news-releases/global-process-mining-market-research-report-2023-2028-opportunities-in-artificial-intelligence-and-machine-learning-integration-and-rising-demand-for-cloud-based-solutions-302042109.html",
            "time_published": "20240123T184500",
            "authors": [
                "Research and Markets"
            ],
            "summary": "Global Process Mining Market Research Report 2023-2028: Opportunities in Artificial Intelligence and Machine ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.429279,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HTHIF",
                    "relevance_score": "0.063763",
                    "ticker_sentiment_score": "0.158545",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PATH",
                    "relevance_score": "0.063763",
                    "ticker_sentiment_score": "0.158545",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.063763",
                    "ticker_sentiment_score": "0.158545",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson's Settlement For Talc Cancer Lawsuits Reaches $700M Settlement With US States - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/general/biotech/24/01/36743981/johnson-johnsons-settlement-for-talc-cancer-lawsuits-reaches-700m-settlement-with-us-states",
            "time_published": "20240123T181825",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Johnson & Johnson JNJ announced on Tuesday a tentative settlement to address investigations by 42 U.S. states and Washington, D.C., regarding alleged misleading information about the safety of its talc products linked to cancer cases.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/johnsons-5671315-1920.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.179505,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.428632",
                    "ticker_sentiment_score": "-0.289603",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Why Johnson & Johnson Stock Was Pulling Back Today",
            "url": "https://www.fool.com/investing/2024/01/23/why-johnson-johnson-stock-was-pulling-back-today/",
            "time_published": "20240123T174111",
            "authors": [
                "Jeremy Bowman"
            ],
            "summary": "The healthcare giant matched estimates, but it wasn't enough to please investors.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F762325%2Fsmiling-healthcare-nurse.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.961735"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.117271,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.122269",
                    "ticker_sentiment_score": "0.132548",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.355588",
                    "ticker_sentiment_score": "0.067453",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is Medtronic Stock a Buy Now?",
            "url": "https://www.fool.com/investing/2024/01/23/is-medtronic-stock-a-buy-now/",
            "time_published": "20240123T164500",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "This longtime healthcare leader still has tricks up its sleeve.",
            "banner_image": "https://media.ycharts.com/charts/449df07f857feea40b1d409022b66dee.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.839681"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.962106"
                }
            ],
            "overall_sentiment_score": 0.305087,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MDT",
                    "relevance_score": "0.753867",
                    "ticker_sentiment_score": "0.552984",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.061631",
                    "ticker_sentiment_score": "0.173458",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.061631",
                    "ticker_sentiment_score": "0.173458",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Here's the message yet another bullish Wall Street call sends on this Big Tech stock",
            "url": "https://www.cnbc.com/2024/01/23/wall-street-issues-bullish-call-on-this-big-tech-name-heres-our-take.html",
            "time_published": "20240123T164301",
            "authors": [
                "Morgan Chittum"
            ],
            "summary": "The Investing Club holds its \"Morning Meeting\" every weekday at 10:20 a.m. ET.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/106956311-1633692334197-gettyimages-1227666240-GERMANY_HYDROGEN.jpeg?v=1705940216&w=600&h=300&vtcrop=y",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.995973"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.838487"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.206223,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.226301",
                    "ticker_sentiment_score": "0.154142",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SBUX",
                    "relevance_score": "0.368227",
                    "ticker_sentiment_score": "0.223605",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.076358",
                    "ticker_sentiment_score": "0.089127",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.076358",
                    "ticker_sentiment_score": "0.089127",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.076358",
                    "ticker_sentiment_score": "0.089127",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.152018",
                    "ticker_sentiment_score": "0.115714",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.076358",
                    "ticker_sentiment_score": "0.089127",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.152018",
                    "ticker_sentiment_score": "0.115714",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Lice Treatment Market Analysis 2024-2028: Expected Market Size, Major Drivers And Leading Segments As Per The Business Research Company's Lice Treatment Global Market Report 2024",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36741497/lice-treatment-market-analysis-2024-2028-expected-market-size-major-drivers-and-leading-segments-a",
            "time_published": "20240123T163000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LONDON, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Lice Treatment Global Market Report 2024, the global lice treatment market has demonstrated robust growth, reaching $1.05 billion in 2024 with an impressive compound annual growth rate ( CAGR ) of 7.7%.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.614606"
                }
            ],
            "overall_sentiment_score": 0.339723,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PFE",
                    "relevance_score": "0.064623",
                    "ticker_sentiment_score": "0.175309",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.064623",
                    "ticker_sentiment_score": "0.175309",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "J&J's  ( JNJ )  Q4 Earnings Beat, Darzalex, Stelara Drive Sales",
            "url": "https://www.zacks.com/stock/news/2214342/jjs-jnj-q4-earnings-beat-darzalex-stelara-drive-sales",
            "time_published": "20240123T160300",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "J&J (JNJ) beats estimates for fourth-quarter earnings and sales. Sales of several key drugs like Darzalex, Stelara and Tremfya beat estimates.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7d/1177.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.796627"
                }
            ],
            "overall_sentiment_score": 0.19171,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.06623",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.06623",
                    "ticker_sentiment_score": "0.067094",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.099202",
                    "ticker_sentiment_score": "0.041704",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.099202",
                    "ticker_sentiment_score": "0.059246",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Mixed Q4 Earnings Report",
            "url": "https://www.zacks.com/stock/news/2214340/mixed-q4-earnings-report",
            "time_published": "20240123T160000",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Pre-market futures are mixed at this hour, coming off two strong trading days as Q4 earnings season begins to hit its stride. The Dow is -0.55% currently, while the S&P 500 and Nasdaq are +0.21% and +0.36%, respectively.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/573.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.9545"
                }
            ],
            "overall_sentiment_score": 0.282992,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GE",
                    "relevance_score": "0.33514",
                    "ticker_sentiment_score": "0.370016",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.171485",
                    "ticker_sentiment_score": "0.084771",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.171485",
                    "ticker_sentiment_score": "0.207522",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Q4 Earnings for J&J, Procter, GE & More",
            "url": "https://www.zacks.com/stock/news/2214313/q4-earnings-for-jj-procter-ge-more",
            "time_published": "20240123T152500",
            "authors": [
                "Mark Vickery"
            ],
            "summary": "Pre-market trading fortunes are mixed for this morning's reportees, including JNJ, PG, GE, MMM and DHI.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/60/857.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.990678"
                }
            ],
            "overall_sentiment_score": 0.267274,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GE",
                    "relevance_score": "0.31583",
                    "ticker_sentiment_score": "0.330327",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.16117",
                    "ticker_sentiment_score": "0.081282",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.16117",
                    "ticker_sentiment_score": "0.260185",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "US Stocks Mixed; Johnson & Johnson Posts Upbeat Earnings - FaZe Hldgs  ( NASDAQ:FAZE ) , Etao International Co  ( NASDAQ:ETAO ) ",
            "url": "https://www.benzinga.com/news/earnings/24/01/36739183/us-stocks-mixed-johnson-johnson-posts-upbeat-earnings",
            "time_published": "20240123T150438",
            "authors": [
                "Avi Kapoor"
            ],
            "summary": "U.S. stocks traded mixed this morning, with the Dow Jones index falling around 90 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.23% to 37,915.41 while the NASDAQ rose 0.12% to 15,378.87. The S&P 500 also rose, gaining, 0.07% to 4,853.64.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/23/image44.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.682689"
                }
            ],
            "overall_sentiment_score": 0.103893,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "VRM",
                    "relevance_score": "0.162255",
                    "ticker_sentiment_score": "0.115889",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVVE",
                    "relevance_score": "0.241284",
                    "ticker_sentiment_score": "0.610096",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "FAZE",
                    "relevance_score": "0.162255",
                    "ticker_sentiment_score": "0.014128",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.241284",
                    "ticker_sentiment_score": "0.093444",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RVSN",
                    "relevance_score": "0.241284",
                    "ticker_sentiment_score": "0.302996",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ETAO",
                    "relevance_score": "0.162255",
                    "ticker_sentiment_score": "-0.248028",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "NUTX",
                    "relevance_score": "0.241284",
                    "ticker_sentiment_score": "0.162908",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson's Clock 12% Q4 Revenue Growth, Cancer and Crohn's Disease Drugs Account as Largest Sellers - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/general/biotech/24/01/36738885/johnson-johnsons-clock-12-q4-revenue-growth-cancer-and-crohns-disease-drugs-account-as-largest-se",
            "time_published": "20240123T144932",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "On Tuesday, Johnson & Johnson JNJ reported fourth-quarter 2023 adjusted earnings of $2.29 per share, up 11.7% year-over-year, beating the consensus of $2.28. Sales increased 7.3% Y/Y to $21.4 billion, beating the consensus of $20.99 billion, with operational growth of 7.2% and adjusted ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/jnj-johnson-shutter_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.210646,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.674691",
                    "ticker_sentiment_score": "0.299757",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Why J&J's Narrow Beat Is A Blessing For Medtech Stocks",
            "url": "https://www.investors.com/news/technology/jnj-stock-johnson-johnson-earnings-q4-2023/",
            "time_published": "20240123T135100",
            "authors": [
                "Investor's Business Daily",
                "ALLISON GATLIN"
            ],
            "summary": "JNJ Stock Inches Higher As Medtech Strength Drives Fourth-Quarter Beat Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2021/01/Stock-JohnsonAndJohnson-syringe-shut.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.87644"
                }
            ],
            "overall_sentiment_score": 0.192258,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.843611",
                    "ticker_sentiment_score": "0.454772",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment - Johnson & Johnson  ( NYSE:JNJ ) , Novartis  ( NYSE:NVS ) , Gilead Sciences  ( NASDAQ:GILD ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",
            "url": "https://www.benzinga.com/general/biotech/24/01/36736043/focus-on-bristol-myers-gilead-sciences-johnson-johnson-novartis-fda-to-issue-classwide-black-box-",
            "time_published": "20240123T131918",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "In a significant development, the FDA is set to impose a classwide black box warning following its investigation into secondary T-cell cancers arising from the use of existing CAR-T therapies. In its January 19 notification letters, the agency stressed that the potential risk applies to all ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/cancer_3.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.069177,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LEGN",
                    "relevance_score": "0.175859",
                    "ticker_sentiment_score": "-0.091337",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.175859",
                    "ticker_sentiment_score": "0.31793",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GRCL",
                    "relevance_score": "0.175859",
                    "ticker_sentiment_score": "0.31793",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.175859",
                    "ticker_sentiment_score": "0.007437",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.175859",
                    "ticker_sentiment_score": "0.007437",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.175859",
                    "ticker_sentiment_score": "0.007437",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.175859",
                    "ticker_sentiment_score": "0.007437",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Futures Mixed After Earnings Reports",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-big-earnings-reports-magnificent-seven-stock-netflix-to-report-next/",
            "time_published": "20240123T131200",
            "authors": [
                "Investor's Business Daily",
                "SCOTT LEHTONEN"
            ],
            "summary": "Dow Jones Futures Fall On Big Earnings Reports. Magnificent Seven Stock Netflix To Report Next Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2017/04/stock-wallstreet-shutter.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.161722,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "DKNG",
                    "relevance_score": "0.170576",
                    "ticker_sentiment_score": "0.215034",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.170576",
                    "ticker_sentiment_score": "0.08804",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.042953",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.085782",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPOT",
                    "relevance_score": "0.212301",
                    "ticker_sentiment_score": "0.165004",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.128363",
                    "ticker_sentiment_score": "0.0644",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.170576",
                    "ticker_sentiment_score": "0.224647",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.085782",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AWON",
                    "relevance_score": "0.042953",
                    "ticker_sentiment_score": "0.044623",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.042953",
                    "ticker_sentiment_score": "0.118591",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.170576",
                    "ticker_sentiment_score": "0.096618",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MELI",
                    "relevance_score": "0.212301",
                    "ticker_sentiment_score": "0.251407",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HAL",
                    "relevance_score": "0.128363",
                    "ticker_sentiment_score": "0.031178",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.042953",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.128363",
                    "ticker_sentiment_score": "0.0644",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.170576",
                    "ticker_sentiment_score": "0.166315",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.128363",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.170576",
                    "ticker_sentiment_score": "0.150137",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.128363",
                    "ticker_sentiment_score": "0.031178",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "FDA Demands \"Boxed Warning\" to CAR T-Cell Therapy Labels",
            "url": "https://www.zacks.com/stock/news/2214008/fda-demands-boxed-warning-to-car-t-cell-therapy-labels",
            "time_published": "20240123T130800",
            "authors": [
                "Ekta Bagri"
            ],
            "summary": "The FDA directs companies like NVS, BMY, GILD and others to add \"boxed warning\" to the labels of their CAR T-cell immunotherapies after it identified adverse events.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/13/54831.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.002389,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "TSVT",
                    "relevance_score": "0.056143",
                    "ticker_sentiment_score": "0.065992",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.167322",
                    "ticker_sentiment_score": "0.034274",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LEGN",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.075902",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "-0.058239",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "US Stocks Prepare For Nervy Start Ahead of Netflix, TI Earnings: Analyst Says Cash Waiting On Sidelines Could Flood Street If This Happens - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",
            "url": "https://www.benzinga.com/news/earnings/24/01/36734767/us-stocks-prepare-for-nervy-start-ahead-of-netflix-ti-earnings-analyst-says-cash-waiting-on-sidelin",
            "time_published": "20240123T123203",
            "authors": [
                "Shanthi Rexaline"
            ],
            "summary": "The mood turned circumspect on Tuesday as traders digested a deluge of earnings reports and anticipated market-moving economic data for the week. Earnings releases from 3M Company MMM and General Electric Co. GE led to a pullback in their stocks during premarket trading.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/nyse-shutter_3.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Blockchain",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.997902"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.682689"
                }
            ],
            "overall_sentiment_score": 0.059945,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.158519",
                    "ticker_sentiment_score": "-0.040407",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "0.191116",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "0.048514",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LOGI",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "-0.27216",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "0.048514",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BKR",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TXN",
                    "relevance_score": "0.158519",
                    "ticker_sentiment_score": "-0.040407",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.053153",
                    "ticker_sentiment_score": "0.21978",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MMM",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "0.022026",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COIN",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "-0.217386",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "HAL",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "0.048514",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "0.048514",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.158519",
                    "ticker_sentiment_score": "0.038721",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.158519",
                    "ticker_sentiment_score": "0.038721",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNI",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STLD",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:JPY",
                    "relevance_score": "0.053153",
                    "ticker_sentiment_score": "-0.173706",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "FOREX:EUR",
                    "relevance_score": "0.053153",
                    "ticker_sentiment_score": "-0.173706",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "-0.078403",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:BTC",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "-0.018227",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Cough Suppressant Market to Hit US$ 39,216.3 Million by 2030 | Updated Insights Report by Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36734013/cough-suppressant-market-to-hit-us-39-216-3-million-by-2030-updated-insights-report-by-persistence",
            "time_published": "20240123T120000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Cough suppressants, also known as antitussives, are pharmaceutical substances engineered to alleviate cough symptoms.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.291889,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HLCO",
                    "relevance_score": "0.020848",
                    "ticker_sentiment_score": "0.009603",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.041682",
                    "ticker_sentiment_score": "0.183297",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.062488",
                    "ticker_sentiment_score": "0.179295",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson earnings beat estimates with boost from medtech sales",
            "url": "https://www.marketwatch.com/story/johnson-johnson-q4-earnings-beat-estimates-amid-strength-in-medtech-1803820f",
            "time_published": "20240123T113500",
            "authors": [
                "Ciara Linnane"
            ],
            "summary": "Medtech sales were up more than 13% in the latest quarter.",
            "banner_image": "https://images.mktw.net/im-305622/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.875462"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": 0.188782,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.252987",
                    "ticker_sentiment_score": "0.317354",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.371523",
                    "ticker_sentiment_score": "0.206173",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Genmab Announces Net Sales of DARZALEX®  ( daratumumab )  for 2023",
            "url": "https://www.globenewswire.com/news-release/2024/01/23/2813898/0/en/Genmab-Announces-Net-Sales-of-DARZALEX-daratumumab-for-2023.html",
            "time_published": "20240123T112400",
            "authors": [
                "Genmab A/S"
            ],
            "summary": "Company Announcement ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.064714,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GMAB",
                    "relevance_score": "0.646056",
                    "ticker_sentiment_score": "0.099378",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.133841",
                    "ticker_sentiment_score": "0.011832",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump",
            "url": "https://www.cnbc.com/2024/01/23/johnson-johnson-jnj-earnings-q4-2023.html",
            "time_published": "20240123T112237",
            "authors": [
                "Annika Kim Constantino"
            ],
            "summary": "The results come six months after J&J completed its spinoff of consumer health unit Kenvue, the company's biggest shake-up in its nearly 140-year history.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/106974800-1636726117188-gettyimages-1234001052-RAFAPRESS_15072021-9655.jpeg?v=1705948573&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Earnings",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.988787"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.021707,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.173333",
                    "ticker_sentiment_score": "-0.0242",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.087185",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Invest in the iShares U.S. Healthcare ETF  ( IYH ) ?",
            "url": "https://www.zacks.com/stock/news/2213920/should-you-invest-in-the-ishares-us-healthcare-etf-iyh",
            "time_published": "20240123T112006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default46.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.221904,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.066784",
                    "ticker_sentiment_score": "0.088171",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.1331",
                    "ticker_sentiment_score": "0.069906",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.1331",
                    "ticker_sentiment_score": "0.069906",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.1331",
                    "ticker_sentiment_score": "0.069906",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Invest in the Health Care Select Sector SPDR ETF  ( XLV ) ?",
            "url": "https://www.zacks.com/stock/news/2213924/should-you-invest-in-the-health-care-select-sector-spdr-etf-xlv",
            "time_published": "20240123T112005",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default19.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.2573,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.127456",
                    "ticker_sentiment_score": "0.063784",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.127397",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STT",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.089059",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.127456",
                    "ticker_sentiment_score": "0.063784",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.127456",
                    "ticker_sentiment_score": "0.063784",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Accent Therapeutics Announces $75 Million Series C Financing to Advance Small Molecule Precision Cancer Therapies",
            "url": "https://www.prnewswire.com/news-releases/accent-therapeutics-announces-75-million-series-c-financing-to-advance-small-molecule-precision-cancer-therapies-302041338.html",
            "time_published": "20240123T110000",
            "authors": [
                "Inc.",
                "Accent Therapeutics"
            ],
            "summary": "Financing led by Mirae Asset Capital Life Science with participation from additional new and existing investors Funds will support advancement of lead programs through early clinical development, including Accent's first-in-class DHX9 inhibitor and newly unveiled, potentially best-in-class KIF18A ...",
            "banner_image": "https://mma.prnewswire.com/media/2048641/Accent_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.796627"
                }
            ],
            "overall_sentiment_score": 0.072022,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.039418",
                    "ticker_sentiment_score": "0.045323",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.039418",
                    "ticker_sentiment_score": "0.045323",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.039418",
                    "ticker_sentiment_score": "0.045323",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "S&P 500 futures hold at record highs as earnings season ramps up",
            "url": "https://www.marketwatch.com/story/s-p-500-futures-hold-at-record-highs-as-earnings-season-ramps-up-netflix-eyed-after-the-close-de2923e4",
            "time_published": "20240123T103100",
            "authors": [
                "Jamie Chisholm"
            ],
            "summary": "U.S. stock index futures showed benchmarks holding at record levels as bond markets stabilized and traders eyed an accelerating flow of corporate earnings reports.",
            "banner_image": "https://images.mktw.net/im-20251080/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.839681"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.190016,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BKR",
                    "relevance_score": "0.202366",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.202366",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TXN",
                    "relevance_score": "0.202366",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.202366",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.202366",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.202366",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2 Genius Safe Stocks to Buy for 2024 and Beyond",
            "url": "https://www.fool.com/investing/2024/01/23/2-genius-safe-stocks-to-buy-for-2024-and-beyond/",
            "time_published": "20240123T101500",
            "authors": [
                "Rachel Warren"
            ],
            "summary": "These companies have considerable profits and tried-and-true dividends in common.",
            "banner_image": "https://g.foolcdn.com/editorial/images/761857/businesswoman-working-finances-1.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.623304"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.918141"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.078877,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.047465",
                    "ticker_sentiment_score": "0.041354",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CERE",
                    "relevance_score": "0.047465",
                    "ticker_sentiment_score": "0.076708",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.234006",
                    "ticker_sentiment_score": "0.072217",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.047465",
                    "ticker_sentiment_score": "-0.030904",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.279015",
                    "ticker_sentiment_score": "0.002106",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Expectorant Drugs Market Poised to Reach US$22.9 Billion by 2030 with a Steady 4.5% CAGR | Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36732382/expectorant-drugs-market-poised-to-reach-us-22-9-billion-by-2030-with-a-steady-4-5-cagr-persistenc",
            "time_published": "20240123T093000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: The global expectorant drugs market is projected to grow at a robust CAGR of 4.5%, surging from US$16.8 billion in 2023 to reach US$22.9 billion by the conclusion of 2030.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.714479"
                }
            ],
            "overall_sentiment_score": 0.399092,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MFCSF",
                    "relevance_score": "0.015226",
                    "ticker_sentiment_score": "0.124442",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.015226",
                    "ticker_sentiment_score": "0.306033",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.015226",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.015226",
                    "ticker_sentiment_score": "0.119248",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.015226",
                    "ticker_sentiment_score": "0.066705",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Surgical Staplers Market Soars, Forecasting an 4.7% CAGR Surge to Reach US$5.5 Billion by 2030 | Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36732339/surgical-staplers-market-soars-forecasting-an-4-7-cagr-surge-to-reach-us-5-5-billion-by-2030-persi",
            "time_published": "20240123T091500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The Surgical Staplers Market is a vital segment within the broader medical device industry, dedicated to simplifying and enhancing surgical procedures.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                }
            ],
            "overall_sentiment_score": 0.375422,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MDT",
                    "relevance_score": "0.014506",
                    "ticker_sentiment_score": "0.049119",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNMD",
                    "relevance_score": "0.029008",
                    "ticker_sentiment_score": "-0.04468",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.057977",
                    "ticker_sentiment_score": "0.147179",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.043499",
                    "ticker_sentiment_score": "0.189608",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Surgical Dressing Market Valuation to Reach US$1.9 Billion by 2030, Driven by 6.1% CAGR | Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36732234/surgical-dressing-market-valuation-to-reach-us-1-9-billion-by-2030-driven-by-6-1-cagr-persistence-",
            "time_published": "20240123T085000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The surgical dressing market plays a vital role in the healthcare industry, providing essential products that aid in the post-operative care of patients and promote wound healing.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                }
            ],
            "overall_sentiment_score": 0.320894,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HLCO",
                    "relevance_score": "0.014757",
                    "ticker_sentiment_score": "0.040595",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.04425",
                    "ticker_sentiment_score": "-0.038999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MCK",
                    "relevance_score": "0.014757",
                    "ticker_sentiment_score": "0.418091",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.04425",
                    "ticker_sentiment_score": "-0.038999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.04425",
                    "ticker_sentiment_score": "0.014969",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.04425",
                    "ticker_sentiment_score": "0.056789",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLPBY",
                    "relevance_score": "0.04425",
                    "ticker_sentiment_score": "0.125902",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Fear & Greed Index Remains In 'Greed' Zone; Dow Settles Above 38,000 - Johnson & Johnson  ( NYSE:JNJ ) , Archer-Daniels Midland  ( NYSE:ADM ) ",
            "url": "https://www.benzinga.com/news/earnings/24/01/36731525/fear-greed-index-remains-in-greed-zone-dow-settles-above-38-000",
            "time_published": "20240123T073346",
            "authors": [
                "Avi Kapoor"
            ],
            "summary": "The CNN Money Fear and Greed index remained in the \"Greed\" zone on Monday. U.S. stocks closed higher on Monday, with the Dow Jones index settling above the 38,000 mark for the first time.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/23/image38.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": -0.204857,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.263942",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.263942",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.263942",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.263942",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WBD",
                    "relevance_score": "0.133841",
                    "ticker_sentiment_score": "-0.489041",
                    "ticker_sentiment_label": "Bearish"
                },
                {
                    "ticker": "ADM",
                    "relevance_score": "0.263942",
                    "ticker_sentiment_score": "0.095791",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "M",
                    "relevance_score": "0.133841",
                    "ticker_sentiment_score": "0.058844",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Verizon, Netflix And 3 Stocks To Watch Heading Into Tuesday - Netflix  ( NASDAQ:NFLX ) , Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/news/earnings/24/01/36731409/verizon-netflix-and-3-stocks-to-watch-heading-into-tuesday",
            "time_published": "20240123T065300",
            "authors": [
                "Avi Kapoor"
            ],
            "summary": "With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Verizon Communications Inc. VZ to report quarterly earnings at $1.08 per share on revenue of $34.58 billion before the opening bell.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/23/verizon_communications_-_logo.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.986564"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.23435,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.504646",
                    "ticker_sentiment_score": "0.338779",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.504646",
                    "ticker_sentiment_score": "0.333483",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.504646",
                    "ticker_sentiment_score": "0.39389",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.504646",
                    "ticker_sentiment_score": "0.404618",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.504646",
                    "ticker_sentiment_score": "0.39389",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Medical Adhesive Tape Market Is Projected to Reach a Value of US$13.1 Billion by The End 2030, According to Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36731378/medical-adhesive-tape-market-is-projected-to-reach-a-value-of-us-13-1-billion-by-the-end-2030-acco",
            "time_published": "20240123T063000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Medical Adhesive Tape Market Booming with Growing Demand and Technological Advancements Medical adhesive tapes are essential in wound care, surgeries, and medical applications.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.381388,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MFCSF",
                    "relevance_score": "0.017795",
                    "ticker_sentiment_score": "0.128518",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HLCO",
                    "relevance_score": "0.017795",
                    "ticker_sentiment_score": "0.197876",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NDEKF",
                    "relevance_score": "0.035582",
                    "ticker_sentiment_score": "0.155746",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NHBAF",
                    "relevance_score": "0.017795",
                    "ticker_sentiment_score": "0.149182",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.017795",
                    "ticker_sentiment_score": "0.149182",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVY",
                    "relevance_score": "0.035582",
                    "ticker_sentiment_score": "0.155746",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.017795",
                    "ticker_sentiment_score": "0.149182",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.017795",
                    "ticker_sentiment_score": "0.149182",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.035582",
                    "ticker_sentiment_score": "0.137674",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "S&P 500 ends with record high for 2nd session in row",
            "url": "https://www.moneycontrol.com/news/business/markets/sp-500-ends-with-record-high-for-2nd-session-in-row-12105241.html",
            "time_published": "20240123T010143",
            "authors": [],
            "summary": "Friday's finish confirmed that the SP 500 has been in a bull market since it closed at its low on Oct. 12, 2022, according to one commonly used measure.",
            "banner_image": "https://images.moneycontrol.com/static-mcnews/2020/08/wall-street-1.jpg?impolicy=website&width=168&height=118",
            "source": "Money Control",
            "category_within_source": "Markets",
            "source_domain": "www.moneycontrol.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.77141"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.14298,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.087824",
                    "ticker_sentiment_score": "0.11768",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.087824",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.087824",
                    "ticker_sentiment_score": "0.21237",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.087824",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.087824",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.087824",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.087824",
                    "ticker_sentiment_score": "0.04322",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADM",
                    "relevance_score": "0.087824",
                    "ticker_sentiment_score": "0.010699",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LPLA",
                    "relevance_score": "0.087824",
                    "ticker_sentiment_score": "0.063858",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Genmab Announces Decision in Arbitration Appeal under License Agreement with Janssen",
            "url": "https://www.globenewswire.com/news-release/2024/01/22/2813563/0/en/Genmab-Announces-Decision-in-Arbitration-Appeal-under-License-Agreement-with-Janssen.html",
            "time_published": "20240122T234000",
            "authors": [
                "Genmab A/S"
            ],
            "summary": "Company Announcement ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.112587,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GMAB",
                    "relevance_score": "0.612343",
                    "ticker_sentiment_score": "0.129232",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.062597",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Rehabilitation Equipment Global Market to Showcase Growth at a CAGR of ~5% by 2028, Examines DelveInsight",
            "url": "https://www.prnewswire.com/news-releases/rehabilitation-equipment-global-market-to-showcase-growth-at-a-cagr-of-5-by-2028-examines-delveinsight-302040512.html",
            "time_published": "20240122T223100",
            "authors": [
                "DelveInsight Business Research",
                "LLP"
            ],
            "summary": "The increasing demand for rehabilitation equipment is driven by several factors, including a growing number of accidents, injuries, and falls.",
            "banner_image": "https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.218223,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MFCSF",
                    "relevance_score": "0.02668",
                    "ticker_sentiment_score": "0.089754",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVRO",
                    "relevance_score": "0.02668",
                    "ticker_sentiment_score": "0.026075",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.079921",
                    "ticker_sentiment_score": "-0.002038",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EKSO",
                    "relevance_score": "0.02668",
                    "ticker_sentiment_score": "0.098104",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OFIX",
                    "relevance_score": "0.05333",
                    "ticker_sentiment_score": "0.003986",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RWLK",
                    "relevance_score": "0.02668",
                    "ticker_sentiment_score": "0.098104",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GMED",
                    "relevance_score": "0.05333",
                    "ticker_sentiment_score": "0.003986",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.05333",
                    "ticker_sentiment_score": "0.004985",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.079921",
                    "ticker_sentiment_score": "-0.002038",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ATEC",
                    "relevance_score": "0.02668",
                    "ticker_sentiment_score": "-0.011827",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SRGAQ",
                    "relevance_score": "0.02668",
                    "ticker_sentiment_score": "-0.011827",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANIK",
                    "relevance_score": "0.02668",
                    "ticker_sentiment_score": "0.020645",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.02668",
                    "ticker_sentiment_score": "0.026075",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DNPUF",
                    "relevance_score": "0.02668",
                    "ticker_sentiment_score": "0.098104",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSUMF",
                    "relevance_score": "0.02668",
                    "ticker_sentiment_score": "0.098104",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TRUMF",
                    "relevance_score": "0.02668",
                    "ticker_sentiment_score": "0.020645",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IART",
                    "relevance_score": "0.02668",
                    "ticker_sentiment_score": "-0.023117",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVCRQ",
                    "relevance_score": "0.02668",
                    "ticker_sentiment_score": "0.098104",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DYNT",
                    "relevance_score": "0.02668",
                    "ticker_sentiment_score": "0.098104",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MAAL",
                    "relevance_score": "0.02668",
                    "ticker_sentiment_score": "0.098104",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.079921",
                    "ticker_sentiment_score": "0.011181",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BVS",
                    "relevance_score": "0.02668",
                    "ticker_sentiment_score": "0.020645",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CMAX",
                    "relevance_score": "0.02668",
                    "ticker_sentiment_score": "0.098104",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.02668",
                    "ticker_sentiment_score": "0.020645",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "From 3M To Intel, A Big Earnings Week For Dow Jones Stocks",
            "url": "https://www.investors.com/news/dow-jones-stocks-from-3m-to-intel-a-big-earnings-week-for-blue-chips/",
            "time_published": "20240122T210200",
            "authors": [
                "Investor's Business Daily",
                "ALAN R. ELLIOTT"
            ],
            "summary": "The biggest reporting week of the season for Dow Jones Industrials stocks begins Tuesday, when Verizon ( VZ ) , Johnson & Johnson ( JNJ ) , Procter & Gamble ( PG ) and 3M ( MMM ) all deliver results. It is one of the season's biggest reporting days for Dow Jones stocks.",
            "banner_image": "https://www.investors.com/wp-content/uploads/2020/07/Stock-NYSExchange-71-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.87644"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.938793"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.082306,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.223522",
                    "ticker_sentiment_score": "0.107842",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.150122",
                    "ticker_sentiment_score": "0.181858",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.294977",
                    "ticker_sentiment_score": "-0.041106",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.294977",
                    "ticker_sentiment_score": "0.02552",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.150122",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.223522",
                    "ticker_sentiment_score": "-0.070824",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.223522",
                    "ticker_sentiment_score": "0.025524",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.294977",
                    "ticker_sentiment_score": "0.02552",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.150122",
                    "ticker_sentiment_score": "0.081084",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "JNJ: Johnson & Johnson  ( JNJ ) : Analyzing Signals Before Quarterly Earnings",
            "url": "https://stocknews.com/news/jnj-nvs-nvo-snphy-amam-johnson-johnson-jnj-analyzing-signals-before-quarterly-earnings/",
            "time_published": "20240122T181128",
            "authors": [
                "StockNews.com Staff"
            ],
            "summary": "Boasting a market cap of $389.21 billion, leading pharma giant Johnson & Johnson ( JNJ ) is all set to lift the curtains on its fourth-quarter results ( ended December 2023 ) on January 23, 2024. Thus, this article sheds light on the fundamentals of JNJ to determine the stock's worthiness as an ...",
            "banner_image": "https://stocknews.com/wp-content/uploads/2023/06/Anushka-Mukherjee_Headshot-2.jpg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "stocknews.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.623304"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.87644"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.240609,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NVS",
                    "relevance_score": "0.080593",
                    "ticker_sentiment_score": "0.113018",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNPHF",
                    "relevance_score": "0.040348",
                    "ticker_sentiment_score": "0.10791",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.080593",
                    "ticker_sentiment_score": "-0.124994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.080593",
                    "ticker_sentiment_score": "0.113018",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.55206",
                    "ticker_sentiment_score": "0.312855",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Talc lawsuit: J&J sets up 3rd bankruptcy bid by moving unit to Texas",
            "url": "https://www.business-standard.com/world-news/talc-lawsuit-j-j-sets-up-3rd-bankruptcy-bid-by-moving-unit-to-texas-124012201028_1.html",
            "time_published": "20240122T171255",
            "authors": [
                "Bloomberg"
            ],
            "summary": "Johnson & Johnson is seeking to move a unit to Texas as it prepares for a potential third bankruptcy court filing to resolve more than 50,000 lawsuits alleging tainted talc in its baby powder caused cancer.",
            "banner_image": "https://bsmedia.business-standard.com/_media/bs/img/article/2023-05/02/full/1683045756-614.jpg?im=FeatureCrop,size=(826,465)",
            "source": "Business Standard",
            "category_within_source": "GoogleRSS",
            "source_domain": "www.business-standard.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.122886,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.110209",
                    "ticker_sentiment_score": "-0.213977",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Secures Complete FDA Approval For Bladder Cancer Drug Balversa, After Almost Five Years Of Accelerated Approval - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/general/biotech/24/01/36719728/johnson-johnson-secures-complete-fda-approval-for-bladder-cancer-drug-balversa-after-almost-five-",
            "time_published": "20240122T165959",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Friday afternoon, the FDA approved Johnson & Johnson's JNJ supplemental New Drug Application ( sNDA ) for Balversa ( erdafitinib ) for adult patients with locally advanced or metastatic urothelial carcinoma ( mUC ) with susceptible fibroblast growth factor receptor 3 ( FGFR3 ) genetic ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/JNJ.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.197358,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.262522",
                    "ticker_sentiment_score": "0.234595",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.597963",
                    "ticker_sentiment_score": "0.363424",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Earnings Season Heats Up This Week Along With Inflation Data",
            "url": "https://www.forbes.com/sites/jjkinahan/2024/01/22/earnings-season-heats-up-this-week-along-with-inflation-data/",
            "time_published": "20240122T153816",
            "authors": [
                "JJ Kinahan"
            ],
            "summary": "• Netflix And Tesla Among Companies Reporting This Week • Market Unconcerned With Much Of Anything Equity markets are picking up steam and setting records. Last week, the S&P 500 closed at an all-time high with a gain of 1.17%. Meanwhile, the Nasdaq Composite is coming up on its all-time highs ...",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65ae8b76560d7db299b844c1/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.955357"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.990678"
                }
            ],
            "overall_sentiment_score": 0.038463,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.129866",
                    "ticker_sentiment_score": "-0.03444",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.129866",
                    "ticker_sentiment_score": "-0.03444",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "M",
                    "relevance_score": "0.193723",
                    "ticker_sentiment_score": "0.16306",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.06515",
                    "ticker_sentiment_score": "-0.017046",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Tissue Engineering Market is Expected to Reach $8.9 Billion | MarketsandMarkets™",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36713761/tissue-engineering-market-is-expected-to-reach-8-9-billion-marketsandmarkets",
            "time_published": "20240122T123000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Chicago, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- Tissue Engineering market in terms of revenue was estimated to be worth $4.4 Billion in 2023 and is poised to reach $8.9 Billion by 2028, growing at a CAGR of 15.3% from 2023 to 2028 according to a latest report published by MarketsandMarkets™.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.22176,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.03792",
                    "ticker_sentiment_score": "-0.040123",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDXG",
                    "relevance_score": "0.03792",
                    "ticker_sentiment_score": "-0.040123",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.03792",
                    "ticker_sentiment_score": "-0.040123",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.03792",
                    "ticker_sentiment_score": "-0.040123",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TINLF",
                    "relevance_score": "0.03792",
                    "ticker_sentiment_score": "-0.040123",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.03792",
                    "ticker_sentiment_score": "-0.040123",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DNPUF",
                    "relevance_score": "0.03792",
                    "ticker_sentiment_score": "-0.040123",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.03792",
                    "ticker_sentiment_score": "-0.040123",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SAUHF",
                    "relevance_score": "0.03792",
                    "ticker_sentiment_score": "-0.040123",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSUMF",
                    "relevance_score": "0.03792",
                    "ticker_sentiment_score": "-0.040123",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TRUMF",
                    "relevance_score": "0.03792",
                    "ticker_sentiment_score": "-0.040123",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IART",
                    "relevance_score": "0.03792",
                    "ticker_sentiment_score": "-0.040123",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.03792",
                    "ticker_sentiment_score": "-0.040123",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VCEL",
                    "relevance_score": "0.03792",
                    "ticker_sentiment_score": "-0.040123",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Tim Czartoski Appointed as CEO of Genesis Innovation Group",
            "url": "https://www.prnewswire.com/news-releases/tim-czartoski-appointed-as-ceo-of-genesis-innovation-group-302040014.html",
            "time_published": "20240122T114500",
            "authors": [
                "Genesis Innovation Group"
            ],
            "summary": "GRAND RAPIDS, Mich., Jan. 22, 2024 /PRNewswire/ -- Genesis Innovation Group ( GIG ) , a leader in medical device innovation, is excited to announce the appointment of Tim Czartoski as Chief Executive Officer effective April 1, 2024, and serving in an advisory role until that time.",
            "banner_image": "https://mma.prnewswire.com/media/787220/Genesis_Innovation_Group_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.486428,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.066047",
                    "ticker_sentiment_score": "0.087133",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Orthopedic Implants Market Size to Worth USD 61 Million by 2030| According to Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36712657/orthopedic-implants-market-size-to-worth-usd-61-million-by-2030-according-to-persistence-market-re",
            "time_published": "20240122T113000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- The projected rise in the number of patients in need of orthopedic implant surgery is anticipated to propel the global orthopedic implants market in the coming years.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.300831,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "TINLF",
                    "relevance_score": "0.020197",
                    "ticker_sentiment_score": "0.038733",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.040382",
                    "ticker_sentiment_score": "0.103875",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.020197",
                    "ticker_sentiment_score": "0.038733",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GMED",
                    "relevance_score": "0.020197",
                    "ticker_sentiment_score": "0.038733",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.020197",
                    "ticker_sentiment_score": "0.145597",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.020197",
                    "ticker_sentiment_score": "0.038733",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.020197",
                    "ticker_sentiment_score": "0.145597",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.020197",
                    "ticker_sentiment_score": "0.038733",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KYOCF",
                    "relevance_score": "0.020197",
                    "ticker_sentiment_score": "0.038733",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Legal-Bay Pre-Settlement Funding Reports Johnson & Johnson Talc Powder Settlement of $700MM with 40 States Nationwide",
            "url": "https://www.prnewswire.com/news-releases/legal-bay-pre-settlement-funding-reports-johnson--johnson-talc-powder-settlement-of-700mm-with-40-states-nationwide-302039711.html",
            "time_published": "20240122T113000",
            "authors": [
                "Legal-Bay",
                "LLC"
            ],
            "summary": "Legal-Bay Pre-Settlement Funding Reports Johnson & Johnson Talc Powder Settlement of $700MM with 40 States ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/126845/legal_bay_llc_logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.623304"
                }
            ],
            "overall_sentiment_score": -0.163952,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.145583",
                    "ticker_sentiment_score": "-0.157113",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Tesla, Netflix, Intel Take Center Stage In Pivotal Q4 Earnings Week As S&P 500 Eyes Breaking New Highs - SPDR S&P 500  ( ARCA:SPY ) ",
            "url": "https://www.benzinga.com/news/earnings/24/01/36711792/tesla-netflix-intel-take-center-stage-in-pivotal-q4-earnings-week-as-s-p-500-eyes-breaking-new-high",
            "time_published": "20240122T100045",
            "authors": [
                "Shanthi Rexaline"
            ],
            "summary": "The earnings season is gaining momentum as the tech reporting season kicks off this week. With the S&P 500 Index reaching a new high on Friday, investors are keenly watching earnings reports to sustain the market's upward momentum.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/SP-500.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.997335"
                }
            ],
            "overall_sentiment_score": 0.02392,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ALK",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.037843",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.049774",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MBLY",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.037843",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.049774",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TXN",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STM",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.037843",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DFS",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "-0.053689",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FITB",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.193511",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.053749",
                    "ticker_sentiment_score": "0.021995",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CMA",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.193511",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UNP",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.037843",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WDC",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COF",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AGYS",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.049774",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NSC",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XRX",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.037843",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KLAC",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.21258",
                    "ticker_sentiment_score": "0.028138",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HUM",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.037843",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NOC",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.037843",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "-0.053689",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BKR",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZIONL",
                    "relevance_score": "0.053749",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CL",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NOK",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.037843",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAL",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.037843",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "-0.053689",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LUV",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.037843",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MMM",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.049774",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DOW",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.037843",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TMUS",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HAL",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.049774",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.049774",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RF",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.193511",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.160277",
                    "ticker_sentiment_score": "0.021545",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.049774",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CCZ",
                    "relevance_score": "0.053749",
                    "ticker_sentiment_score": "0.034838",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNI",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STLD",
                    "relevance_score": "0.107255",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Chronic Wound Care Market is expected to see an expansion to US$16.7 billion, as per the projections, By the end of 2030 | Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36710946/chronic-wound-care-market-is-expected-to-see-an-expansion-to-us-16-7-billion-as-per-the-projection",
            "time_published": "20240122T061500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- Chronic Wound Care Market Booms as Advanced Solutions Emerge to Combat Rising Burden Chronic wound care involves the management and treatment of wounds that fail to progress through normal stages of healing within an expected timeframe.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                }
            ],
            "overall_sentiment_score": 0.262494,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "IART",
                    "relevance_score": "0.014384",
                    "ticker_sentiment_score": "0.199415",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAX",
                    "relevance_score": "0.028764",
                    "ticker_sentiment_score": "0.225905",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CLPBY",
                    "relevance_score": "0.014384",
                    "ticker_sentiment_score": "0.215192",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.014384",
                    "ticker_sentiment_score": "0.091828",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.014384",
                    "ticker_sentiment_score": "0.215192",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Little-Known Biotech Company Shows How Hard It Is To Ride The Ozempic Wave",
            "url": "https://www.forbes.com/sites/johnkang/2024/01/21/little-known-biotech-company-shows-how-hard-it-is-to-ride-the-ozempic-wave/",
            "time_published": "20240122T030041",
            "authors": [
                "John Kang"
            ],
            "summary": "Shares of Korea-listed Caregen surged on hope its diabetes-weight loss supplement could give the little-known biotech company an Ozempic-like boost. But then the stock crashed.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65a8fe6352659d2a5930c678/0x0.jpg?format=jpg&crop=1920,1080,x0,y0,safe&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.961735"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.858979"
                }
            ],
            "overall_sentiment_score": 0.085989,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NVO",
                    "relevance_score": "0.096283",
                    "ticker_sentiment_score": "0.080917",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.024126",
                    "ticker_sentiment_score": "0.187772",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.024126",
                    "ticker_sentiment_score": "0.187772",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "I'm Putting My Cash Stockpile to Work on These 3 Stocks",
            "url": "https://www.fool.com/investing/2024/01/21/im-putting-my-cash-stockpile-to-work-on-these-3-st/",
            "time_published": "20240121T174700",
            "authors": [
                "Matthew DiLallo"
            ],
            "summary": "With the market selling off to start the year, this Fool plans to put some of his growing cash pile to work.",
            "banner_image": "https://g.foolcdn.com/editorial/images/761642/dividends-cart-full-of-money-on-hundred-dollar-bills.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.723405"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.268567,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "VICI",
                    "relevance_score": "0.342262",
                    "ticker_sentiment_score": "0.313662",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CRBO",
                    "relevance_score": "0.050465",
                    "ticker_sentiment_score": "0.107322",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CVX",
                    "relevance_score": "0.431065",
                    "ticker_sentiment_score": "0.294136",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HES",
                    "relevance_score": "0.100729",
                    "ticker_sentiment_score": "0.075834",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.050465",
                    "ticker_sentiment_score": "-0.019973",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.248343",
                    "ticker_sentiment_score": "0.371032",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "BOWL",
                    "relevance_score": "0.050465",
                    "ticker_sentiment_score": "0.195335",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Nearing Retirement? These Stocks Are as Safe as They Come",
            "url": "https://www.fool.com/investing/2024/01/21/nearing-retirement-these-stocks-are-as-safe-as-the/",
            "time_published": "20240121T165100",
            "authors": [
                "Keith Speights"
            ],
            "summary": "These stocks should provide solid income with little drama.",
            "banner_image": "https://g.foolcdn.com/editorial/images/761623/retired-couple-looking-at-computer-screen.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.875462"
                }
            ],
            "overall_sentiment_score": 0.298878,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.401331",
                    "ticker_sentiment_score": "0.348195",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.27432",
                    "ticker_sentiment_score": "0.180187",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "March Rate Cut Odds Plummet As Magnificent 7 Surge",
            "url": "https://www.forbes.com/sites/bill_stone/2024/01/21/march-rate-cut-odds-plummet-as-magnificent-7-surge/",
            "time_published": "20240121T163956",
            "authors": [
                "Bill Stone"
            ],
            "summary": "The earnings season continued its slow start last week, with only 23 S&P 500 companies reporting. Banks were a large contingent of the reporters, which weighed on earnings again. The S&P 500 rose 1.2% for the week, finally eclipsing its all-time high from 2022. The 10-year Treasury yield rose ...",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65ad45a1ae514cbbefbb53ce/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.838487"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.796627"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.140026,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.11983",
                    "ticker_sentiment_score": "0.107429",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.11983",
                    "ticker_sentiment_score": "0.066592",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TFC",
                    "relevance_score": "0.11983",
                    "ticker_sentiment_score": "-0.06199",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.11983",
                    "ticker_sentiment_score": "0.107429",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.11983",
                    "ticker_sentiment_score": "0.107429",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.11983",
                    "ticker_sentiment_score": "0.107429",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.236972",
                    "ticker_sentiment_score": "0.156901",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.11983",
                    "ticker_sentiment_score": "-0.06199",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.11983",
                    "ticker_sentiment_score": "0.066592",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.11983",
                    "ticker_sentiment_score": "0.066592",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Prediction: This Will Be the First Trillion-Dollar Healthcare Stock",
            "url": "https://www.fool.com/investing/2024/01/21/prediction-this-will-be-the-first-trillion-dollar/",
            "time_published": "20240121T160200",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "This company is currently firing on all cylinders.",
            "banner_image": "https://g.foolcdn.com/editorial/images/761056/doctor-with-patient-talking.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.929393"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.77141"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.267579,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.637818",
                    "ticker_sentiment_score": "0.397667",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.220809",
                    "ticker_sentiment_score": "0.191225",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.220809",
                    "ticker_sentiment_score": "0.213931",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.166551",
                    "ticker_sentiment_score": "0.132619",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Walgreens Boots Alliance Just Cut Its Dividend: Here Are 2 Companies That Won't",
            "url": "https://www.fool.com/investing/2024/01/21/walgreens-boots-alliance-just-cut-its-dividend-her/",
            "time_published": "20240121T154500",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "Not every dividend stock is created equal, and these two far exceed Walgreens Boots Alliance.",
            "banner_image": "https://g.foolcdn.com/editorial/images/761057/patient-and-doctor-talking.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.87644"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.23915,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.393241",
                    "ticker_sentiment_score": "0.306164",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.340915",
                    "ticker_sentiment_score": "0.071285",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WBA",
                    "relevance_score": "0.116914",
                    "ticker_sentiment_score": "-0.109065",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Markets tried to fight the Fed on rate cuts. It didn't work | Business",
            "url": "https://www.cnn.com/2024/01/21/markets/stocks-week-ahead-markets-fight-the-fed/index.html",
            "time_published": "20240121T123000",
            "authors": [
                "Bryan Mena"
            ],
            "summary": "Markets are trying to fight the Fed on rate cuts. It's not working ...",
            "banner_image": "https://media.cnn.com/api/v1/images/stellar/prod/2024-01-17t192225z-1409670814-rc207s9xpy7v-rtrmadp-3-usa-fed-beigebook.JPG?c=16x9&q=w_800,c_fill",
            "source": "CNN",
            "category_within_source": "Markets",
            "source_domain": "www.cnn.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.999937"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.682689"
                }
            ],
            "overall_sentiment_score": -0.036215,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.029292",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.029292",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.029292",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.029292",
                    "ticker_sentiment_score": "0.103343",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.029292",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAH",
                    "relevance_score": "0.029292",
                    "ticker_sentiment_score": "0.048689",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CL",
                    "relevance_score": "0.029292",
                    "ticker_sentiment_score": "0.048689",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAL",
                    "relevance_score": "0.029292",
                    "ticker_sentiment_score": "-0.001895",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LUV",
                    "relevance_score": "0.029292",
                    "ticker_sentiment_score": "-0.001895",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.029292",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.029292",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CMA",
                    "relevance_score": "0.029292",
                    "ticker_sentiment_score": "-0.015733",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.029292",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WBD",
                    "relevance_score": "0.087717",
                    "ticker_sentiment_score": "-0.036394",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.029292",
                    "ticker_sentiment_score": "0.048689",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.029292",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CCZ",
                    "relevance_score": "0.029292",
                    "ticker_sentiment_score": "-0.001895",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COF",
                    "relevance_score": "0.029292",
                    "ticker_sentiment_score": "-0.001895",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.029292",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "My 5 Top Dividend Stocks to Buy Hand Over Fist in 2024",
            "url": "https://www.fool.com/investing/2024/01/21/my-5-top-dividend-stocks-to-buy-in-2024/",
            "time_published": "20240121T111700",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "These stocks may help you win in 2024 -- no matter what the market does.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F761894%2Fgettyimages-1172040755.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999365"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.983783"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.344613,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.231332",
                    "ticker_sentiment_score": "0.17327",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.078099",
                    "ticker_sentiment_score": "0.311035",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.116914",
                    "ticker_sentiment_score": "0.107532",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.155451",
                    "ticker_sentiment_score": "0.226339",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.078099",
                    "ticker_sentiment_score": "0.188048",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "24 Dividend Growth Stocks to Buy and Hold in 2024",
            "url": "https://www.fool.com/investing/2024/01/21/24-dividend-growth-stocks-to-buy-and-hold-in-2024/",
            "time_published": "20240121T105100",
            "authors": [
                "Keith Speights"
            ],
            "summary": "Dividends are good. Growing dividends are even better.",
            "banner_image": "https://g.foolcdn.com/editorial/images/761751/excited-investor-looks-at-financial-charts-on-computer.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.658903"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.714479"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.360211,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "IIPR",
                    "relevance_score": "0.030958",
                    "ticker_sentiment_score": "0.140815",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.153863",
                    "ticker_sentiment_score": "0.303904",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.061869",
                    "ticker_sentiment_score": "0.190566",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.092688",
                    "ticker_sentiment_score": "0.175204",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MA",
                    "relevance_score": "0.030958",
                    "ticker_sentiment_score": "0.391015",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.030958",
                    "ticker_sentiment_score": "0.141351",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.030958",
                    "ticker_sentiment_score": "0.225235",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.030958",
                    "ticker_sentiment_score": "0.141351",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.061869",
                    "ticker_sentiment_score": "0.127185",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.030958",
                    "ticker_sentiment_score": "0.391015",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "The 4 most important things we're watching in the stock market this coming week",
            "url": "https://www.cnbc.com/2024/01/20/4-most-important-things-were-watching-in-the-stock-market-this-week.html",
            "time_published": "20240120T151348",
            "authors": [
                "Zev Fima"
            ],
            "summary": "On tap: A handful of key economic updates and a ramp up of quarterly earnings reports.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107228796-16820124152023-04-20t170239z_662865409_rc2gi0azj08i_rtrmadp_0_procter-gamble-discounts.jpeg?v=1682077018&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.838487"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.98396"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.838487"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.142857"
                }
            ],
            "overall_sentiment_score": 0.050355,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SMBK",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LVS",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SASR",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "-0.028099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GSBC",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFC",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RJF",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OLN",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RBB",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.063313",
                    "ticker_sentiment_score": "0.109065",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STX",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CZBS",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FIZN",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WDC",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VBTX",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LBRT",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FNLC",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "0.025984",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NSC",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KMB",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "0.239932",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "FXNC",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "0.025984",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PEBO",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "-0.028099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BKR",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FRBA",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAL",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AIT",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CASH",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BKU",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TFIN",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CVLG",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WSBC",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FCX",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PGR",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HXL",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CFB",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNI",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PCAR",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "-0.028099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ONB",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "-0.028099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "0.023582",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AGNC",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TXN",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "URI",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ASML",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OFG",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TXT",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EWBC",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KNX",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IBM",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BX",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HAFC",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRCX",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VLO",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CACI",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNUN",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COF",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LHX",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMI",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KLAC",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.255971",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VLY",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RMD",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CL",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SFNC",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NEE",
                    "relevance_score": "0.063313",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HAL",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "-0.028099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UCBI",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CFFN",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ETD",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BOKF",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NEP",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TRST",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "APPF",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TAL",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IBTX",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALK",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BLFY",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DCOM",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LOGI",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "-0.028099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNXC",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRN",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GNTX",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALV",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AUB",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "-0.028099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ELV",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EFSG",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EDU",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HBT",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MMYT",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "-0.028099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYF",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "-0.028099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NOC",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SHW",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMP",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "-0.106994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZIONL",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MUR",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NOK",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MMM",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "-0.028099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PKG",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NOW",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BFST",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MNRO",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RNST",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TRMK",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STLD",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FHB",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SAP",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "-0.028099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HBCP",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MBLY",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNB",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "-0.025109",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FCCO",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "-0.028099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "0.239932",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UNP",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CBU",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "-0.028099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GD",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AGYS",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "-0.028099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "0.239932",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CVRX",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CCI",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TDY",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAH",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WBS",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "-0.028099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LUV",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QCRH",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TMUS",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "-0.028099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PB",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WTBA",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.063313",
                    "ticker_sentiment_score": "-0.020003",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "APH",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TEL",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.029072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CCZ",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COLB",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRO",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 High-Flying Stocks That Could Soar Even More in 2024",
            "url": "https://www.fool.com/investing/2024/01/20/3-high-flying-stocks-that-could-soar-even-more-in/",
            "time_published": "20240120T115000",
            "authors": [
                "David Jagielski",
                "Keith Speights",
                "and Prosper Junior Bakiny"
            ],
            "summary": "These big winners could keep the momentum going.",
            "banner_image": "https://g.foolcdn.com/editorial/images/761822/dna-on-monitor-scientists.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.87644"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.284698,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.260652",
                    "ticker_sentiment_score": "0.195213",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.044222",
                    "ticker_sentiment_score": "0.26179",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.044222",
                    "ticker_sentiment_score": "0.056817",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.30211",
                    "ticker_sentiment_score": "0.160317",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.044222",
                    "ticker_sentiment_score": "-0.005924",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The 2024 Dogs of the Dow: Which Ones Are Buys Right Now?",
            "url": "https://www.fool.com/investing/2024/01/20/the-2024-dogs-of-the-dow-which-ones-are-buys/",
            "time_published": "20240120T105000",
            "authors": [
                "Keith Speights"
            ],
            "summary": "A few of these Dogs of the Dow can probably hunt in the new year.",
            "banner_image": "https://g.foolcdn.com/editorial/images/761534/dog-laptop-person.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.143805,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KO",
                    "relevance_score": "0.067536",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "0.198925",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WBA",
                    "relevance_score": "0.067536",
                    "ticker_sentiment_score": "-0.114585",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - RYZB, THRX, AMAM, CSTR",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36704959/shareholder-alert-the-m-a-class-action-firm-continues-investigating-the-merger-ryzb-thrx-amam-cstr",
            "time_published": "20240120T010000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "NEW YORK, Jan. 19, 2024 ( GLOBE NEWSWIRE ) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC ( the \"M&A Class Action Firm\" ) , a national securities firm rated Top 50 in the 2018-2022 ISS Securities Class Action Services Report and ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.928769"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.348873,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CSTR",
                    "relevance_score": "0.269033",
                    "ticker_sentiment_score": "0.312256",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ONB",
                    "relevance_score": "0.068502",
                    "ticker_sentiment_score": "0.15954",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.269033",
                    "ticker_sentiment_score": "0.251355",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.068502",
                    "ticker_sentiment_score": "0.127176",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RYZB",
                    "relevance_score": "0.269033",
                    "ticker_sentiment_score": "0.239471",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "THRX",
                    "relevance_score": "0.269033",
                    "ticker_sentiment_score": "0.22137",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.068502",
                    "ticker_sentiment_score": "0.121075",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Cramer's week ahead: Earnings from Procter & Gamble, Tesla, Lockheed Martin",
            "url": "https://www.cnbc.com/2024/01/19/cramers-week-ahead-earnings-from-procter-gamble-tesla-lockheed-martin.html",
            "time_published": "20240119T233625",
            "authors": [
                "Julie Coleman"
            ],
            "summary": "CNBC's Jim Cramer guided investors through next week's Wall Street action, telling them to gear up for a slew of earnings reports.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107059904-1652322792218-200222_IMG_0732.jpg?v=1694819187&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.891286"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.110729,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.07913",
                    "ticker_sentiment_score": "0.195526",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.07913",
                    "ticker_sentiment_score": "-0.091502",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.07913",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SHW",
                    "relevance_score": "0.07913",
                    "ticker_sentiment_score": "-0.05726",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.157483",
                    "ticker_sentiment_score": "0.251301",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LOGI",
                    "relevance_score": "0.07913",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.07913",
                    "ticker_sentiment_score": "0.195526",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.234307",
                    "ticker_sentiment_score": "0.235046",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.234307",
                    "ticker_sentiment_score": "0.212822",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UNP",
                    "relevance_score": "0.07913",
                    "ticker_sentiment_score": "-0.05726",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NOW",
                    "relevance_score": "0.07913",
                    "ticker_sentiment_score": "0.187334",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.308891",
                    "ticker_sentiment_score": "0.38553",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "LRCX",
                    "relevance_score": "0.07913",
                    "ticker_sentiment_score": "0.187334",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.07913",
                    "ticker_sentiment_score": "-0.05726",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.07913",
                    "ticker_sentiment_score": "0.195526",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NSC",
                    "relevance_score": "0.07913",
                    "ticker_sentiment_score": "-0.05726",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Tesla, Netflix, GE Earnings: Investing Action Plan",
            "url": "https://www.investors.com/research/investing-action-plan/tesla-netflix-ge-earnings-investing-action-plan/",
            "time_published": "20240119T220000",
            "authors": [
                "Investor's Business Daily",
                "IBD STAFF"
            ],
            "summary": "The Nasdaq set a hot pace as the market's rally hammered out yet another weekly gain. The S&P 500 turned early-week losses into a 1.5% advance, taking a record high. The Dow rose 0.7% to test resistance just below 38,000. IBD continues to hold its exposure recommendation to between 80% and 100%.",
            "banner_image": "https://www.investors.com/wp-content/uploads/2018/04/stock-GE-12-company.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.977154"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999998"
                }
            ],
            "overall_sentiment_score": 0.104897,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KLAC",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.015303",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.206685",
                    "ticker_sentiment_score": "0.142639",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.069596",
                    "ticker_sentiment_score": "0.145709",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GTLB",
                    "relevance_score": "0.138663",
                    "ticker_sentiment_score": "0.136532",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INTU",
                    "relevance_score": "0.138663",
                    "ticker_sentiment_score": "0.136532",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LOGI",
                    "relevance_score": "0.069596",
                    "ticker_sentiment_score": "0.050162",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.069596",
                    "ticker_sentiment_score": "0.042131",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TXN",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.015303",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAL",
                    "relevance_score": "0.069596",
                    "ticker_sentiment_score": "0.145709",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ASML",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.015303",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TXT",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.05994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.069596",
                    "ticker_sentiment_score": "-0.054788",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.172836",
                    "ticker_sentiment_score": "0.038869",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.172836",
                    "ticker_sentiment_score": "0.001425",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRCX",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.015303",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.154859",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "RCL",
                    "relevance_score": "0.138663",
                    "ticker_sentiment_score": "0.136532",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SAVE",
                    "relevance_score": "0.069596",
                    "ticker_sentiment_score": "0.145709",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HXL",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.05994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.069596",
                    "ticker_sentiment_score": "0.103426",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AFRM",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.120286",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.138663",
                    "ticker_sentiment_score": "0.008798",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Q4 Earnings Results Reflect Stability",
            "url": "https://www.zacks.com/commentary/2213047/q4-earnings-results-reflect-stability",
            "time_published": "20240119T214800",
            "authors": [
                "Sheraz Mian"
            ],
            "summary": "The picture emerging from the Q4 earnings season thus far has been good enough - not great, but definitely not bad either. Next week, we shift into a much higher gear, with 71 S&P 500 members scheduled to report.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/82/15974.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.014277,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.098862",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.098862",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.098862",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.098862",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "How Is The Market Feeling About Johnson & Johnson? - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/insights/short-sellers/24/01/36700113/how-is-the-market-feeling-about-johnson-johnson",
            "time_published": "20240119T190026",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Johnson & Johnson's JNJ short percent of float has fallen 18.75% since its last report. The company recently reported that it has 12.47 million shares sold short, which is 0.52% of all regular shares that are available for trading.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.237013,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.221819",
                    "ticker_sentiment_score": "0.081322",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Global Transdermal Skin Patches Market Forecast Report, 2024-2030: A $9.9B Projected Industry, Dominated by Teva Pharma, 3M Company, Nitto Denko Corporation, and Johnson & Johnson",
            "url": "https://www.prnewswire.com/news-releases/global-transdermal-skin-patches-market-forecast-report-2024-2030-a-9-9b-projected-industry-dominated-by-teva-pharma-3m-company-nitto-denko-corporation-and-johnson--johnson-302039341.html",
            "time_published": "20240119T171500",
            "authors": [
                "Research and Markets"
            ],
            "summary": "Global Transdermal Skin Patches Market Forecast Report, 2024-2030: A $9.9B Projected Industry, Dominated by Teva ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.292081,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NDEKF",
                    "relevance_score": "0.031738",
                    "ticker_sentiment_score": "0.121467",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BDRFF",
                    "relevance_score": "0.031738",
                    "ticker_sentiment_score": "0.121467",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.031738",
                    "ticker_sentiment_score": "0.121467",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.063425",
                    "ticker_sentiment_score": "0.143639",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VTRS",
                    "relevance_score": "0.031738",
                    "ticker_sentiment_score": "0.121467",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LYPHF",
                    "relevance_score": "0.031738",
                    "ticker_sentiment_score": "0.121467",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.031738",
                    "ticker_sentiment_score": "0.121467",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.031738",
                    "ticker_sentiment_score": "0.121467",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MMM",
                    "relevance_score": "0.063425",
                    "ticker_sentiment_score": "0.126538",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Hyaluronic Acid Serums Market Targets US$ 506.4 Million by 2033 at 5.9% CAGR, Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36697064/hyaluronic-acid-serums-market-targets-us-506-4-million-by-2033-at-5-9-cagr-persistence-market-rese",
            "time_published": "20240119T154500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 19, 2024 ( GLOBE NEWSWIRE ) -- Hyaluronic Acid Serums have witnessed significant growth in recent years, driven by increasing consumer awareness of skincare and anti-aging products.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.378706,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.022389",
                    "ticker_sentiment_score": "0.296668",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.022389",
                    "ticker_sentiment_score": "-0.0018",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSDOF",
                    "relevance_score": "0.022389",
                    "ticker_sentiment_score": "-0.0018",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.022389",
                    "ticker_sentiment_score": "-0.0018",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LFCR",
                    "relevance_score": "0.022389",
                    "ticker_sentiment_score": "-0.0018",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.022389",
                    "ticker_sentiment_score": "-0.0018",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BHC",
                    "relevance_score": "0.022389",
                    "ticker_sentiment_score": "-0.0018",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRLCF",
                    "relevance_score": "0.022389",
                    "ticker_sentiment_score": "-0.0018",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.022389",
                    "ticker_sentiment_score": "-0.0018",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "J&J  ( JNJ )  Gears Up to Report Q4 Earnings: What's in Store?",
            "url": "https://www.zacks.com/stock/news/2212628/jj-jnj-gears-up-to-report-q4-earnings-whats-in-store",
            "time_published": "20240119T123900",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "J&J's (JNJ) Innovative Medicines unit sales are expected to have been driven by drugs like Darzalex and Stelara. Surgical procedure recovery and new products are likely to have driven MedTech sales.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/39/612.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.99989"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.796627"
                }
            ],
            "overall_sentiment_score": 0.169178,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.113597",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.279015",
                    "ticker_sentiment_score": "-0.03092",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.224903",
                    "ticker_sentiment_score": "0.093117",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Shampoo Market to Surge with 5.57% CAGR, Anticipated Valuation Exceeds US$ 50.37 Billion by 2034 | Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36691119/shampoo-market-to-surge-with-5-57-cagr-anticipated-valuation-exceeds-us-50-37-billion-by-2034-pers",
            "time_published": "20240119T085000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 19, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The shampoo market is a vital segment within the broader personal care and grooming industry, catering to the basic hygiene and aesthetic needs of consumers worldwide.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": 0.44268,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KAOCF",
                    "relevance_score": "0.02866",
                    "ticker_sentiment_score": "0.108676",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRLCF",
                    "relevance_score": "0.057284",
                    "ticker_sentiment_score": "0.114999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.02866",
                    "ticker_sentiment_score": "0.107706",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.02866",
                    "ticker_sentiment_score": "0.09809",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UL",
                    "relevance_score": "0.042979",
                    "ticker_sentiment_score": "0.127015",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Hepatitis C Virus Testing Market Poised to Expand at a 5.8% CAGR, Surpassing US$1,185.2 Million by 2030 | Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36691001/hepatitis-c-virus-testing-market-poised-to-expand-at-a-5-8-cagr-surpassing-us-1-185-2-million-by-2",
            "time_published": "20240119T083000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 19, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The Hepatitis C Virus ( HCV ) Testing Market is a dynamic and evolving sector within the healthcare industry, driven by the persistent threat posed by the Hepatitis C Virus.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.33534,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HOLX",
                    "relevance_score": "0.025775",
                    "ticker_sentiment_score": "0.244618",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.038655",
                    "ticker_sentiment_score": "0.080127",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OSUR",
                    "relevance_score": "0.012889",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.012889",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TMO",
                    "relevance_score": "0.012889",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIO",
                    "relevance_score": "0.025775",
                    "ticker_sentiment_score": "0.116589",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QGEN",
                    "relevance_score": "0.025775",
                    "ticker_sentiment_score": "0.151882",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "List Price Of Ozempic And Other Drugs Reportedly Rise: Here's What That Means For Consumers",
            "url": "https://www.forbes.com/sites/ariannajohnson/2024/01/18/list-price-of-ozempic-and-other-drugs-reportedly-rise-heres-what-that-means-for-consumers/",
            "time_published": "20240118T194930",
            "authors": [
                "Arianna Johnson"
            ],
            "summary": "Almost 800 medications-including Ozempic and Mounjaro-had a median list price increase of 4.5% this month, according to a Wall Street Journal report, meaning copays may increase for consumers.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/651ed914b753a9b834db1a57/0x0.jpg?format=jpg&crop=3317,1864,x0,y171,safe&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.061908,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.113329",
                    "ticker_sentiment_score": "0.068214",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.056808",
                    "ticker_sentiment_score": "0.046999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.113329",
                    "ticker_sentiment_score": "0.052573",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.056808",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.113329",
                    "ticker_sentiment_score": "0.052573",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Wall Street's Insights Into Key Metrics Ahead of Johnson & Johnson  ( JNJ )  Q4 Earnings",
            "url": "https://www.zacks.com/stock/news/2212378/wall-streets-insights-into-key-metrics-ahead-of-johnson-johnson-jnj-q4-earnings",
            "time_published": "20240118T175600",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Get a deeper insight into the potential performance of Johnson & Johnson (JNJ) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default175.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.947132"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.070098,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.345674",
                    "ticker_sentiment_score": "0.079971",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Nivolumab Market Overview 2024-2028: Global Expansion Driven By Immunotherapy Advancements And Rising Cancer Incidence As Per The Business Research Company's Nivolumab Global Market Report 2024",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36681451/nivolumab-market-overview-2024-2028-global-expansion-driven-by-immunotherapy-advancements-and-risi",
            "time_published": "20240118T163000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LONDON, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Nivolumab Global Market Report 2024, nivolumab market has experienced remarkable growth in recent years and is set to continue its upward trajectory, with the market size projected to reach $1.69 billion in 2024, ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.26794,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PFE",
                    "relevance_score": "0.061315",
                    "ticker_sentiment_score": "0.115659",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.061315",
                    "ticker_sentiment_score": "0.115659",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.061315",
                    "ticker_sentiment_score": "0.115659",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Otic Drugs Market To Surge At A CAGR Of 7.0%: Global Growth Driven By Rising Prevalence Of Ear Infections And Innovations In Drug Formulations As Per The Business Research Company's Otic Drugs Global Market Report 2024",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36681448/otic-drugs-market-to-surge-at-a-cagr-of-7-0-global-growth-driven-by-rising-prevalence-of-ear-infec",
            "time_published": "20240118T163000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LONDON, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Otic Drugs Global Market Report 2024, the otic drugs market has witnessed robust growth in recent years and is poised to continue its upward trajectory, with the market size projected to reach $1.71 billion in ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.255916,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PFE",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.097064",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.097064",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Inactivated Vaccines Market Set to Reach $7.3 Billion in 2028 - Global Growth Driven by Immunization Initiatives and Advancements in Biomanufacturing As Per The Business Research Company's Inactivated Vaccines Global Market Report 2024",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36681454/inactivated-vaccines-market-set-to-reach-7-3-billion-in-2028-global-growth-driven-by-immunization-",
            "time_published": "20240118T163000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LONDON, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Inactivated Vaccines Global Market Report 2024, the inactivated vaccines market has exhibited consistent growth, with the market size reaching $5.95 billion in 2023 and expected to climb to $6.19 billion in 2024, ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.277902,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SHTDF",
                    "relevance_score": "0.056808",
                    "ticker_sentiment_score": "0.180983",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GSK",
                    "relevance_score": "0.056808",
                    "ticker_sentiment_score": "0.180983",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.056808",
                    "ticker_sentiment_score": "0.180983",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.056808",
                    "ticker_sentiment_score": "0.180983",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Feminine Hygiene Market is poised to reach US$ 56.5 billion by 2033, with a projected CAGR of 6.0%, Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36681181/feminine-hygiene-market-is-poised-to-reach-us-56-5-billion-by-2033-with-a-projected-cagr-of-6-0-pe",
            "time_published": "20240118T161500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- The global market for feminine hygiene products has experienced notable growth and transformation due to evolving societal attitudes, increased awareness of women's health, and advancements in product innovation.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.272667,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "EPC",
                    "relevance_score": "0.038499",
                    "ticker_sentiment_score": "0.135783",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.019255",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KMB",
                    "relevance_score": "0.057721",
                    "ticker_sentiment_score": "0.085963",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.038499",
                    "ticker_sentiment_score": "0.171373",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.038499",
                    "ticker_sentiment_score": "0.137755",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Cardiac Sutures Market Estimated to Reach USD 2.3 billion, Advancing at a CAGR of 6.8% by 2031: Transparency Market Research, Inc.",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36680030/cardiac-sutures-market-estimated-to-reach-usd-2-3-billion-advancing-at-a-cagr-of-6-8-by-2031-trans",
            "time_published": "20240118T153000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Wilmington, Delaware, United States, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global cardiac sutures market is estimated to flourish at a CAGR of 6.8% from 2023 to 2031.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": 0.419293,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.036532",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.072987",
                    "ticker_sentiment_score": "0.121937",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMGTF",
                    "relevance_score": "0.109289",
                    "ticker_sentiment_score": "0.084521",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.036532",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.109289",
                    "ticker_sentiment_score": "0.118142",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TFX",
                    "relevance_score": "0.072987",
                    "ticker_sentiment_score": "0.328045",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Fibromyalgia Treatment Market Projected to Surpass US$ 2.7 Billion in Revenue by 2033, According to Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36679018/fibromyalgia-treatment-market-projected-to-surpass-us-2-7-billion-in-revenue-by-2033-according-to-",
            "time_published": "20240118T144500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The global revenue from the fibromyalgia treatment market stands at US$ 1.3 billion in 2022, with the global market expected to grow at a CAGR of 7.0% to reach a valuation of approximately US$ 2.7 billion by the end of 2033.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.256784,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "VIRI",
                    "relevance_score": "0.014775",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.014775",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WLDS",
                    "relevance_score": "0.014775",
                    "ticker_sentiment_score": "0.165509",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TNXP",
                    "relevance_score": "0.014775",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSOI",
                    "relevance_score": "0.014775",
                    "ticker_sentiment_score": "0.191305",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.014775",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2024 Will Be a Good Year for the Pharma Industry: The Kiplinger Letter",
            "url": "https://www.kiplinger.com/business/a-good-year-for-the-pharma-industry-the-kiplinger-letter",
            "time_published": "20240118T133015",
            "authors": [
                "Matthew Housiaux"
            ],
            "summary": "2024: The Pharma Industry's Good Year Kiplinger's Personal Finance ...",
            "banner_image": "https://cdn.mos.cms.futurecdn.net/UjiFXv5gKrsiSW4baf7dkN-415-80.jpg",
            "source": "Kiplinger",
            "category_within_source": "n/a",
            "source_domain": "www.kiplinger.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": 0.237549,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.19661",
                    "ticker_sentiment_score": "-0.0803",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.19661",
                    "ticker_sentiment_score": "0.059379",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.291182",
                    "ticker_sentiment_score": "0.032821",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.099066",
                    "ticker_sentiment_score": "0.066677",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.19661",
                    "ticker_sentiment_score": "-0.0803",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.099066",
                    "ticker_sentiment_score": "0.066677",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Active Wound Care Market Size to be Worth USD 451.9 million by 2031, with Notable CAGR of 7.3%| Transparency Market Research, Inc.",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36676060/active-wound-care-market-size-to-be-worth-usd-451-9-million-by-2031-with-notable-cagr-of-7-3-trans",
            "time_published": "20240118T130000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Wilmington, Delaware, United States, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global active wound care market was projected to attain US$ 242.2 million in 2022. It is anticipated to garner a 7.3% CAGR from 2023 to 2031 and by 2031.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                }
            ],
            "overall_sentiment_score": 0.176319,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "IART",
                    "relevance_score": "0.037155",
                    "ticker_sentiment_score": "0.385239",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.037155",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMGTF",
                    "relevance_score": "0.111144",
                    "ticker_sentiment_score": "0.070156",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.037155",
                    "ticker_sentiment_score": "0.385239",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Oral Hygiene Products Market Size & Share to Surpass US$ 34.1 Billion by 2033 | Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36673864/oral-hygiene-products-market-size-share-to-surpass-us-34-1-billion-by-2033-persistence-market-rese",
            "time_published": "20240118T104500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: In 2022, the global revenue from oral hygiene products reached US$ 22.3 billion, and it is projected to experience a Compound Annual Growth Rate ( CAGR ) of 3.9%, reaching a valuation of US$ 34.1 billion by 2033.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Blockchain",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.342232,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CL",
                    "relevance_score": "0.017219",
                    "ticker_sentiment_score": "0.316684",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MMM",
                    "relevance_score": "0.017219",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.017219",
                    "ticker_sentiment_score": "0.388599",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.017219",
                    "ticker_sentiment_score": "0.132825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UL",
                    "relevance_score": "0.017219",
                    "ticker_sentiment_score": "0.189217",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Catheter Associated Urinary Tract Infections Treatment Market Surges with a Promising CAGR of 4.0% through 2033 | Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36673659/catheter-associated-urinary-tract-infections-treatment-market-surges-with-a-promising-cagr-of-4-0-",
            "time_published": "20240118T101500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: The global market for treating catheter-associated urinary tract infections ( CAUTIs ) is projected to grow at a compound annual growth rate ( CAGR ) of 4.0%.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                }
            ],
            "overall_sentiment_score": 0.31153,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.044359",
                    "ticker_sentiment_score": "0.083244",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAYZF",
                    "relevance_score": "0.029581",
                    "ticker_sentiment_score": "0.12093",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.029581",
                    "ticker_sentiment_score": "0.063368",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.059121",
                    "ticker_sentiment_score": "0.096069",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSOI",
                    "relevance_score": "0.014793",
                    "ticker_sentiment_score": "0.096609",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.044359",
                    "ticker_sentiment_score": "0.123953",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.029581",
                    "ticker_sentiment_score": "0.13709",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( JNJ )  Stock Moves -0.06%: What You Should Know",
            "url": "https://www.zacks.com/stock/news/2211717/johnson-johnson-jnj-stock-moves--006-what-you-should-know",
            "time_published": "20240117T224519",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Johnson & Johnson (JNJ) concluded the recent trading session at $160.43, signifying a -0.06% move from its prior day's close.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default89.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.95493"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": 0.149789,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.556576",
                    "ticker_sentiment_score": "0.16099",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Dry Skin Cream, Lotion, And Ointment Market Set to Soar 8.5% to $59.4 Billion by 2030, Insights by Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36662794/dry-skin-cream-lotion-and-ointment-market-set-to-soar-8-5-to-59-4-billion-by-2030-insights-by-pers",
            "time_published": "20240117T160000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 17, 2024 ( GLOBE NEWSWIRE ) -- Dry skin cream, lotion, and ointment form an essential category dedicated to fulfilling the needs of individuals dealing with dry skin conditions. These formulations are intricately designed to provide hydration, nourishment, and relief to dry and ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.411708,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LRLCF",
                    "relevance_score": "0.017915",
                    "ticker_sentiment_score": "0.274721",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.035821",
                    "ticker_sentiment_score": "0.234516",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.017915",
                    "ticker_sentiment_score": "-0.097645",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UL",
                    "relevance_score": "0.017915",
                    "ticker_sentiment_score": "0.274721",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Tr1X, Inc. Announces $75 Million Series A Financing to Develop Best-in-Class Universal Allogeneic Regulatory T  ( Treg )  and CAR-Treg Cell Therapies to Treat and Potentially Cure Autoimmune and Inflammatory Diseases",
            "url": "https://www.prnewswire.com/news-releases/tr1x-inc-announces-75-million-series-a-financing-to-develop-best-in-class-universal-allogeneic-regulatory-t-treg-and-car-treg-cell-therapies-to-treat-and-potentially-cure-autoimmune-and-inflammatory-diseases-302036679.html",
            "time_published": "20240117T133000",
            "authors": [
                "Inc.",
                "Tr1X"
            ],
            "summary": "Tr1X, Inc. Announces $75 Million Series A Financing to Develop Best-in-Class Universal Allogeneic Regulatory T ( Treg ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/2320244/Tr1X_logo_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.15206,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ANAB",
                    "relevance_score": "0.022202",
                    "ticker_sentiment_score": "0.015893",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GRPH",
                    "relevance_score": "0.022202",
                    "ticker_sentiment_score": "0.061917",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.022202",
                    "ticker_sentiment_score": "0.061917",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.044386",
                    "ticker_sentiment_score": "0.048031",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HHH",
                    "relevance_score": "0.022202",
                    "ticker_sentiment_score": "0.015893",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INCY",
                    "relevance_score": "0.022202",
                    "ticker_sentiment_score": "0.061013",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JSPR",
                    "relevance_score": "0.022202",
                    "ticker_sentiment_score": "0.028304",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EGRNQ",
                    "relevance_score": "0.022202",
                    "ticker_sentiment_score": "0.015893",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.044386",
                    "ticker_sentiment_score": "0.043125",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:GBP",
                    "relevance_score": "0.022202",
                    "ticker_sentiment_score": "0.015893",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Cell Therapy Market Global Surge to Over USD 26.8 Billion by 2033, Fueled by Growing Demand in United States",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36658512/cell-therapy-market-global-surge-to-over-usd-26-8-billion-by-2033-fueled-by-growing-demand-in-unit",
            "time_published": "20240117T132147",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 17, 2024 ( GLOBE NEWSWIRE ) -- According to Market.us, the global Cell Therapy Market size is forecasted to exceed USD 26.8 Billion by 2033, with a promising CAGR of 16.9% from 2024 to 2033.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.310463,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ALLO",
                    "relevance_score": "0.018802",
                    "ticker_sentiment_score": "0.168923",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BLUE",
                    "relevance_score": "0.018802",
                    "ticker_sentiment_score": "0.187222",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.018802",
                    "ticker_sentiment_score": "-0.142541",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.018802",
                    "ticker_sentiment_score": "0.187222",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.056363",
                    "ticker_sentiment_score": "0.182015",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ATRA",
                    "relevance_score": "0.018802",
                    "ticker_sentiment_score": "-0.142541",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSOI",
                    "relevance_score": "0.037593",
                    "ticker_sentiment_score": "0.167406",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.037593",
                    "ticker_sentiment_score": "0.071135",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JCRRF",
                    "relevance_score": "0.018802",
                    "ticker_sentiment_score": "-0.142541",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TAK",
                    "relevance_score": "0.018802",
                    "ticker_sentiment_score": "-0.142541",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors - Kymera Therapeutics  ( NASDAQ:KYMR ) , Nanobiotix  ( NASDAQ:NBTX ) ",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36657953/invo-bioscience-files-s-4-registration-and-preliminary-joint-proxy-statements-in-connection-with-m",
            "time_published": "20240117T130000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "INVO INVO and NAYA Biosciences expect to close their previously announced merger in the first quarter of 2024 Experienced, entrepreneurial leadership team to help structure merged public company and accelerate growth",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "Mergers",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.938238"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999999"
                }
            ],
            "overall_sentiment_score": 0.270204,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KYMR",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.062746",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PTCT",
                    "relevance_score": "0.019928",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VIRX",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ORTX",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SLN",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.019928",
                    "ticker_sentiment_score": "0.03272",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MRES",
                    "relevance_score": "0.019928",
                    "ticker_sentiment_score": "0.069924",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INVO",
                    "relevance_score": "0.575903",
                    "ticker_sentiment_score": "0.425763",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NBTX",
                    "relevance_score": "0.059736",
                    "ticker_sentiment_score": "0.037994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HCSG",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.149526",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.019928",
                    "ticker_sentiment_score": "0.03272",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Invest in the Vanguard Health Care ETF  ( VHT ) ?",
            "url": "https://www.zacks.com/stock/news/2211196/should-you-invest-in-the-vanguard-health-care-etf-vht",
            "time_published": "20240117T112007",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default100.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.232494,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.064698",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.068306",
                    "ticker_sentiment_score": "0.125875",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.064698",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.064698",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Skin Toner Market Set to Surge to US$ 2.0 Billion by 2030 Driven by Soaring Worldwide Demand for Full Ingredient Transparency | Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36655653/skin-toner-market-set-to-surge-to-us-2-0-billion-by-2030-driven-by-soaring-worldwide-demand-for-fu",
            "time_published": "20240117T101500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 17, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: The skin toner market is expected to witness a compound annual growth rate ( CAGR ) of 5.3%, leading to an increase from US$1.3 billion in 2023 to US$2.0 billion by the end of 2030.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.77141"
                }
            ],
            "overall_sentiment_score": 0.364975,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.039966",
                    "ticker_sentiment_score": "0.104837",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NAII",
                    "relevance_score": "0.02665",
                    "ticker_sentiment_score": "0.232565",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Alzheimer's Disease Diagnostics & Treatment Market Revenues to Reach US$11.9 Billion by 2030 - Market Size, Share, Forecasts, & Trends Analysis Report by Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36655498/alzheimers-disease-diagnostics-treatment-market-revenues-to-reach-us-11-9-billion-by-2030-market-s",
            "time_published": "20240117T100000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 17, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: The global market for Alzheimer's disease diagnostics and treatment is projected to experience a compound annual growth rate ( CAGR ) of 8.9%, reaching a value of US$11.9 billion by the end of 2030, up from US$6.5 billion ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.329342,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.01403",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.01403",
                    "ticker_sentiment_score": "0.076513",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.028056",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WLDS",
                    "relevance_score": "0.01403",
                    "ticker_sentiment_score": "0.16322",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ESALF",
                    "relevance_score": "0.028056",
                    "ticker_sentiment_score": "-0.053084",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.042073",
                    "ticker_sentiment_score": "0.148051",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.111877",
                    "ticker_sentiment_score": "0.14894",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates FGH, AXNX, AMAM, HARP - Ambrx Biopharma  ( NASDAQ:AMAM ) , Axonics  ( NASDAQ:AXNX ) ",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36653978/shareholder-rights-investigation-halper-sadeh-llc-investigates-fgh-axnx-amam-harp",
            "time_published": "20240117T050000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "NEW YORK, Jan. 17, 2024 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: FG Group Holdings Inc.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.77141"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.092629,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "FGF",
                    "relevance_score": "0.247838",
                    "ticker_sentiment_score": "0.131811",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.12546",
                    "ticker_sentiment_score": "0.089947",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.12546",
                    "ticker_sentiment_score": "0.089947",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HARP",
                    "relevance_score": "0.12546",
                    "ticker_sentiment_score": "0.089947",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXNX",
                    "relevance_score": "0.247838",
                    "ticker_sentiment_score": "0.142764",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.12546",
                    "ticker_sentiment_score": "0.089947",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Top 5 Life Science ETFs",
            "url": "https://investingnews.com/daily/life-science-investing/biotech-investing/top-performing-life-science-etfs/",
            "time_published": "20240116T211500",
            "authors": [
                "Melissa Pistilli"
            ],
            "summary": "Taking a position in a life science exchange-traded fund ( ETF ) provides exposure to a basket of stocks focused on the healthcare sector, while mitigating the risks of holding shares in a single company.",
            "banner_image": "https://investingnews.com/media-library/two-scientists-in-a-lab.jpg?id=27732936&width=1200&height=800&quality=85&coordinates=0%2C0%2C0%2C0",
            "source": "Investing News Network",
            "category_within_source": "n/a",
            "source_domain": "investingnews.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999476"
                }
            ],
            "overall_sentiment_score": 0.182618,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ARWR",
                    "relevance_score": "0.060085",
                    "ticker_sentiment_score": "0.081",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CYTK",
                    "relevance_score": "0.060085",
                    "ticker_sentiment_score": "0.081",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EXAS",
                    "relevance_score": "0.060085",
                    "ticker_sentiment_score": "0.052998",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.1789",
                    "ticker_sentiment_score": "0.109406",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KRTX",
                    "relevance_score": "0.060085",
                    "ticker_sentiment_score": "0.081",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RXRX",
                    "relevance_score": "0.060085",
                    "ticker_sentiment_score": "0.052998",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.060085",
                    "ticker_sentiment_score": "0.02205",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.1789",
                    "ticker_sentiment_score": "0.109406",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Options Trading: A Deep Dive into Market Sentiment - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/markets/options/24/01/36648551/johnson-johnson-options-trading-a-deep-dive-into-market-sentiment",
            "time_published": "20240116T193052",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Whales with a lot of money to spend have taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 11 trades. If we consider the specifics of each trade, it is accurate to state that 18% of the investors opened trades with bullish ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                }
            ],
            "overall_sentiment_score": 0.159589,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.083251",
                    "ticker_sentiment_score": "0.142327",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.535653",
                    "ticker_sentiment_score": "0.313788",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Molecular Diagnostics Market Hits US$ 39.5 Billion in 2022, Expected to Reach US$ 59.4 Billion by 2033 with a 4.2% CAGR, Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36643857/molecular-diagnostics-market-hits-us-39-5-billion-in-2022-expected-to-reach-us-59-4-billion-by-203",
            "time_published": "20240116T153000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- The Molecular Diagnostics Market is experiencing robust growth due to technological advancements and increasing demand for personalized medicine. Key applications include oncology, infectious diseases, genetic testing, and cardiovascular diseases.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.263389,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "A",
                    "relevance_score": "0.019797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HOLX",
                    "relevance_score": "0.019797",
                    "ticker_sentiment_score": "-0.14516",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BDX",
                    "relevance_score": "0.019797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.019797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TMO",
                    "relevance_score": "0.019797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIO",
                    "relevance_score": "0.019797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GRFS",
                    "relevance_score": "0.019797",
                    "ticker_sentiment_score": "0.089741",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QGEN",
                    "relevance_score": "0.019797",
                    "ticker_sentiment_score": "0.071657",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DHR",
                    "relevance_score": "0.019797",
                    "ticker_sentiment_score": "0.132145",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Liquid Soap Market Bubbles Up to USD 35.70 Billion by 2030, Report by Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36642766/liquid-soap-market-bubbles-up-to-usd-35-70-billion-by-2030-report-by-persistence-market-research",
            "time_published": "20240116T144500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The global liquid soap market size was valued at USD 21.18 billion in 2022 and is projected to grow from USD 22.46 billion in 2023 to USD 35.70 billion by 2030, exhibiting a CAGR of 6.84% during the forecast period.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.349971,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BDRFF",
                    "relevance_score": "0.016383",
                    "ticker_sentiment_score": "0.14692",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.032758",
                    "ticker_sentiment_score": "0.085756",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.016383",
                    "ticker_sentiment_score": "0.084095",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UL",
                    "relevance_score": "0.032758",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HENKY",
                    "relevance_score": "0.016383",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CL",
                    "relevance_score": "0.016383",
                    "ticker_sentiment_score": "0.102022",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ECL",
                    "relevance_score": "0.032758",
                    "ticker_sentiment_score": "0.090551",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RBGPF",
                    "relevance_score": "0.032758",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "After-sun Products Market is Anticipated to Reach USD 3.3 billion at a CAGR of 3.7 % CAGR by 2031 - Report by Transparency Market Research, Inc.",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36642400/after-sun-products-market-is-anticipated-to-reach-usd-3-3-billion-at-a-cagr-of-3-7-cagr-by-2031-re",
            "time_published": "20240116T143000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Wilmington, Delaware, United States, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - After-sun products accounted for a global market value of US$ 2.4 billion in 2022. From 2023 to 2031, it is expected to expand at a CAGR of 3.7%, reaching US$ 3.3 billion by 2031.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.382977,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.038407",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMGTF",
                    "relevance_score": "0.114865",
                    "ticker_sentiment_score": "0.160374",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.038407",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.038407",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc.  ( Nasdaq - AMAM ) , Gracell Biotechnologies Inc.  ( Nasdaq - GRCL ) , Axonics, Inc.  ( Nasdaq - AXNX ) , Harpoon Therapeutics, Inc.  ( Nasdaq - HARP ) ",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36638641/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ambrx-biophar",
            "time_published": "20240116T130500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "BALA CYNWYD, Pa., Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.796627"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.232971,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.233556",
                    "ticker_sentiment_score": "0.266779",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.233556",
                    "ticker_sentiment_score": "0.068874",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GRCL",
                    "relevance_score": "0.07887",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.07887",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.233556",
                    "ticker_sentiment_score": "0.235274",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HARP",
                    "relevance_score": "0.07887",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.15697",
                    "ticker_sentiment_score": "0.156505",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AXNX",
                    "relevance_score": "0.233556",
                    "ticker_sentiment_score": "0.216405",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Ecovyst Names Kara L. Thornton Vice President and Chief Human Resources Officer",
            "url": "https://www.prnewswire.com/news-releases/ecovyst-names-kara-l-thornton-vice-president-and-chief-human-resources-officer-302033970.html",
            "time_published": "20240116T120000",
            "authors": [
                "Ecovyst Inc."
            ],
            "summary": "MALVERN, Pa., Jan. 16, 2024 /PRNewswire/ -- Ecovyst Inc. ( NYSE: ECVT ) ( \"Ecovyst\" or the \"Company\" ) , a leading integrated and innovative global provider of advanced materials,specialty catalysts and services, today announced that Kara L. Thornton has been appointed Vice President and Chief ...",
            "banner_image": "https://mma.prnewswire.com/media/2243202/Ecovyst_hi_res_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.410021,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SKXJF",
                    "relevance_score": "0.102013",
                    "ticker_sentiment_score": "-0.057567",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STIM",
                    "relevance_score": "0.102013",
                    "ticker_sentiment_score": "-0.057567",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ECVT",
                    "relevance_score": "0.558244",
                    "ticker_sentiment_score": "0.673579",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.102013",
                    "ticker_sentiment_score": "-0.057567",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Asia Pacific Facial Care Market Projected to Reach USD 88.4 billion, Growing at a CAGR of 6.9% by 2031: Transparency Market Research, Inc.",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36634032/asia-pacific-facial-care-market-projected-to-reach-usd-88-4-billion-growing-at-a-cagr-of-6-9-by-20",
            "time_published": "20240116T023000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Wilmington, Delaware, United States, Jan. 15, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The Asia Pacific facial care market is estimated to flourish at a CAGR of 6.9% from 2021 to 2031.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.480199,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.03448",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KAOCF",
                    "relevance_score": "0.103183",
                    "ticker_sentiment_score": "0.430142",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "SSDOF",
                    "relevance_score": "0.068896",
                    "ticker_sentiment_score": "0.368024",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "KOSCF",
                    "relevance_score": "0.068896",
                    "ticker_sentiment_score": "0.426907",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.03448",
                    "ticker_sentiment_score": "-0.185059",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.03448",
                    "ticker_sentiment_score": "-0.185059",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "LRLCF",
                    "relevance_score": "0.068896",
                    "ticker_sentiment_score": "0.182255",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WMGTF",
                    "relevance_score": "0.103183",
                    "ticker_sentiment_score": "0.155413",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Bioplastics Packaging Market Projected to Hit US$ 8,913.1 Million by 2033 with a CAGR of 12.5% | Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36632333/bioplastics-packaging-market-projected-to-hit-us-8-913-1-million-by-2033-with-a-cagr-of-12-5-persi",
            "time_published": "20240115T183000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- In this section, we delve into a comprehensive analysis of the Bioplastics Packaging Market, offering insights into its current dynamics and future prospects.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.30023,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "EVKIF",
                    "relevance_score": "0.017729",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KDSKF",
                    "relevance_score": "0.017729",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.03545",
                    "ticker_sentiment_score": "0.214402",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.03545",
                    "ticker_sentiment_score": "0.265317",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MTLHF",
                    "relevance_score": "0.017729",
                    "ticker_sentiment_score": "0.246885",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.03545",
                    "ticker_sentiment_score": "0.265317",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CSNVF",
                    "relevance_score": "0.017729",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSBHF",
                    "relevance_score": "0.017729",
                    "ticker_sentiment_score": "0.246885",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ADM",
                    "relevance_score": "0.03545",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAK",
                    "relevance_score": "0.017729",
                    "ticker_sentiment_score": "0.08311",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Forget Meme Stocks and Bitcoin. These Investors Are Hunting Quality.",
            "url": "https://www.wsj.com/finance/stocks/forget-meme-stocks-and-bitcoin-these-investors-are-hunting-quality-1576454e",
            "time_published": "20240115T103000",
            "authors": [
                "Brenda León"
            ],
            "summary": "The targets are shares of companies with some combination of growth, reliable profits and strong balance sheets.",
            "banner_image": "https://images.wsj.net/im-911681/social",
            "source": "Wall Street Journal",
            "category_within_source": "Markets",
            "source_domain": "www.wsj.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.552435,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.535653",
                    "ticker_sentiment_score": "0.741737",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.535653",
                    "ticker_sentiment_score": "0.741737",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.535653",
                    "ticker_sentiment_score": "0.741737",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.535653",
                    "ticker_sentiment_score": "0.741737",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Eye Health Products Market: Projected to Attain US$ 4.7 Billion by 2033, Propelled by a Resilient 7.3% CAGR | Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36627196/eye-health-products-market-projected-to-attain-us-4-7-billion-by-2033-propelled-by-a-resilient-7-3",
            "time_published": "20240115T081000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 15, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The eye health products market is experiencing a surge in demand, fueled by a growing awareness of eye health, rising prevalence of eye diseases, and an aging global population.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.384775,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ALC",
                    "relevance_score": "0.036954",
                    "ticker_sentiment_score": "0.268271",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BLCO",
                    "relevance_score": "0.036954",
                    "ticker_sentiment_score": "0.133154",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BHC",
                    "relevance_score": "0.018482",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ESLOF",
                    "relevance_score": "0.018482",
                    "ticker_sentiment_score": "0.108049",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.018482",
                    "ticker_sentiment_score": "0.233091",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth",
            "url": "https://www.cnbc.com/2024/01/14/cancer-drugs-renewed-interest-in-adcs-will-continue-in-2024.html",
            "time_published": "20240114T131240",
            "authors": [
                "Annika Kim Constantino"
            ],
            "summary": "The JPMorgan Healthcare Conference was likely just the beginning of another year of heightened interest and investments in ADC cancer drugs.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107238280-1683650170075-gettyimages-1238822565-20090101220228-99-316819.jpeg?v=1705225358&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Business",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.099245,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.032691",
                    "ticker_sentiment_score": "-0.025298",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.032691",
                    "ticker_sentiment_score": "-0.024714",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.032691",
                    "ticker_sentiment_score": "0.092444",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.032691",
                    "ticker_sentiment_score": "-0.024714",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SKXJF",
                    "relevance_score": "0.065327",
                    "ticker_sentiment_score": "0.044577",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSKYF",
                    "relevance_score": "0.065327",
                    "ticker_sentiment_score": "0.044577",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.2258",
                    "ticker_sentiment_score": "0.05974",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.032691",
                    "ticker_sentiment_score": "-0.166405",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Virpax: A Promising Stock In A Sickly Biotech Market",
            "url": "https://www.forbes.com/sites/lawrencelight/2024/01/14/virpax-a-promising-stock-in-a-sickly-biotech-market/",
            "time_published": "20240114T130000",
            "authors": [
                "Larry Light"
            ],
            "summary": "Biotech always is a tough line of work, with a high failure rate because the research folks' ideas don't pan out, or even if they do, the Food and Drug Administration fails to approve their applications. Of the three FDA stages needed to greenlight a drug, the first has a mere 9% approval rate.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65a2ef10da7904ef829d856a/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.938793"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": -0.073166,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "REGN",
                    "relevance_score": "0.061949",
                    "ticker_sentiment_score": "0.165124",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VRPX",
                    "relevance_score": "0.061949",
                    "ticker_sentiment_score": "-0.125278",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.061949",
                    "ticker_sentiment_score": "-0.145062",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Super-Safe High-Yield Dividend Stocks You Can Buy Right Now",
            "url": "https://www.fool.com/investing/2024/01/14/super-safe-high-yield-dividend-stocks-buy-now/",
            "time_published": "20240114T105000",
            "authors": [
                "Keith Speights"
            ],
            "summary": "You shouldn't lose any sleep worrying about these great dividends.",
            "banner_image": "https://g.foolcdn.com/editorial/images/760991/man-with-arms-behind-head-looking-at-laptop.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.962106"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.239025,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.310843",
                    "ticker_sentiment_score": "0.219693",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BIPC",
                    "relevance_score": "0.251032",
                    "ticker_sentiment_score": "0.180186",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.127119",
                    "ticker_sentiment_score": "0.042741",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2 Former Warren Buffett Stocks That Stand Out as Stong Buys in 2024",
            "url": "https://www.fool.com/investing/2024/01/14/2-former-warren-buffett-stocks-that-stand-out-as-s/",
            "time_published": "20240114T103000",
            "authors": [
                "George Budwell"
            ],
            "summary": "Berkshire Hathaway exited its positions in these two blue chip dividend stocks last year, but they are still superb buys for certain types of investors.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F761125%2Ftime-to-buy.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.990999"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.839681"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.295593,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.135347",
                    "ticker_sentiment_score": "0.146372",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CURN",
                    "relevance_score": "0.067919",
                    "ticker_sentiment_score": "-0.025615",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.135347",
                    "ticker_sentiment_score": "0.2802",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.449219",
                    "ticker_sentiment_score": "0.134039",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2 Average Stocks That Could Make You Rich",
            "url": "https://www.fool.com/investing/2024/01/13/2-average-stocks-that-could-make-you-rich/",
            "time_published": "20240113T141000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "You don't always have to pick a game-changing company to win in the stock market.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F760974%2Fgettyimages-1272759382.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.904684"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.410321,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.050465",
                    "ticker_sentiment_score": "0.048562",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.513698",
                    "ticker_sentiment_score": "0.606803",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.050465",
                    "ticker_sentiment_score": "0.145883",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.100729",
                    "ticker_sentiment_score": "0.052034",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - RYZB, FGH, AMAM, CSTR",
            "url": "https://www.prnewswire.com/news-releases/stockholder-alert-the-ma-class-action-firm-continues-investigating-the-merger--ryzb-fgh-amam-cstr-302033994.html",
            "time_published": "20240113T013000",
            "authors": [
                "Monteverde & Associates PC"
            ],
            "summary": "NEW YORK, Jan. 12, 2024 /PRNewswire/ -- , founder and managing partner of the class action firm ( the \"M&A Class Action Firm\" ) , a national securities firm rated Top 50 in the 2018-2022 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, ...",
            "banner_image": "https://mma.prnewswire.com/media/443626/Monteverde_Associates_PC_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.95493"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.385265,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CSTR",
                    "relevance_score": "0.22421",
                    "ticker_sentiment_score": "0.232225",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ONB",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "0.137439",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FGF",
                    "relevance_score": "0.150592",
                    "ticker_sentiment_score": "0.175595",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.22421",
                    "ticker_sentiment_score": "0.232225",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "0.137439",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RYZB",
                    "relevance_score": "0.295867",
                    "ticker_sentiment_score": "0.287065",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "0.137439",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Gene Therapy Global Market is Projected to Grow at a CAGR of ~19% by 2028, Predicts DelveInsight",
            "url": "https://www.prnewswire.com/news-releases/gene-therapy-global-market-is-projected-to-grow-at-a-cagr-of-19-by-2028-predicts-delveinsight-302033381.html",
            "time_published": "20240112T220100",
            "authors": [
                "LLP",
                "DelveInsight Business Research"
            ],
            "summary": "LAS VEGAS, Jan. 12, 2024 /PRNewswire/ -- DelveInsight's Gene Therapy Market Insights report provides the current and forecast market analysis, individual leading gene therapy companies' market shares, challenges, gene therapy market drivers, barriers, trends, and key market gene therapy ...",
            "banner_image": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.203913,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "FOLD",
                    "relevance_score": "0.060694",
                    "ticker_sentiment_score": "-0.036112",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RARE",
                    "relevance_score": "0.060694",
                    "ticker_sentiment_score": "0.078001",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BLUE",
                    "relevance_score": "0.030369",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SRPT",
                    "relevance_score": "0.030369",
                    "ticker_sentiment_score": "0.096229",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAYZF",
                    "relevance_score": "0.060694",
                    "ticker_sentiment_score": "0.055",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.030369",
                    "ticker_sentiment_score": "0.096229",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.030369",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.090931",
                    "ticker_sentiment_score": "0.00954",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FRLN",
                    "relevance_score": "0.060694",
                    "ticker_sentiment_score": "-0.036112",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PTCT",
                    "relevance_score": "0.030369",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SLDB",
                    "relevance_score": "0.030369",
                    "ticker_sentiment_score": "0.096229",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LXEO",
                    "relevance_score": "0.030369",
                    "ticker_sentiment_score": "0.096229",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RGNX",
                    "relevance_score": "0.090931",
                    "ticker_sentiment_score": "0.00954",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SIOX",
                    "relevance_score": "0.030369",
                    "ticker_sentiment_score": "-0.05095",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.030369",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Cytokinetics  ( CYTK )  Down on Report of Novartis Not Interested",
            "url": "https://www.zacks.com/stock/news/2209728/cytokinetics-cytk-down-on-report-of-novartis-not-interested",
            "time_published": "20240112T194700",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Cytokinetics (CYTK) slumps after a report stating Novartis not interested in acquiring the company surface.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ab/2180.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.166093,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CYTK",
                    "relevance_score": "0.654522",
                    "ticker_sentiment_score": "0.242155",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.149656",
                    "ticker_sentiment_score": "0.058089",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.075161",
                    "ticker_sentiment_score": "0.04437",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.075161",
                    "ticker_sentiment_score": "0.04437",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KDNY",
                    "relevance_score": "0.075161",
                    "ticker_sentiment_score": "0.067603",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Market Rebounds As Nvidia Leads; Bitcoin ETFs, Tesla Fall: Weekly Review",
            "url": "https://www.investors.com/news/stock-market-rally-rebounds-nvidia-tesla-jpmorgan-bitcoin-etfs-in-focus/",
            "time_published": "20240112T191300",
            "authors": [
                "Investor's Business Daily",
                "IBD STAFF"
            ],
            "summary": "Market Rebounds As Nvidia Leads. Bitcoin ETFs, Tesla Fall: Weekly Review Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2019/11/Stock-bounce-05-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.99489"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.142857"
                }
            ],
            "overall_sentiment_score": -0.007321,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ALK",
                    "relevance_score": "0.045612",
                    "ticker_sentiment_score": "-0.11938",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BLK",
                    "relevance_score": "0.068371",
                    "ticker_sentiment_score": "0.028338",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.045612",
                    "ticker_sentiment_score": "-0.11938",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.091075",
                    "ticker_sentiment_score": "0.060214",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.136242",
                    "ticker_sentiment_score": "0.010052",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CROX",
                    "relevance_score": "0.068371",
                    "ticker_sentiment_score": "0.189572",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.045612",
                    "ticker_sentiment_score": "-0.022883",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HPQ",
                    "relevance_score": "0.022815",
                    "ticker_sentiment_score": "-0.000921",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BK",
                    "relevance_score": "0.068371",
                    "ticker_sentiment_score": "0.028338",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COIN",
                    "relevance_score": "0.045612",
                    "ticker_sentiment_score": "0.128458",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.113705",
                    "ticker_sentiment_score": "0.011467",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "URBN",
                    "relevance_score": "0.068371",
                    "ticker_sentiment_score": "0.131736",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KBH",
                    "relevance_score": "0.068371",
                    "ticker_sentiment_score": "-0.140846",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.022815",
                    "ticker_sentiment_score": "0.001816",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TGTX",
                    "relevance_score": "0.045612",
                    "ticker_sentiment_score": "-0.022883",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EADSF",
                    "relevance_score": "0.022815",
                    "ticker_sentiment_score": "-0.111175",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.136242",
                    "ticker_sentiment_score": "-0.148914",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPR",
                    "relevance_score": "0.045612",
                    "ticker_sentiment_score": "-0.11938",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.045612",
                    "ticker_sentiment_score": "0.027908",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HARP",
                    "relevance_score": "0.045612",
                    "ticker_sentiment_score": "-0.022883",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMD",
                    "relevance_score": "0.068371",
                    "ticker_sentiment_score": "0.002016",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WT",
                    "relevance_score": "0.022815",
                    "ticker_sentiment_score": "0.120065",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DXCM",
                    "relevance_score": "0.091075",
                    "ticker_sentiment_score": "0.027513",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXNX",
                    "relevance_score": "0.045612",
                    "ticker_sentiment_score": "-0.022883",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MARA",
                    "relevance_score": "0.045612",
                    "ticker_sentiment_score": "0.128458",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.068371",
                    "ticker_sentiment_score": "0.087256",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.136242",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.045612",
                    "ticker_sentiment_score": "0.027908",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNPR",
                    "relevance_score": "0.068371",
                    "ticker_sentiment_score": "-0.001011",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.045612",
                    "ticker_sentiment_score": "-0.022883",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AEO",
                    "relevance_score": "0.045612",
                    "ticker_sentiment_score": "0.185014",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SWN",
                    "relevance_score": "0.068371",
                    "ticker_sentiment_score": "0.150164",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DAL",
                    "relevance_score": "0.136242",
                    "ticker_sentiment_score": "-0.020069",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LULU",
                    "relevance_score": "0.045612",
                    "ticker_sentiment_score": "0.185014",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GCO",
                    "relevance_score": "0.045612",
                    "ticker_sentiment_score": "0.185014",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ANF",
                    "relevance_score": "0.068371",
                    "ticker_sentiment_score": "0.131736",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EXEL",
                    "relevance_score": "0.045612",
                    "ticker_sentiment_score": "-0.022883",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HPE",
                    "relevance_score": "0.180967",
                    "ticker_sentiment_score": "-0.001504",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.045612",
                    "ticker_sentiment_score": "-0.022883",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.068371",
                    "ticker_sentiment_score": "0.026257",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.091075",
                    "ticker_sentiment_score": "-0.023423",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:BTC",
                    "relevance_score": "0.246923",
                    "ticker_sentiment_score": "0.097548",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Lung Cancer Surgery Market Projected to Reach USD 20.2 billion with Registering at a CAGR of 5.6% by 2031| Transparency Market Research Inc.",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36613349/lung-cancer-surgery-market-projected-to-reach-usd-20-2-billion-with-registering-at-a-cagr-of-5-6-b",
            "time_published": "20240112T161947",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Wilmington, Delaware, United States, Jan. 12, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global lung cancer surgery market is estimated to flourish at a CAGR of 5.6% from 2023 to 2031.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.195235,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.034233",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ARAY",
                    "relevance_score": "0.136306",
                    "ticker_sentiment_score": "0.140847",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.034233",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TFX",
                    "relevance_score": "0.068404",
                    "ticker_sentiment_score": "0.014449",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.068404",
                    "ticker_sentiment_score": "0.105458",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OCPNF",
                    "relevance_score": "0.102449",
                    "ticker_sentiment_score": "0.233034",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.034233",
                    "ticker_sentiment_score": "0.178081",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WMGTF",
                    "relevance_score": "0.102449",
                    "ticker_sentiment_score": "0.023021",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( JNJ )  is Attracting Investor Attention: Here is What You Should Know",
            "url": "https://www.zacks.com/stock/news/2209423/johnson-johnson-jnj-is-attracting-investor-attention-here-is-what-you-should-know",
            "time_published": "20240112T140011",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default70.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.5855"
                }
            ],
            "overall_sentiment_score": 0.232787,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.473208",
                    "ticker_sentiment_score": "0.173211",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "There's A Paradigm Shift In Immunology; And Big Pharma Is Paying Richly For It",
            "url": "https://www.investors.com/news/technology/biotech-stocks-forge-a-paradigm-shift-in-immunology-and-big-pharma-pays-handsomely-for-it/",
            "time_published": "20240112T140000",
            "authors": [
                "ALLISON GATLIN",
                "Investor's Business Daily"
            ],
            "summary": "There's A Paradigm Shift In Immunology. And Big Pharma Is Paying Richly For It Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2017/10/stock-Merck-02-shutter.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.929393"
                }
            ],
            "overall_sentiment_score": 0.130928,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.023838",
                    "ticker_sentiment_score": "-0.146266",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.047654",
                    "ticker_sentiment_score": "0.208731",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ROIV",
                    "relevance_score": "0.047654",
                    "ticker_sentiment_score": "-0.00099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RXDX",
                    "relevance_score": "0.023838",
                    "ticker_sentiment_score": "-0.000896",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.047654",
                    "ticker_sentiment_score": "-0.155656",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.118764",
                    "ticker_sentiment_score": "-0.008046",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Antibiotic Resistance Market Projected to Hit US$ 17.8 Billion by 2033 with a CAGR of 5.3% | Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36606656/antibiotic-resistance-market-projected-to-hit-us-17-8-billion-by-2033-with-a-cagr-of-5-3-persisten",
            "time_published": "20240112T090835",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 12, 2024 ( GLOBE NEWSWIRE ) -- The growing demand for new antibiotic therapies to combat antibiotic resistance is a prominent driver in the global market. In a July 2023 Science Daily article, the World Health Organization ( WHO ) recognized antibiotic-resistant bacteria as a major ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.014889,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BIO",
                    "relevance_score": "0.018187",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.018187",
                    "ticker_sentiment_score": "-0.055056",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.018187",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.036365",
                    "ticker_sentiment_score": "-0.083171",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.018187",
                    "ticker_sentiment_score": "-0.131837",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TMO",
                    "relevance_score": "0.018187",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The Zacks Analyst Blog Highlights Johnson & Johnson, Micron Technology, The Southern Company, TotalEnergies and PACCAR",
            "url": "https://www.zacks.com/stock/news/2208844/the-zacks-analyst-blog-highlights-johnson-johnson-micron-technology-the-southern-company-totalenergies-and-paccar",
            "time_published": "20240111T142200",
            "authors": [
                "Zacks Investment Research"
            ],
            "summary": "Johnson & Johnson, Micron Technology, The Southern Company, TotalEnergies and PACCAR are part of the Zacks top Analyst Blog.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7d/1177.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.275813,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MU",
                    "relevance_score": "0.210579",
                    "ticker_sentiment_score": "0.049748",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PCAR",
                    "relevance_score": "0.14131",
                    "ticker_sentiment_score": "0.037825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SO",
                    "relevance_score": "0.210579",
                    "ticker_sentiment_score": "0.05539",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TTE",
                    "relevance_score": "0.14131",
                    "ticker_sentiment_score": "0.037825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.278222",
                    "ticker_sentiment_score": "0.188508",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Walgreens Cut Its Dividend by 48%: Here Are 5 Better Dow Dividend Stocks to Buy in January",
            "url": "https://www.fool.com/investing/2024/01/11/walgreens-cuts-dividend-better-dow-stocks-buy-now/",
            "time_published": "20240111T110800",
            "authors": [
                "Daniel Foelber"
            ],
            "summary": "Businesses with efficient operations and growth potential open the door to dividend raises for years to come.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F760509%2Fgettyimages-1007651732-1200x754-6541a54.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.238805,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "TGT",
                    "relevance_score": "0.03642",
                    "ticker_sentiment_score": "0.175279",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.215894",
                    "ticker_sentiment_score": "0.18948",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CVX",
                    "relevance_score": "0.28511",
                    "ticker_sentiment_score": "0.060705",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.180595",
                    "ticker_sentiment_score": "0.107463",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.108958",
                    "ticker_sentiment_score": "-0.018214",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WBA",
                    "relevance_score": "0.072765",
                    "ticker_sentiment_score": "0.011311",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.03642",
                    "ticker_sentiment_score": "0.060978",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.384532",
                    "ticker_sentiment_score": "0.235928",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Baby Wipes Market Is Estimated to Translate to a Revenue of US$ 9.9 Billion by 2032, According to Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36589950/baby-wipes-market-is-estimated-to-translate-to-a-revenue-of-us-9-9-billion-by-2032-according-to-pe",
            "time_published": "20240111T110000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 11, 2024 ( GLOBE NEWSWIRE ) -- The Wriggling World of Baby Wipes: A Market Deep Dive Baby wipes are moistened, disposable cloths used for cleaning infants during diaper changes and for general hygiene purposes. They are typically formulated to be gentle on a baby's delicate ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.292668,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HEGIF",
                    "relevance_score": "0.040484",
                    "ticker_sentiment_score": "0.131624",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.040484",
                    "ticker_sentiment_score": "0.244139",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.040484",
                    "ticker_sentiment_score": "0.244139",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Why Eli Lilly Stock Skyrocketed 59% in 2023",
            "url": "https://www.fool.com/investing/2024/01/11/why-eli-lilly-stock-skyrocketed-59-in-2023/",
            "time_published": "20240111T104900",
            "authors": [
                "Keith Speights"
            ],
            "summary": "Lilly's pipeline success in 2023 allowed it to to claim the crown as the biggest drugmaker on the planet by market cap.",
            "banner_image": "https://g.foolcdn.com/editorial/images/760865/scientists-smiling-and-shaking-hands.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.857896"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.163735,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.722311",
                    "ticker_sentiment_score": "0.243335",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DICE",
                    "relevance_score": "0.078611",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.078611",
                    "ticker_sentiment_score": "0.155496",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "2 Dow Stocks to Buy Hand Over Fist in 2024 and 1 to Avoid Like the Plague",
            "url": "https://www.fool.com/investing/2024/01/11/2-dow-stocks-to-buy-2024-and-1-avoid-like-plague/",
            "time_published": "20240111T102100",
            "authors": [
                "Sean Williams"
            ],
            "summary": "Among the Dow Jones Industrial Average's 30 time-tested components, there are two that are historically cheap and ripe for the picking, while another outperformer is riddled with issues.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F760630%2Fnyse-wall-street-trading-new-york-financial-stock-market-getty.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.990999"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.988787"
                }
            ],
            "overall_sentiment_score": 0.148655,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.029149",
                    "ticker_sentiment_score": "0.09816",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TWOH",
                    "relevance_score": "0.029149",
                    "ticker_sentiment_score": "0.1698",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.365235",
                    "ticker_sentiment_score": "0.060384",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.201884",
                    "ticker_sentiment_score": "0.130795",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Traditional Wound Dressings Market Regain Ground in Evolving Healthcare Landscape: Market Projected to Reach US$ 6.93 Billion by 2032, Report by Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36588271/traditional-wound-dressings-market-regain-ground-in-evolving-healthcare-landscape-market-projected",
            "time_published": "20240111T053000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 11, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The global traditional wound dressing market recorded a valuation of US$ 5.1 Billion in 2022 and is expected to reach US$ 6.93 billion by the end of 2032, expanding at a CAGR of 3.2% from 2022 to 2032.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.12904,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "HLCO",
                    "relevance_score": "0.025299",
                    "ticker_sentiment_score": "0.074524",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAH",
                    "relevance_score": "0.012651",
                    "ticker_sentiment_score": "-0.007008",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.012651",
                    "ticker_sentiment_score": "-0.007008",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Top Analyst Reports for Johnson & Johnson, Micron Technology & Southern Company",
            "url": "https://www.zacks.com/research-daily/2208227/top-analyst-reports-for-johnson-johnson-micron-technology-southern-company",
            "time_published": "20240110T221600",
            "authors": [
                "Mark Vickery"
            ],
            "summary": "Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Micron Technology, Inc. (MU) and The Southern Company (SO).",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f8/4049.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.340444,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SO",
                    "relevance_score": "0.098255",
                    "ticker_sentiment_score": "0.047229",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.098255",
                    "ticker_sentiment_score": "0.266129",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Mastercard crosses $400 billion market-cap level in a sign of spending resilience",
            "url": "https://www.marketwatch.com/story/mastercard-crosses-400-billion-market-cap-level-in-a-sign-of-spending-resilience-59fe2392",
            "time_published": "20240110T214600",
            "authors": [
                "Emily Bary"
            ],
            "summary": "Mastercard vaulted into $400 billion territory for the first time Wednesday in a testament to confidence about consumer spending.",
            "banner_image": "https://images.mktw.net/im-290935/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.294342,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PYPL",
                    "relevance_score": "0.271274",
                    "ticker_sentiment_score": "0.294333",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MA",
                    "relevance_score": "0.512093",
                    "ticker_sentiment_score": "0.389798",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.397098",
                    "ticker_sentiment_score": "0.335518",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.271274",
                    "ticker_sentiment_score": "0.094822",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.271274",
                    "ticker_sentiment_score": "0.094822",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "In An Age Of 'Cancel Culture,' Some Voices Persist-On Smaller Platforms",
            "url": "https://www.forbes.com/sites/cmo/2024/01/10/in-an-age-of-cancel-culture-some-voices-persist-on-smaller-platforms/",
            "time_published": "20240110T191547",
            "authors": [
                "Megan Poinski"
            ],
            "summary": "This is the published version of Forbes' CMO newsletter, which offers the latest news for chief marketing officers and other messaging-focused leaders. Click here to get it delivered to your inbox every Wednesday.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/659ede1077df2ab4adf6607f/0x0.jpg?format=jpg&crop=3094,1739,x0,y13,safe&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.06445,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.019962",
                    "ticker_sentiment_score": "0.151052",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WBD",
                    "relevance_score": "0.039911",
                    "ticker_sentiment_score": "-0.034522",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CCZ",
                    "relevance_score": "0.019962",
                    "ticker_sentiment_score": "0.021104",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOX",
                    "relevance_score": "0.019962",
                    "ticker_sentiment_score": "0.021104",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.059835",
                    "ticker_sentiment_score": "0.049758",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "A Closer Look at Johnson & Johnson's Options Market Dynamics - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/markets/options/24/01/36579369/a-closer-look-at-johnson-johnsons-options-market-dynamics",
            "time_published": "20240110T161701",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Deep-pocketed investors have adopted a bearish approach towards Johnson & Johnson JNJ, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.180773,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.071357",
                    "ticker_sentiment_score": "0.139898",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.071357",
                    "ticker_sentiment_score": "-0.180309",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.629492",
                    "ticker_sentiment_score": "0.35671",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Will Q4 Earnings Push Dow ETF Higher?",
            "url": "https://www.zacks.com/stock/news/2208372/will-q4-earnings-push-dow-etf-higher",
            "time_published": "20240110T161000",
            "authors": [
                "Sweta Killa"
            ],
            "summary": "Let's delve deeper into the probable fourth-quarter earnings picture that will likely aid Dow ETF in the coming days.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default161.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.998333"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.115267,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "DOW",
                    "relevance_score": "0.131164",
                    "ticker_sentiment_score": "0.016405",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IBM",
                    "relevance_score": "0.174272",
                    "ticker_sentiment_score": "0.078148",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.131164",
                    "ticker_sentiment_score": "0.055623",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.174272",
                    "ticker_sentiment_score": "-0.015449",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.131164",
                    "ticker_sentiment_score": "-0.001181",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.131164",
                    "ticker_sentiment_score": "0.017822",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Mens Grooming Products Market Projected to Reach $139,588.4 Million Globally by 2033, with a CAGR of 7.5%, According to Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36575377/mens-grooming-products-market-projected-to-reach-139-588-4-million-globally-by-2033-with-a-cagr-of",
            "time_published": "20240110T133433",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 10, 2024 ( GLOBE NEWSWIRE ) -- Snapshot of the Men's Grooming Products Market: In 2022, the men's grooming products market raked in a revenue of $63,140.3 million, as reported by Persistence Market Research. The demand for these products is set to rise, with key players ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.400912,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PRBZF",
                    "relevance_score": "0.027603",
                    "ticker_sentiment_score": "0.056832",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.027603",
                    "ticker_sentiment_score": "-0.309225",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.055173",
                    "ticker_sentiment_score": "0.244008",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "IFF",
                    "relevance_score": "0.027603",
                    "ticker_sentiment_score": "0.199431",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CL",
                    "relevance_score": "0.027603",
                    "ticker_sentiment_score": "-0.309225",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "EPC",
                    "relevance_score": "0.027603",
                    "ticker_sentiment_score": "-0.309225",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "LRLCF",
                    "relevance_score": "0.027603",
                    "ticker_sentiment_score": "0.056832",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Wall Street Doesn't Expect Eli Lilly Stock to Move Much Higher in 2024. Here's Why Analysts Could Be Wrong.",
            "url": "https://www.fool.com/investing/2024/01/10/wall-street-doesnt-expect-eli-lilly-stock-to-move/",
            "time_published": "20240110T105100",
            "authors": [
                "Keith Speights"
            ],
            "summary": "Lilly's sizzle might not fizzle in the new year.",
            "banner_image": "https://g.foolcdn.com/editorial/images/760650/stock-charts-on-screen-analysts.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.503496"
                }
            ],
            "overall_sentiment_score": 0.164182,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.759979",
                    "ticker_sentiment_score": "0.161885",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.062434",
                    "ticker_sentiment_score": "0.020019",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is Johnson & Johnson Stock a Buy Now?",
            "url": "https://www.fool.com/investing/2024/01/10/is-johnson-johnson-stock-a-buy-now/",
            "time_published": "20240110T102500",
            "authors": [
                "David Jagielski"
            ],
            "summary": "The pharmaceutical giant recently announced another acquisition.",
            "banner_image": "https://g.foolcdn.com/editorial/images/760434/pharmacist-helping-a-customer.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.929393"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.118318,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.054983",
                    "ticker_sentiment_score": "0.035885",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.509589",
                    "ticker_sentiment_score": "0.197609",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Bone Wax Market to Reach USD 107.8 billion by 2031, Rising at a CAGR of 3.3% | Transparency Market Research, Inc.",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36571219/bone-wax-market-to-reach-usd-107-8-billion-by-2031-rising-at-a-cagr-of-3-3-transparency-market-res",
            "time_published": "20240110T075618",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Wilmington, Delaware, United States, Jan. 10, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global bone wax market is estimated to rise at a CAGR of 3.3% from 2023 to 2031. Transparency Market Research projects that the overall sales revenue for bone wax is estimated to reach ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.303616,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BAX",
                    "relevance_score": "0.096932",
                    "ticker_sentiment_score": "0.205777",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.032382",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.096932",
                    "ticker_sentiment_score": "0.055751",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMGTF",
                    "relevance_score": "0.096932",
                    "ticker_sentiment_score": "0.056001",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.06471",
                    "ticker_sentiment_score": "-0.016098",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( JNJ )  Ascends While Market Falls: Some Facts to Note",
            "url": "https://www.zacks.com/stock/news/2207775/johnson-johnson-jnj-ascends-while-market-falls-some-facts-to-note",
            "time_published": "20240109T224520",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "The latest trading day saw Johnson & Johnson (JNJ) settling at $161.63, representing a +0.06% change from its previous close.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default280.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.947132"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                }
            ],
            "overall_sentiment_score": 0.205225,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.601928",
                    "ticker_sentiment_score": "0.258805",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - AMAM, CSTR, PGTI, WAVD",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36567500/shareholder-alert-the-m-a-class-action-firm-continues-investigating-the-merger-amam-cstr-pgti-wavd",
            "time_published": "20240109T222750",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "NEW YORK, Jan. 09, 2024 ( GLOBE NEWSWIRE ) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC ( the \"M&A Class Action Firm\" ) , a national securities firm rated Top 50 in the 2018-2022 ISS Securities Class Action Services Report and ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.928769"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.348879,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "WAVD",
                    "relevance_score": "0.269776",
                    "ticker_sentiment_score": "0.167077",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CSTR",
                    "relevance_score": "0.269776",
                    "ticker_sentiment_score": "0.312899",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ONB",
                    "relevance_score": "0.068698",
                    "ticker_sentiment_score": "0.15958",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.269776",
                    "ticker_sentiment_score": "0.251887",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.068698",
                    "ticker_sentiment_score": "0.127207",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PGTI",
                    "relevance_score": "0.269776",
                    "ticker_sentiment_score": "0.285704",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DOOR",
                    "relevance_score": "0.068698",
                    "ticker_sentiment_score": "0.145313",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Ambrx  ( AMAM )  Skyrockets 102% on $2B Buyout Offer From J&J",
            "url": "https://www.zacks.com/stock/news/2207649/ambrx-amam-skyrockets-102-on-2b-buyout-offer-from-jj",
            "time_published": "20240109T180400",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "J&J (JNJ) is set to acquire Ambrx Biopharma (AMAM) in an all-cash transaction for $2.0 billion. The transaction will likely close in first-half 2024.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/34/973.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.120661,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SKXJF",
                    "relevance_score": "0.059488",
                    "ticker_sentiment_score": "-0.019018",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSKYF",
                    "relevance_score": "0.059488",
                    "ticker_sentiment_score": "-0.019018",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.234684",
                    "ticker_sentiment_score": "0.29989",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HARP",
                    "relevance_score": "0.059488",
                    "ticker_sentiment_score": "-0.019018",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.234684",
                    "ticker_sentiment_score": "0.122646",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.118647",
                    "ticker_sentiment_score": "0.213928",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Breast Biopsy Market Set to Achieve US$ 3.8 Billion in Revenue by 2033, Report by Persistence Market Research",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36561357/breast-biopsy-market-set-to-achieve-us-3-8-billion-in-revenue-by-2033-report-by-persistence-market",
            "time_published": "20240109T171000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, Jan. 09, 2024 ( GLOBE NEWSWIRE ) -- Breast biopsy is a medical procedure involving the removal of a sample of breast tissue for diagnostic examination. It is a crucial step in the early detection and diagnosis of breast cancer, enabling healthcare professionals to determine the presence ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.191585,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HOLX",
                    "relevance_score": "0.020491",
                    "ticker_sentiment_score": "0.205118",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BDX",
                    "relevance_score": "0.040969",
                    "ticker_sentiment_score": "0.02072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.020491",
                    "ticker_sentiment_score": "0.069883",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Illumina Shares Trading Higher After Confirming Partnership With Johnson & Johnson Unit - Illumina  ( NASDAQ:ILMN ) ",
            "url": "https://www.benzinga.com/news/earnings/24/01/36559887/illumina-shares-trading-higher-after-confirming-partnership-with-johnson-johnson-unit",
            "time_published": "20240109T165059",
            "authors": [
                "Nabaparna Bhattacharya"
            ],
            "summary": "Illumina, Inc. ILMN shares are trading higher after announcing preliminary financial results for the fourth quarter ( Q4 ) and fiscal year 2023. For Q4, the company reported preliminary consolidated revenue of approximately $1.115 billion, up 3% from Q4 2022. The analyst consensus stands at ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/09/bz_pharma_briefs.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.684621"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.106718,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ILMN",
                    "relevance_score": "0.766141",
                    "ticker_sentiment_score": "0.294902",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.366061",
                    "ticker_sentiment_score": "0.365218",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Biotech ETFs Stage Solid Comeback at the Start of 2024",
            "url": "https://www.zacks.com/stock/news/2207551/biotech-etfs-stage-solid-comeback-at-the-start-of-2024",
            "time_published": "20240109T160500",
            "authors": [
                "Sweta Killa"
            ],
            "summary": "The biotech space staged a strong comeback at the start of 2024, driven by multi-billion dollar deals, upbeat clinical results and cutting-edge medical advances like CRISPR gene-editing hitting prime-time.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7b/850.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.147642,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NVO",
                    "relevance_score": "0.133346",
                    "ticker_sentiment_score": "0.162037",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.084886",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KRTX",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.058856",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.084886",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RYZB",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.058856",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.058856",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.133346",
                    "ticker_sentiment_score": "0.06769",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.058856",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GRCL",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.058856",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HARP",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.084886",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.133346",
                    "ticker_sentiment_score": "0.162037",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.133346",
                    "ticker_sentiment_score": "0.071668",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OMGA",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.140918",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030 - Ambrx Biopharma  ( NASDAQ:AMAM ) , Amgen  ( NASDAQ:AMGN ) ",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36558906/global-oncology-cancer-drugs-market-revenue-projected-to-surpass-289-billion-by-2030",
            "time_published": "20240109T152500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "PALM BEACH, Fla., Jan. 09, 2024 ( GLOBE NEWSWIRE ) -- FN Media Group News Commentary - According to the report titled \"Aging in the United States,\" published by the Population Reference Bureau, \"the number of Americans aged 65 and older is projected to increase more than double over 95 million ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.998947"
                }
            ],
            "overall_sentiment_score": 0.103242,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "DNPUF",
                    "relevance_score": "0.019474",
                    "ticker_sentiment_score": "0.086828",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NKTX",
                    "relevance_score": "0.077782",
                    "ticker_sentiment_score": "-0.066051",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.077782",
                    "ticker_sentiment_score": "-0.065019",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSUMF",
                    "relevance_score": "0.019474",
                    "ticker_sentiment_score": "0.086828",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.058377",
                    "ticker_sentiment_score": "0.166162",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ELEV",
                    "relevance_score": "0.097141",
                    "ticker_sentiment_score": "0.001107",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INCY",
                    "relevance_score": "0.038937",
                    "ticker_sentiment_score": "0.095682",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.097141",
                    "ticker_sentiment_score": "-0.069713",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GLYC",
                    "relevance_score": "0.019474",
                    "ticker_sentiment_score": "0.133755",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Dr. Rama Kondru Named Chief Executive Officer of Veridix AI - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/dr-rama-kondru-named-chief-executive-officer-of-veridix-ai-302029873.html",
            "time_published": "20240109T140000",
            "authors": [],
            "summary": "Dr. Rama Kondru Named Chief Executive Officer of Veridix AI PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.301566,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JPM",
                    "relevance_score": "0.059488",
                    "ticker_sentiment_score": "0.079997",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.059488",
                    "ticker_sentiment_score": "0.046009",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "NeuroTrauma Sciences Appoints William Fricker, CPA, MBA, as Chief Financial Officer",
            "url": "https://www.prnewswire.com/news-releases/neurotrauma-sciences-appoints-william-fricker-cpa-mba-as-chief-financial-officer-302029049.html",
            "time_published": "20240109T133000",
            "authors": [
                "LLC",
                "NeuroTrauma Sciences"
            ],
            "summary": "David Lawrence Departs as CFO; Appointed to Board of Directors",
            "banner_image": "https://mma.prnewswire.com/media/2073146/Neurotrauma_Sciences_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.08129,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BMY",
                    "relevance_score": "0.082677",
                    "ticker_sentiment_score": "0.026635",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.082677",
                    "ticker_sentiment_score": "0.026635",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Daily: One Of Nike's Most Famous Partnerships Comes To An End",
            "url": "https://www.forbes.com/sites/forbesdaily/2024/01/09/forbes-daily-one-of-nikes-most-famous-partnerships-comes-to-an-end/",
            "time_published": "20240109T130922",
            "authors": [
                "Danielle Chemtob"
            ],
            "summary": "Forbes Daily: Nike and Tiger Woods End Endorsement Deal After 27 Years Forbes ...",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/659d42ecbc4db0ba654cf37c/0x0.jpg?format=jpg&crop=3600,2025,x0,y158,safe&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.0,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.071428",
                    "ticker_sentiment_score": "-0.012243",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NKE",
                    "relevance_score": "0.142284",
                    "ticker_sentiment_score": "0.06845",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SZIHF",
                    "relevance_score": "0.023838",
                    "ticker_sentiment_score": "-0.035521",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.023838",
                    "ticker_sentiment_score": "0.029355",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.023838",
                    "ticker_sentiment_score": "-0.232573",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Want to Win in the Stock Market? Be Average.",
            "url": "https://www.fool.com/investing/2024/01/09/want-to-win-in-the-stock-market-be-average/",
            "time_published": "20240109T103000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "Start with companies that have proven themselves.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F760525%2Fgettyimages-1323758599.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999896"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.357023,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LTRCF",
                    "relevance_score": "0.061315",
                    "ticker_sentiment_score": "0.171433",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVAX",
                    "relevance_score": "0.061315",
                    "ticker_sentiment_score": "0.104012",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.122269",
                    "ticker_sentiment_score": "0.187826",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.061315",
                    "ticker_sentiment_score": "0.104012",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.122269",
                    "ticker_sentiment_score": "0.187826",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "This Dividend Stock Has a $13 Billion Secret Weapon",
            "url": "https://www.fool.com/investing/2024/01/09/this-dividend-stock-has-a-13-billion-secret-weapon/",
            "time_published": "20240109T100000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "Johnson & Johnson made a key decision last year.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F760520%2Finvestor-excited-computer.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.744043"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.300616,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.119532",
                    "ticker_sentiment_score": "0.124738",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.119532",
                    "ticker_sentiment_score": "0.320641",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( NYSE:JNJ )  Upgraded at StockNews.com",
            "url": "https://www.defenseworld.net/2024/01/09/johnson-johnson-nysejnj-upgraded-at-stocknews-com.html",
            "time_published": "20240109T061446",
            "authors": [
                "Defense World Staff"
            ],
            "summary": "Johnson & Johnson ( NYSE:JNJ - Get Free Report ) was upgraded by stock analysts at StockNews.com from a \"buy\" rating to a \"strong-buy\" rating in a research note issued on Tuesday. Other equities research analysts also recently issued research reports about the stock.",
            "banner_image": "https://www.marketbeat.com/logos/johnson--johnson-logo.png?v=20221020135923",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "www.defenseworld.net",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.658903"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.818451"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.258919,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BCS",
                    "relevance_score": "0.057628",
                    "ticker_sentiment_score": "0.056",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.057628",
                    "ticker_sentiment_score": "0.056",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.057628",
                    "ticker_sentiment_score": "0.056",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.057628",
                    "ticker_sentiment_score": "0.078207",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.851762",
                    "ticker_sentiment_score": "0.430073",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates HARP, AMAM, AXNX, EAR - Ambrx Biopharma  ( NASDAQ:AMAM ) , Axonics  ( NASDAQ:AXNX ) ",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36548462/shareholder-rights-investigation-halper-sadeh-llc-investigates-harp-amam-axnx-ear",
            "time_published": "20240109T012135",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "NEW YORK, Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Harpoon Therapeutics, Inc.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.10714,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.095681",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.095681",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HARP",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.095681",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXNX",
                    "relevance_score": "0.279015",
                    "ticker_sentiment_score": "0.157051",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "EAR",
                    "relevance_score": "0.279015",
                    "ticker_sentiment_score": "0.294303",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.095681",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc.  ( Nasdaq - AMAM ) , Gracell Biotechnologies Inc.  ( Nasdaq - GRCL ) , Axonics, Inc.  ( Nasdaq - AXNX ) , Harpoon Therapeutics, Inc.  ( Nasdaq - HARP ) ",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36547175/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ambrx-biophar",
            "time_published": "20240108T223137",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "BALA CYNWYD, Pa., Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.796627"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.232971,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.233556",
                    "ticker_sentiment_score": "0.266779",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.233556",
                    "ticker_sentiment_score": "0.068874",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GRCL",
                    "relevance_score": "0.07887",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.07887",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.233556",
                    "ticker_sentiment_score": "0.235274",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HARP",
                    "relevance_score": "0.07887",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.15697",
                    "ticker_sentiment_score": "0.156505",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AXNX",
                    "relevance_score": "0.233556",
                    "ticker_sentiment_score": "0.216405",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Tech sector powers stock market higher with the Nasdaq jumping 2%",
            "url": "https://markets.businessinsider.com/news/stocks/stock-market-news-today-tech-sector-nasdaq-surge-ces-conference-2024-1",
            "time_published": "20240108T210500",
            "authors": [
                "Matthew Fox"
            ],
            "summary": "Stock Market News Today: Tech Sector Powers Markets Higher With 2% Gain - Markets Insider ...",
            "banner_image": null,
            "source": "Business Insider",
            "category_within_source": "GoogleRSS",
            "source_domain": "markets.businessinsider.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.858979"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Blockchain",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": -0.196462,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "-0.097935",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "0.065814",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SCBFF",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "-0.097935",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "0.057295",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "0.057295",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "0.057295",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.199037",
                    "ticker_sentiment_score": "-0.186779",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "CRYPTO:BTC",
                    "relevance_score": "0.199037",
                    "ticker_sentiment_score": "-0.143892",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "ALLENTOWN ANNOUNCES STRATEGIC ACQUISITION OF CLORDISYS - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/allentown-announces-strategic-acquisition-of-clordisys-302028906.html",
            "time_published": "20240108T200400",
            "authors": [],
            "summary": "ALLENTOWN ANNOUNCES STRATEGIC ACQUISITION OF CLORDISYS PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.962106"
                }
            ],
            "overall_sentiment_score": 0.363979,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.041181",
                    "ticker_sentiment_score": "0.125941",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Dow Surges Over 100 Points; Commercial Metals Posts Upbeat Q1 Results - Ambrx Biopharma  ( NASDAQ:AMAM ) , Commercial Metals  ( NYSE:CMC ) ",
            "url": "https://www.benzinga.com/news/earnings/24/01/36542311/dow-surges-over-100-points-commercial-metals-posts-upbeat-q1-results",
            "time_published": "20240108T193300",
            "authors": [
                "Avi Kapoor"
            ],
            "summary": "U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.35% to 37,596.43 while the NASDAQ rose 1.89% to 14,799.21. The S&P 500 also rose, gaining, 1.11% to 4,749.41. Information technology shares jumped by 2.1% on ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/08/image42.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.929393"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.145846,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "DTC",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "-0.068927",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DADA",
                    "relevance_score": "0.217508",
                    "ticker_sentiment_score": "-0.017984",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NKTX",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "0.305231",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "0.259181",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HARP",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "0.225398",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LMDX",
                    "relevance_score": "0.217508",
                    "ticker_sentiment_score": "-0.032527",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.073321",
                    "ticker_sentiment_score": "0.209122",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CMC",
                    "relevance_score": "0.217508",
                    "ticker_sentiment_score": "0.162001",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "How To Buy Hot And Promising - But Uncertain - Biotech Stocks",
            "url": "https://www.investors.com/research/how-to-find-the-best-stocks-to-buy/xbi-etf-how-to-buy-hot-and-promising-but-uncertain-biotech-stocks/",
            "time_published": "20240108T173400",
            "authors": [
                "Investor's Business Daily",
                "MATTHEW GALGANI"
            ],
            "summary": "A mix of choppy or nonexistent earnings alongside the promise of game-changing breakthroughs make biotech stocks a challenge for investors. The SPDR S&P Biotech ETF ( XBI ) , now on the IBD Leaderboard watchlist, offers an alternative to betting on a single biotech name.",
            "banner_image": "https://www.investors.com/wp-content/uploads/2024/01/Stock-petridishmolecule-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.972476"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.268824,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.083541",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ARWR",
                    "relevance_score": "0.166169",
                    "ticker_sentiment_score": "0.070153",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.166169",
                    "ticker_sentiment_score": "0.200529",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.166169",
                    "ticker_sentiment_score": "0.200529",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KRTX",
                    "relevance_score": "0.246999",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.400052",
                    "ticker_sentiment_score": "0.433085",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.166169",
                    "ticker_sentiment_score": "0.070153",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.246999",
                    "ticker_sentiment_score": "0.430266",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.166169",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Crude Oil Falls Sharply; Ambrx Biopharma Shares Spike Higher - Ambrx Biopharma  ( NASDAQ:AMAM ) , Commercial Metals  ( NYSE:CMC ) ",
            "url": "https://www.benzinga.com/news/earnings/24/01/36539499/crude-oil-falls-sharply-ambrx-biopharma-shares-spike-higher",
            "time_published": "20240108T172201",
            "authors": [
                "Avi Kapoor"
            ],
            "summary": "U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining more than 1% on Monday. The Dow traded down 0.19% to 37,396.28 while the NASDAQ rose 1.20% to 14,698.88. The S&P 500 also rose, gaining, 0.55% to 4,722.93. Information technology shares jumped by 2% on Monday.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/08/crude_oil_4-_logo.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.929393"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.143659,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "DTC",
                    "relevance_score": "0.152018",
                    "ticker_sentiment_score": "-0.070681",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DADA",
                    "relevance_score": "0.226301",
                    "ticker_sentiment_score": "-0.01855",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.152018",
                    "ticker_sentiment_score": "0.265191",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HARP",
                    "relevance_score": "0.152018",
                    "ticker_sentiment_score": "0.230693",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LMDX",
                    "relevance_score": "0.226301",
                    "ticker_sentiment_score": "-0.033548",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.076358",
                    "ticker_sentiment_score": "0.209987",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CMC",
                    "relevance_score": "0.226301",
                    "ticker_sentiment_score": "0.167054",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SPEC",
                    "relevance_score": "0.152018",
                    "ticker_sentiment_score": "0.485307",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Predicine Announces Collaboration with Janssen to Develop PredicineCARE™ as a Companion Diagnostic Assay in Localized Bladder Cancer",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36538805/predicine-announces-collaboration-with-janssen-to-develop-predicinecare-as-a-companion-diagnostic-",
            "time_published": "20240108T170113",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "HAYWARD, Calif., Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- Predicine, Inc., a leading molecular insights company, today announced a collaboration with Janssen Pharmaceutica NV ( Janssen ) , a Johnson & Johnson company.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.099925,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.095899",
                    "ticker_sentiment_score": "0.073478",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "J&J's Tentative $700M Agreement To Resolve Talc Powder-Related Lawsuits Across US States - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/news/large-cap/24/01/36537800/j-js-tentative-700m-agreement-to-resolve-talc-powder-related-lawsuits-across-us-states",
            "time_published": "20240108T161950",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Healthcare giant Johnson & Johnson JNJ has reached a tentative agreement to pay approximately $700 million to settle an investigation involving over 40 US states. The settlement seeks to resolve claims that J&J failed to disclose connections between its talc powder and various cancers.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/08/johnsons-5671315_1920.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": -0.164231,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.375251",
                    "ticker_sentiment_score": "0.211091",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Will Pay $700 Million To Resolve Baby Powder Marketing Probe, Report Says",
            "url": "https://www.forbes.com/sites/tylerroush/2024/01/08/johnson--johnson-will-pay-700-million-to-resolve-baby-powder-marketing-probe-report-says/",
            "time_published": "20240108T160256",
            "authors": [
                "Ty Roush"
            ],
            "summary": "Johnson & Johnson will pay an estimated $700 million to resolve an investigation by more than 40 states into the pharmaceutical firm's marketing of its talcum powder, according to Bloomberg, following thousands of lawsuits alleging it failed to warn customers about cancer risks.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/659c1c62514d771e8f6ce544/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.176281,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.769861",
                    "ticker_sentiment_score": "-0.286231",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Today Is Cancer-Focused Deals Day: Johnson & Johnson Scoops Up Ambrx Biopharma As Merck Boosts Cancer Portfolio With Harpoon Deal - Ambrx Biopharma  ( NASDAQ:AMAM ) , Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/general/biotech/24/01/36535176/today-is-cancer-focused-deals-day-johnson-johnson-scoops-up-ambrx-biopharma-as-merck-boosts-cance",
            "time_published": "20240108T151852",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Monday, Johnson & Johnson JNJ has agreed to acquire Ambrx Biopharma Inc AMAM in an all-cash merger transaction for a total equity value of approximately $2.0 billion, or $1.9 billion net of estimated cash acquired. Johnson & Johnson will acquire Ambrx for $28.00/share.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/08/amam.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.070032,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.465901",
                    "ticker_sentiment_score": "0.239313",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HARP",
                    "relevance_score": "0.244109",
                    "ticker_sentiment_score": "0.396085",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.465901",
                    "ticker_sentiment_score": "0.368504",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Health Care Company Johnson & Johnson Announces Merger With Ambrx Biopharma - Ambrx Biopharma  ( NASDAQ:AMAM ) , Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/m-a/24/01/36535899/health-care-company-johnson-johnson-announces-merger-with-ambrx-biopharma",
            "time_published": "20240108T151010",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Johnson & Johnson JNJ has announced a merger with Ambrx Biopharma AMAM that is expected to be completed 2024-H1. Under the terms of the agreement, Johnson & Johnson has agreed to give Ambrx Biopharma $2.00 billion in cash in exchange for AMAM stock.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.10668,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.628066",
                    "ticker_sentiment_score": "0.295837",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.524949",
                    "ticker_sentiment_score": "0.263951",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "US Stocks Mixed; Nasdaq Jumps Over 100 Points - Ambrx Biopharma  ( NASDAQ:AMAM ) , Commercial Metals  ( NYSE:CMC ) ",
            "url": "https://www.benzinga.com/news/earnings/24/01/36535602/us-stocks-mixed-nasdaq-jumps-over-100-points",
            "time_published": "20240108T150054",
            "authors": [
                "Avi Kapoor"
            ],
            "summary": "U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 100 points on Monday. Following the market opening Monday, the Dow traded down 0.45% to 37,296.85 while the NASDAQ rose 0.75% to 14,632.70. The S&P 500 also rose, gaining, 0.26% to 4,709.31.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/08/image33.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.87644"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.056244,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "DTC",
                    "relevance_score": "0.150592",
                    "ticker_sentiment_score": "-0.07026",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DADA",
                    "relevance_score": "0.22421",
                    "ticker_sentiment_score": "-0.018416",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.150592",
                    "ticker_sentiment_score": "0.263746",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HARP",
                    "relevance_score": "0.150592",
                    "ticker_sentiment_score": "0.229419",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LMDX",
                    "relevance_score": "0.22421",
                    "ticker_sentiment_score": "-0.033305",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "0.209768",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CMC",
                    "relevance_score": "0.22421",
                    "ticker_sentiment_score": "0.165853",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SPEC",
                    "relevance_score": "0.150592",
                    "ticker_sentiment_score": "0.48304",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "AAMI and FDA Co-Sponsor Medtech Conference, 'AAMI and FDA neXus'",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36535042/aami-and-fda-co-sponsor-medtech-conference-aami-and-fda-nexus",
            "time_published": "20240108T143700",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Arlington, VA, Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- The Association for the Advancement of Medical Instrumentation ( AAMI ) is delighted to welcome the U.S. Food and Drug Administration as an official co-sponsor of its upcoming medical device standards conference, AAMI and FDA neXus 2024.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.144866,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.075397",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STE",
                    "relevance_score": "0.075397",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.075397",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Two Biotechs Roughly Double After Snagging Splashy Takeover Deals",
            "url": "https://www.investors.com/news/technology/amam-stock-harp-stock-catapult-after-snagging-jnj-merck-buyouts/",
            "time_published": "20240108T141900",
            "authors": [
                "Investor's Business Daily",
                "ALLISON GATLIN"
            ],
            "summary": "AMAM Stock, HARP Stock Catapult After Snagging J&J, Merck Buyouts Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2017/10/stock-JohnsonANDjohnson-02-shutter.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.980922"
                }
            ],
            "overall_sentiment_score": 0.210915,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BSX",
                    "relevance_score": "0.529185",
                    "ticker_sentiment_score": "0.18163",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HARP",
                    "relevance_score": "0.334762",
                    "ticker_sentiment_score": "0.110142",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.114682",
                    "ticker_sentiment_score": "-0.131349",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXNX",
                    "relevance_score": "0.436009",
                    "ticker_sentiment_score": "0.214449",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.114682",
                    "ticker_sentiment_score": "0.37702",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.227007",
                    "ticker_sentiment_score": "0.160288",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion",
            "url": "https://www.cnbc.com/2024/01/08/jj-to-acquire-ambrx-biopharma-a-cancer-drug-developer.html",
            "time_published": "20240108T140931",
            "authors": [
                "Annika Kim Constantino"
            ],
            "summary": "The deal, which was announced on the first day of the annual JPMorgan Healthcare Conference, makes J&J the latest drugmaker to bet on ADCs.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/106974803-1636726862899-gettyimages-1164570932-AFP_1JU2A3.jpeg?v=1704721945&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Business",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.031525,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.154455",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.154455",
                    "ticker_sentiment_score": "-0.076968",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.154455",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.154455",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.154455",
                    "ticker_sentiment_score": "-0.076968",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Health In Her HUE Announces $3 Million In Funding",
            "url": "https://www.prnewswire.com/news-releases/health-in-her-hue-announces-3-million-in-funding-302028034.html",
            "time_published": "20240108T140000",
            "authors": [
                "Health In Her HUE Inc"
            ],
            "summary": "Health tech startup connects Black women and women of color with culturally sensitive and responsive healthcare providers and content.",
            "banner_image": "https://mma.prnewswire.com/media/2312698/Health_In_Her_HUE_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                }
            ],
            "overall_sentiment_score": 0.399515,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MS",
                    "relevance_score": "0.056011",
                    "ticker_sentiment_score": "0.137916",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.111747",
                    "ticker_sentiment_score": "0.152291",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson to Acquire Cancer-Treatment Developer Ambrx for $2 Billion",
            "url": "https://www.wsj.com/health/pharma/johnson-johnson-to-acquire-cancer-treatment-developer-amrbx-for-2b-f7fbafea",
            "time_published": "20240108T130800",
            "authors": [
                "Ben Glickman"
            ],
            "summary": "Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal.",
            "banner_image": "https://images.wsj.net/im-894720?width=700&height=466",
            "source": "Wall Street Journal",
            "category_within_source": "Business",
            "source_domain": "www.wsj.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.337143,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.716023",
                    "ticker_sentiment_score": "0.562146",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Ambrx Announces Sale to Johnson & Johnson",
            "url": "https://www.globenewswire.com/news-release/2024/01/08/2805344/0/en/Ambrx-Announces-Sale-to-Johnson-Johnson.html",
            "time_published": "20240108T123500",
            "authors": [
                "Ambrx Biopharma Inc."
            ],
            "summary": "SAN DIEGO, Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- Ambrx Biopharma, Inc., or Ambrx ( NASDAQ: AMAM ) , today announced that it has entered into a definitive agreement pursuant to which Johnson & Johnson will acquire all of the outstanding shares of Ambrx for $28.00 per share in cash, representing an ...",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/41627844-babb-430c-80e2-7278f3ce733d",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.171581,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.071005",
                    "ticker_sentiment_score": "0.079387",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.187827",
                    "ticker_sentiment_score": "0.16424",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Ambrx Announces Sale to Johnson & Johnson - Ambrx Biopharma  ( NASDAQ:AMAM ) ",
            "url": "https://www.benzinga.com/pressreleases/24/01/g36531191/ambrx-announces-sale-to-johnson-johnson",
            "time_published": "20240108T123500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "SAN DIEGO, Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- Ambrx Biopharma, Inc., or Ambrx AMAM, today announced that it has entered into a definitive agreement pursuant to which Johnson & Johnson will acquire all of the outstanding shares of Ambrx for $28.00 per share in cash, representing an approximately ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "Mergers",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.77141"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.166834,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AMAM",
                    "relevance_score": "0.092837",
                    "ticker_sentiment_score": "0.079204",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.184422",
                    "ticker_sentiment_score": "0.159037",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Human Microbiome Therapeutics Market size to grow by USD 732.95 million from 2022 to 2027, North America to ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/human-microbiome-therapeutics-market-size-to-grow-by-usd-732-95-million-from-2022-to-2027--north-america-to-account-for-41-of-market-growth---technavio-302027860.html",
            "time_published": "20240108T091500",
            "authors": [],
            "summary": "Human Microbiome Therapeutics Market size to grow by USD 732.95 million from 2022 to 2027, North America to ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.243034,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MCRB",
                    "relevance_score": "0.050679",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EVLO",
                    "relevance_score": "0.050679",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PRTC",
                    "relevance_score": "0.050679",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.050679",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EVGN",
                    "relevance_score": "0.050679",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYBX",
                    "relevance_score": "0.050679",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FNCH",
                    "relevance_score": "0.050679",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TAK",
                    "relevance_score": "0.050679",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Dogs Of The Dow 2024: 10 Blue-Chip Dividend Payers",
            "url": "https://www.forbes.com/sites/brettowens/2024/01/07/dogs-of-the-dow-2024-10-blue-chip-dividend-payers/",
            "time_published": "20240107T121500",
            "authors": [
                "Brett Owens"
            ],
            "summary": "The 2024 Dogs of the Dow are particularly homely hounds-which means we're talking big dividends. This year's Dogs yield more than three-times the broader market's paltry payout. So, should we hold our noses and buy? Let's grab some peanut butter treats and investigate.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/5e0e14c60bf81b00072e5836/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.882182"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.917436"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.195231,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CSCO",
                    "relevance_score": "0.077156",
                    "ticker_sentiment_score": "0.156862",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CVX",
                    "relevance_score": "0.115509",
                    "ticker_sentiment_score": "0.073793",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.077156",
                    "ticker_sentiment_score": "-0.095558",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.096361",
                    "ticker_sentiment_score": "0.106898",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IBM",
                    "relevance_score": "0.096361",
                    "ticker_sentiment_score": "0.003278",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.115509",
                    "ticker_sentiment_score": "0.087575",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WBA",
                    "relevance_score": "0.057907",
                    "ticker_sentiment_score": "0.155125",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.038623",
                    "ticker_sentiment_score": "0.1006",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPLK",
                    "relevance_score": "0.038623",
                    "ticker_sentiment_score": "0.25476",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.038623",
                    "ticker_sentiment_score": "0.068065",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.096361",
                    "ticker_sentiment_score": "0.107227",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DOW",
                    "relevance_score": "0.038623",
                    "ticker_sentiment_score": "0.106423",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "5 Top Investing Resolutions for 2024",
            "url": "https://www.fool.com/investing/2024/01/07/5-top-investing-resolutions-for-2024/",
            "time_published": "20240107T100000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "You don't need a fortune to start investing today.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F760281%2Fgettyimages-2024-new-year-resolutions.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999499"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Blockchain",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.30664,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KO",
                    "relevance_score": "0.09186",
                    "ticker_sentiment_score": "0.096983",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.09186",
                    "ticker_sentiment_score": "0.064008",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.09186",
                    "ticker_sentiment_score": "0.096983",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Advanced Wound Care Market size to grow by USD 4.02 billion from 2022 to 2027, North America to account for 41 ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/advanced-wound-care-market-size-to-grow-by-usd-4-02-billion-from-2022-to-2027--north-america-to-account-for-41-of-market-growth--technavio-302026301.html",
            "time_published": "20240105T190000",
            "authors": [],
            "summary": "Advanced Wound Care Market size to grow by USD 4.02 billion from 2022 to 2027, North America to account for 41 ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.23657,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ETTYF",
                    "relevance_score": "0.065327",
                    "ticker_sentiment_score": "0.068069",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.065327",
                    "ticker_sentiment_score": "0.068069",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAH",
                    "relevance_score": "0.065327",
                    "ticker_sentiment_score": "0.068069",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MMM",
                    "relevance_score": "0.130217",
                    "ticker_sentiment_score": "0.051279",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLPBY",
                    "relevance_score": "0.065327",
                    "ticker_sentiment_score": "0.068069",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ORGO",
                    "relevance_score": "0.065327",
                    "ticker_sentiment_score": "0.068069",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNVVF",
                    "relevance_score": "0.065327",
                    "ticker_sentiment_score": "0.068069",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANIK",
                    "relevance_score": "0.065327",
                    "ticker_sentiment_score": "0.068069",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.065327",
                    "ticker_sentiment_score": "0.068069",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.065327",
                    "ticker_sentiment_score": "0.068069",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IART",
                    "relevance_score": "0.065327",
                    "ticker_sentiment_score": "0.068069",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.065327",
                    "ticker_sentiment_score": "0.068069",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VCEL",
                    "relevance_score": "0.065327",
                    "ticker_sentiment_score": "0.068069",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Illumina's MRD Technology For Cancer Testing Collaborates With Johnson & Johnson Unit - Illumina  ( NASDAQ:ILMN ) , Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/markets/equities/24/01/36513008/illuminas-mrd-technology-for-cancer-testing-collaborates-with-johnson-johnson-unit",
            "time_published": "20240105T170110",
            "authors": [
                "Nabaparna Bhattacharya"
            ],
            "summary": "Illumina, Inc. ILMN announced it has signed an agreement with Janssen Research & Development, a unit of Johnson & Johnson JNJ.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/05/ilmn_co.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.29039,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ILMN",
                    "relevance_score": "0.739411",
                    "ticker_sentiment_score": "0.299567",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.29234",
                    "ticker_sentiment_score": "0.324453",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        }
    ]
}